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THE PARADOX OF PREGNANCY 
A fetus has a genetic makeup equally derived from both the father and the 
mother, comprised of both paternal and maternal genes. During pregnancy, the 
maternal immune system is functionally intact, capable of fighting infection and 
protecting from foreign pathogens. The fetus, however, escapes immune rejection 
from the maternal immune system and is tolerated for the duration of pregnancy. 
Historically, the fetus has been termed a successful “semi-allograft,” even a 
tumor or parasite. This phenomenon by which the fetus is tolerated by the 
maternal immune system, known as the paradox of pregnancy, was first 
described in 1953 by Sir Medawar (1). The mechanism by which this paradox 
occurs is the central question in reproductive immunology and has been the focus 
of extensive research for the last fifty years. The field of reproductive 
immunology has progressed to gain a better understanding of not only infertility 
and obstetrics, but also transplantation and immunology. The solution to the 
paradox of pregnancy has many implications in the management and treatment 





The endometrium is the mucosal lining of the uterus. Composed of glandular, 
stromal and immune cells and blood vessels, the endometrium essentially 
undergoes cyclical changes in order to support a potential pregnancy. After 
ovulation during the secretory phase of the menstrual cycle, this tissue begins to 
transform into the decidua under the influence of progesterone and estrogen in 
preparation for implantation. During this process, known as decidualization, 
stromal cells adjacent to spiral arteries enlarge accumulating glycogen and lipid 
and produce growth factors and matrix components to support implantation and 
placental growth, glandular hyperplasia occurs, and leukocytes infiltrate (2). 
 
Implantation is the process by which an embryo attaches to the uterine wall and 
by which the placenta is established. The process depends on a delicate series of 
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events. Upon fertilization, the dividing fertilized egg or ovum travels down the 
fallopian tube to implant on the decidualized endometrium around day 6 or 7 
post-fertilization.  At the blastocyst stage of the development, the fertilized ovum 
consists of an inner cell mass, destined to become the embryo, and an outer cell 
mass formed by placental cells, known as trophoblasts, destined to become the 
placenta (Figure 1) (3). Trophoblasts differentiate into several lineages, such as 
cytotrophoblasts, synctiotrophoblasts and extravillous trophoblasts, which are 










Human placentation is described as hemochorial. Maternal blood bathes the 
outer surface of the fetal villi, within which contain fetal capillaries carrying fetal 
blood (6). Essentially, in the hemochorial arrangement, the maternal and fetal 
circulations are separated by a placental barrier, made up of a continuous layer 
of trophoblasts covering the villi (Figure 2). Throughout pregnancy, the two 
circulatory systems remain entirely separate, while the placental barrier 
undergoes quantitative changes. 
 
As the blastocyst attaches and penetrates into the decidua and uterine 
capillaries, two layers of trophoblasts differentiate from the outer cell mass. The 
penetrating outer layer is comprised of multinucleated synctiotrophoblasts that 
form a synctium, while mononuclear cytotrophoblasts develop from the inner 
trophoblast layer. Pools of maternal blood, known as lacunae, surround and 
develop within the trophoblastic fetal synctium. As the lacunae fuse, 
uteroplacental circulation is created. Fetal villi and the intervillous space are 
derived from the penetrating trophoblasts and developing lacunae (3, 7). 
 
 
                                                                               CHAPTER 1 
Blastocyst cavity 
Inner cell mass: develops into fetus 
Outer cell mass: develops into placenta 
Figure 1. The blastocyst stage of development      
(Adapted from ref. 5). 
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THE PLACENTA AND FETAL MEMBRANES 
The human placenta serves many functions throughout pregnancy, including the 
transport of fetal nutrients and metabolic products such as oxygen and carbon 
dioxide as well as the release of numerous hormones and enzymes into the 
maternal bloodstream. Importantly, the human placenta and membranes are the 
site of direct contact between the maternal and fetal tissue, thus establishing the 
maternal-fetal interface. The placenta and membranes are composed of three 
basic structures or layers, seen in cross-section in Figure 3. The amnion and 
chorion are of fetal origin, while the decidua is of maternal origin. Within these 
layers, there are several cell types present (7). Notably, maternal decidua and 
maternal blood are in contact with extraembryonic cells and not with embryonic 
cells or fetal blood. 
INTRODUCTION 
Figure 2. Schematic cross-section through the hemochorial placenta: 1. The relation 
of the villous chorion to the decidua basalis and the fetal-placental circulation. 2. The 
maternal blood flows into the intervillous spaces in funnel-shaped spurts, and 
exchanges occur with the fetal blood as the maternal blood flows around the villi. 3. 
The inflowing arterial blood pushes blood into the endometrial veins, which are 
scattered over the entire surface of the decidua basalis (Adapted from ref. 5). 
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Decidua 
The decidua, the maternal tissue layer of the placenta and fetal membranes, is 
derived from the endometrium. It was first described by William Hunter, a 
British gynecologist from the 19th century (8). The tissue was considered 
analogous to the leaves of a deciduous tree since the tissue is shed from the 
uterus after delivery just as the leaves on a tree are shed. 
 
The decidua can be divided into three types defined by the anatomic location: 
decidua basalis, decidua parietalis and decidua capsularis. The decidua basalis is 
the site of implantation and the location of the developing placenta. The first site 
of direct contact between maternal and fetal tissue is between the decidua basalis 
and invading chorionic trophoblasts. The decidua capsularis covers the 
developing embryo, and the decidua parietalis lines the remainder of the uterine 
cavity (5). By the end of the first trimester as the fetus develops, the space 
between the decidua capsularis and decidua parietalis is obliterated and the two 
layers fuse, forming the second site of contact between the maternal and fetal 
tissue. Thus, by the second trimester, there are two distinct regions of the 
maternal-fetal interface where maternal decidua comes into direct contact with 
fetal extraembryonic tissue (Figure 4) (5). The focus of most immunologic studies 
has centered primarily on the decidua basalis, where immune interaction is 
expected to take place. Remarkably, the decidua parietalis has not been as well 














































Figure 4. The decidua basalis and decidua parietalis in relation to other uterine 
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Amnion 
The amnion is a translucent membranous tissue adjacent to the amniotic fluid, 
which provides necessary nutrients to the amnion cells. It is composed of an 
epithelial cell layer, a mesenchymal cell layer and an outer intermediate layer  
adjacent to the chorion that can swell to facilitate sliding of the amnion across 
the chorion (9, 10). 
 
Chorion 
The chorion, a more opaque layer, is adjacent to the decidua. The chorion is 
composed of two layers, an outer reticular adjacent to the amnion that is 
structurally similar to the amniotic mesenchymal layer and predominately made 
up of fibroblasts and macrophages, and more importantly, an inner epithelial 
cellular layer composed of trophoblast cells. The primary cells of the chorion are 
trophoblast cells (9, 10). 
 
In the fetal membranes, a remnant space of the early gestational sac separates 
the amnion and chorion prior to approximately 12 weeks gestation after which 
they adhere to one another. In the fetal membranes, the chorion or chorion laeve 
is thin (Figure 5), whereas in the placenta, the chorion forms a thick 
parenchymal layer (Figure 6). Fetal membranes contain many cell types, but are 
avascular and without nerve cells. Notably, the amnion and chorion laeve of the 
fetal membranes form the paracrine arm of maternal-fetal communication by 
transporting a wide variety of hormones, enzymes, and essential molecules 





An immune response involves recognition and elimination of a pathogen or 
foreign material. It is divided into two categories, the innate or non-adaptive 
immune response and the acquired or adaptive immune response. Essentially, 
the innate response is non-specific forming the first line of defense against 
infection; the acquired response is highly specific for a particular pathogen 
improving with successive encounters via memory. Importantly, the immune 
response is primarily produced by leukocytes (11). There are  various 
                                                                               CHAPTER 1 
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Figure 6. Cross-section of the placenta (provided by Margriet de Jong). 
Figure 5. Cross-section of the fetal membranes (provided by Margriet de Jong). 
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subpopulations of leukocytes, including natural killer cells, macrophages, 
dendritic cells, T lymphocytes and B lymphocytes. 
  
Immune Recognition 
The Major Histocompatibility Complex (MHC) encodes genes that are responsible 
for the antigens involved in immune recognition in the human immune system 
known as Human Leukocyte Antigens (HLA). These highly polymorphic genes, 
located on chromosome 6, are organized into regions including Class I and Class 
II HLA molecules (12).  Class I molecules are expressed on nearly all nucleated 
cells and platelets, while Class II molecules are expressed mainly on antigen 
presenting cells, including dendritic cells and macrophages, and also on activated 
T cells. Class I molecules are encoded by three distinct loci, known as HLA-A, 
HLA-B and HLA-C. Class II molecules are encoded by three different loci, known 
as HLA-DR, HLA-DQ and HLA-DP. Class I and Class II molecules are involved 
in the presentation of foreign material to the cells of the immune system by 
different pathways. Generally, endogenous peptides are synthesized from self 
proteins or viral antigens and presented by MHC Class I molecules (13), while 
exogenous peptides are processed from extracellular proteins and bound to MHC 
Class II molecules (14, 15). The recognition of MHC alloantigens by T cells occurs 
via two distinct pathways, a direct and indirect pathway (16). In the direct 
pathway, T cells recognize alloantigens as intact molecules on allogeneic 
stimulator cells. In the indirect pathway, T cells recognize alloantigens presented 
by self MHC molecules. Peptides presented by Class I molecules are mainly 
recognized by antigen specific T cells of the CD8 phenotype (17), while peptides 
presented by Class II molecules are recognized by T cells of the CD4 phenotype 
(18). Incompatibility for these highly polymorphic genes between donor and 
recipient is the basis of graft rejection (19). Interestingly, HLA molecules were 
first recognized over fifty years ago by Dausset, Payne and van Rood who 
demonstrated their presence with agglutinating antibodies in the sera of 
multiparous women and of patients following multiple blood transfusions (20-22).  
 
Cells of the Immune System 
Cells of the immune system are derived from primitive hematopoietic stem cells. 
The development and differentiation of these cells is dependent on the micro-
environment and on cell interactions. Each cell type expresses characteristic cell 
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surface molecules that allow for identification. 
 
Natural Killer (NK) cells and phagocytes, including monocytes, macrophages and 
polymorphonuclear granulocytes, are the primary cells of the innate immune 
system. NK cells are able to produce immunoregulatory cytokines and to 
recognize and kill target cells with low or aberrant expression of HLA Class I 
molecules via killer-cell immunoglobulin-like receptors (KIR) (23, 24). KIR are 
receptors for specific HLA class I molecules and are expressed by both NK and T 
cells. The KIR locus consists of multiple genes, which form numerous haplotypes 
that differ in both gene content and allele combination. KIR haplotypes are 
classified into two groups defined by the relative content of genes encoding 
inhibitory and activating KIR (25). Upon binding, KIR either activate NK cell 
responses or abort activating signals and inhibit NK cell functions. Cells lacking 
Class I molecules are promptly killed by NK cells resulting from the predominant 
effect of activating NK receptors (24, 26). Phenotypically characterized by the 
expression of CD56 and the lack of expression of CD3, NK cells are divided into 
two distinct subsets defined as CD56dimCD16+CD3− and CD56brightCD16−CD3−. 
Ninety percent of NK cells in normal circulating peripheral blood have the 
classical phenotype of CD56dimCD16+CD3−, and the remaining 10% are 
CD56brightCD16−CD3− (27). 
 
Macrophages are a diverse group of resident and recruited antigen presenting 
cells of both the innate and acquired immune system. Widely distributed 
throughout the body, these cells are involved in tissue homeostasis and host 
defense. These cells can produce a variety of molecules including growth factors, 
chemokines, pro-and anti-inflammatory cytokines, proteolytic enzymes and 
adhesion molecules (28). They also express HLA Class II and co-stimulatory 
molecules allowing for antigen presentation and immune activation. 
Macrophages can be activated via the classical or alternative pathway. In the 
classical pathway, cytokines such interferon (IFN)-γ enhance inflammation and 
anti-microbial activity, while cytokines such interleukin (IL)-4 and IL-13 induce 
alternative activation and enhance clearance, antigen presentation to B cells and 
repair allergic and parasitic immune reactions (29). 
 
The adaptive immune system is comprised of antigen presenting cells and 
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lymphocytes. Dendritic cells (DCs) are an essential population of potent antigen 
presenting cells and capable of activating naïve T cells and modulating B and NK 
cells (30, 31). Distributed to almost all tissues, DCs are particularly prominent at 
mucosal surfaces. DCs are defined by the high expression of HLA-DR in the 
absence of expression of lineage specific markers for NK cells, macrophages, B 
cells and T cells and further identified based on maturation or lineage. During 
the maturation process, DCs upregulate the expression of different co-
stimulatory molecules, such as CD40, CD58, CD80 and CD86 as well as CD83 
and MHC molecules, most of which are involved in the subsequent interaction 
between DCs and T cells. Presentation of antigens by immature DCs to T cells 
induces antigen-specific T cell tolerance, whereas antigen capture and 
presentation by DCs after maturation results in activation of naïve, memory and 
cytotoxic T cells and B cells (32, 33). 
 
T cells are an essential part of adaptive immunity.  There are several different 
types of T cells with a variety of functions.  T helper 1 (TH1) cells interact with 
phagocytes and help them destroy intracellular pathogens. TH2 cells interact 
with B cells and help them differentiate and produce antibody. Cytotoxic T cells 
directly destroy infected cells. Importantly, T cells recognize antigen, but only 
when presented on the cell surface of other cells by MHC molecules. T cells exert 
their effect by either cytokine production and release or direct cell-cell 
interaction. In fact, T helper cells can be further subdivided according to the 
cytokines that they produce. TH1 type cytokines lead to the induction of cells such 
as cytotoxic T cells and macrophages and include IFN-γ, tumor necrosis factor 
(TNF)-α, IL-1, IL-2, IL-12 and IL-15 while TH2 type cytokines mediate allergic 
and antibody responses and include IL-4, IL-5, IL-6, IL-10 and granulocyte-
macrophage colony stimulating factor (GM-CSF) (34-36). Regulatory T cells 
represent another important population of T cells.  These naturally occuring cells 
are able to control immune responsiveness to self- and allo-antigens and are 
essential for the active suppression of autoimmunity and for transplantation 
tolerance (37, 38). Recent studies have demonstrated that CD4+CD25+ regulatory 
T cells express CD25 at higher levels and more persistently than activated T cells 
(39, 40). These CD4+CD25bright regulatory T cells are capable of inhibiting 
proliferation and cytokine secretion induced by T-cell receptor cross-linking of 
CD4+CD25- responder T cells in a contact-dependent manner (40). Essentially, 
                                                                               CHAPTER 1 
· 21 
regulatory T cells inhibit inappropriate activation of cell- and antibody-mediated 
immune responses as well as innate immune responses (37, 41). 
 
 
IMMUNOLOGY OF THE MATERNAL-FETAL INTERFACE 
FETAL CELLS 
Trophoblasts 
Trophoblasts are specialized fetal cells that serve an essential role in 
implantation and formation of the maternal-fetal interface. These cells are 
derived from trophoectodermal cells of the outer cell mass of the blastocyst and 
are extraembryonic. Both the placenta and fetal membranes contain 
trophoblasts. Through differentiation, several types of trophoblasts are derived 
including cytotrophoblasts and synctiotrophoblasts (Figure 7). The 
cytotrophoblast is a small germative cell from which other trophoblast lineages 
derive, including the villous and extravillous cytotrophoblast and 
synctiotrophoblast. The synctiotrophoblast is a terminally differentiated, 
multinucleated cell with abundant cytoplasm. Essentially, trophoblast 
differentiation is divided into two pathways, villous and extravillous pathways, 
depending on location and function. The process of differentiation is controlled by 
fetal as well as maternal factors of the placental bed (42, 43).  
 
In the hemochorial placenta of humans, a lacunar network of pooled maternal 
blood from uterine spiral arteries surrounding fetal villi (as seen in Figure 2). 
There are two types of fetal villi: floating and anchoring villi.  In essence, the 
floating villi float in the pool of maternal blood, and the anchoring villi anchor 
into the maternal decidua. Both types of villi have the basic same structure with 
an outer layer of synctiotrophoblast and an inner layer of cytotrophoblasts.  In 
anchoring villi, however, there are two types of cytotrophoblasts, villous and 
extravillous cytotrophoblasts. Unlike villous cytotrophoblasts, extravillous 
cytotrophoblasts are capable of detaching from the proliferating cytotrophoblast 
cell column, invading into the decidua, migrating toward spiral arteries and 
differentiating further to become interstitial or endovascular trophoblasts 
depending on location (4). Via differentiation, trophoblasts can acquire properties 
of leukocytes or endothelial cells that enable many of their specialized functions 
(44). For example, endovascular trophoblasts invade uterine spiral arteries, 
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acquire a vascular adhesion phenotype, and replace the maternal endothelium to 
accommodate for the increased blood flow, allowing these cells to line maternal 
vessels (45-47). Trophoblast migration into decidua is dependent on adhesion 
molecule expression and the binding to extracellular matrix proteins (48). 
Invasion of cytotrophoblasts is also associated with an increase in production of 
proteinases, specifically matrix metalloproteinase-9, thus improving invasion 
(49). Essentially, villous trophoblasts interact with maternal blood and function 
to transport oxygen and nutrients to the fetus. Extravillous trophoblasts interact 
with maternal uterine tissue and function to establish placental blood supply. 
 
All fetal trophoblasts lack Class I HLA-A and HLA-B as well as Class II 
molecules. Only the population of extravillous trophoblasts selectively expresses 
the classical Class Ia HLA-C and non-classical Class Ib molecules HLA-E and 
HLA-G (50-54). Through this unique HLA expression, extravillous trophoblasts 
are capable of interacting with receptors, such as CD94/NKG2A, KIRs and those 
of the immunoglubin-like transcript (ILT) family expressed by uterine NK cells, T 
cell subsets and macrophages leading to activation or inhibition (55-60). The 
ligand-receptor pairs provide an interface between maternal immune cells and 
fetal trophoblasts and are possible candidates for controlling their interaction 
and protecting trophoblasts from attack by maternal cells (61). HLA-G is the 

















Figure 7. Trophoblast differentiation. 
· 23 
ligand for inhibitory receptors of members of the ILT family, ILT2 and ILT4, and 
also inhibitory KIR2DL4 (62-65). Additionally, HLA-G has also been shown to 
recognize the CD8 molecule in humans (66). HLA-E binds CD94/NKG2A/C (54), 
and HLA-C binds KIRs (67). 
 
While HLA-C and HLA-E have ubiquitous expression, HLA-G has limited 
expression, including the placenta and membranes, the thymus and eye, and on 
various types of tumor and stromal cells during inflammation and malignancy 
(68-70). HLA-G has several important features. Via alternative splicing, multiple 
isoforms of the HLA-G gene can be generated, including four membrane-bound 
isoforms and three soluble isoforms (71, 72). Unlike classical HLA, HLA-G has 
few alleles and exhibits limited polymorphism across widely different ethnic 
origins (73, 74). Like classical HLA, HLA-G can bind and present peptides to CD8 
specific T cells (75, 76). Interestingly, HLA-G also is a regulator of HLA-E 
expression (77). HLA-G has been shown to inhibit allogeneic proliferation of T 
cells (78), NK cell cytotoxicty (79) and antigen specific T cell cytotoxicity (80). 
Specifically, HLA-G has been detected in first trimester and term tissue, 
extravillous and villous cytotrophoblasts, including in the chorionic membrane 
(81, 82), in term amnion cells (83), in amniotic fluid (84) and on endothelieal cells 
of fetal vessels rather than maternal spiral arteries. There are generally fewer 
studies on MHC expression in the fetal membranes. HLA-E and HLA-G can be 
detected on the amniochorion (81, 83), while HLA-C has not been detected (85). 
Throughout pregnancy, trophoblast expression of HLA-G is differential and 
decreases as gestation progresses (51). 
 
Trophoblasts also produce or express immunologically relevant molecules such as 
IL-10 (86, 87), GM-CSF (88) and Fas Ligand (89, 90), and therefore may play an 




The decidua is populated by a variety of cell types, including leukocytes, stromal 
cells and mesenchymal stem cells. With regard to leukocytes, there are several 
subpopulations present. In non-pregnant and pregnant decidualized 
endometrium, the three primary leukocyte subpopulations are uterine NK cells, 
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macrophages and T cells (91-97). B cells are virtually absent. Small unique 
subpopulations include natural killer T (NKT) cells, T-cell receptor (TCR) γδ cells 
and DCs (98-100). 
 
Natural Killer Cells 
In contrast to peripheral blood, CD56brightCD16−CD3− cells represent the major 
subset of NK cells in the uterus and are termed large granular lymphocytes or 
uterine NK cells (93, 94, 96, 101-104). Representing a unique population of cells 
in the nonpregnant and pregnant endometrium, these CD56brightCD16− cells have 
prominent cytoplasmic granules (105, 106), are minimally cytotoxic yet highly 
proliferative (102, 107) and express a wide variety of NK and cytokine receptors 
and adhesion molecules (108). The CD56brightCD16− uterine NK cells also produce 
a variety of cytokines, such as GM-CSF, IFN-γ, TNF-α, IL-2, 1L-10 and leukemia 
inhibitory factor (109-113). The proportion of NK cells changes throughout the 
menstrual cycle and pregnancy. Interestingly, NK cells populate the 
endometrium prior to pregnancy, implying that the fetus does not play a direct 
role in their distribution (93, 94, 96, 101, 103). Trafficking, homing, or in situ 
proliferation have been implicated as possible mechanisms in the variation of 
uterine NK cells in the endometrium and decidua (114). Although the specific 
role of uterine NK cells is still unknown, it is suggested that they regulate 
placental development by mediating maternal mucosal and arterial function and 
fetal extraembryonic trophoblast invasion (115). 
 
Macrophages 
Widely distributed throughout the body, macrophages constitute 20-30% of the 
leukocytes in the decidua and are a stable population of cells in this tissue (95, 
116). It is suggested that during pregnancy, these cells may play a role not only 
in host protection to infections, but also in implantation, placental growth, 
vascular transformation and maternal-fetal immune tolerance (117-119). 
Decidual macrophages express HLA-DR and also low levels of the co-stimulatory 
molecules CD80 and CD86, implying that they may induce tolerance of maternal 
T cells by failing to give a sufficient co-stimulatory signal (120). Decidual 
macrophages produce spontaneously high levels of IL-10, a immunoregulatory 
cytokine known to inhibit the expression of HLA-DR and co-stimulatory 
molecules on antigen presenting cells (121) and to modulate DCs and T cells 
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(122), thus possibly reducing potential T-cell activation against fetal antigens. 
Unlike inflammatory macrophages, macrophages populating the decidua produce 
lower levels of proinflammatory IL-1b possibly resulting in less inflammation in 
the setting of intrauterine infection (120). By establishing an adequate 
microenvironment via cytokine production, macrophages promote cell growth and 
inhibit harmful inflammatory immune reactions. 
 
T Cells 
In general, cells of the innate immune system seem to dominate the decidua 
during pregnancy (123); however, T cells represent an important population in 
this tissue that are less well studied in comparison to uterine NK cells. The 
decidual T cell population changes throughout the menstrual cycle and 
pregnancy, progressively declining in early pregnancy and then rising to become 
the most abundant leukocyte population in term pregnancy (124, 125). 
Furthermore, it is also shown that T cells in term pregnancy decidua basalis 
express cell surface markers indicating activation, such as CD25, CD69 and 
HLA-DR (125). The reappearance of T cells during term pregnancy and their 
expression of activation markers could imply that these cells play a more 
important role in the maintenance of pregnancy. Recently, tryptophan 
catabolizing enzyme, indoleamine 2,3-dioxygenase (IDO) was shown to block the 
maternal T cell activation against the murine fetus (126-128). Human placental 
and decidual cells have been shown to express IDO (129-130), further influencing 
immunoregulation at the maternal-fetal interface 
 
Regulatory T Cells 
Regulatory T cells represent another important population of T cells.  These 
naturally occuring cells are able to control immune responsiveness to self- and 
alloantigens and are essential for the active suppression of autoimmunity and for 
transplantation tolerance (37, 38). CD4+CD25bright regulatory T cells recently 
have been implicated as important cells at the maternal-fetal interface.  
Recently, in a mouse model, it has been shown that the absence of CD4+CD25+ 
regulatory T cells led to a failure of gestation due to immunological rejection of 
the fetus, suggesting that these cells may mediate maternal tolerance to the fetus 
(131). Decidual and peripheral blood CD4+CD25high T cells are present during 
early pregnancy, representing approximately 22% of CD4+ cells in early 
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pregnancy decidua and 9% in peripheral blood (132). The proportion of regulatory 
T cells in the decidua of normal term pregnancy has yet to be fully studied. With 
regards to complicated pregnancy, it has been suggested that the function of 
these cells may be impaired in pathological conditions such as recurrent 
spontaneous abortion, preterm labor and preeclampsia (133). Although the 
factors regulating these cells is unknown, regulatory T cells appear to be crucial 
in the maintenance of tolerance in pregnancy. 
 
TCRγδ Cells 
TCRγδ cells are an essential part of the innate immune system recognizing 
antigen upon cell infection, stress or transformation. T cells are divided into two 
lineages defined by their expression of TCR: TCRαβ and TCRγδ cells. 
Approximately, 90 to 95% of circulating T cells use TCR α and β chains, while 5–
10% use TCR γ and δ chains. While the TCRαβ cells are a part of the adaptive 
immune system, TCRγδ cells are part of the innate immune system and  are 
generated in the thymus and in an extrathymic compartment (134). In adult 
animals and humans TCRγδ cells can be further divided into two groups: 
circulating cells and resident cells of the mucosal surfaces, such as in the 
digestive, respiratory and urogenital tracts. Unlike TCRαβ cells, TCRγδ cells are 
not MHC restricted, allowing them to recognize antigens in a fundamentally 
different way than that of αβT cells, more similar to antibodies, able to directly 
recognize molecules without antigen processing and presentation (135).  
 
TCRγδ cells can interact and modulate the activity of other immune cells directly 
or by cytokine production and thus function as regulatory cells (135). TCRγδ cells 
are present in non-pregnant and pregnant decidualized human endometrium (99, 
136, 137). Hormonally controlled, decidual TCRγδ cells are large granular 
lymphocytes with cytoplasmic granules, expressing CD2, CD69, NK receptors 
CD94 and NKG2D and CTLA 4, a marker associated with regulatory T cells and 
lacking expression of both CD4 and CD8 (138, 139). Interestingly, it is suggested 
that extrathymic T-cell maturation occurs in the decidua of early pregnancy and 
that CD56+CD16- decidual NK cells are immature progenitors for T cells (140). 
Similar to resident TCRγδ cells at other mucosal sites, decidual TCRγδ cells are 
activated but resting, possessing a cytotoxic potency and capable of expressing 
and storing cytolytic molecules such as granzyme Fas ligand (FasL), which 
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rapidly available upon stimulation (140). 
 
Natural Killer T Cells 
Natural Killer T cells represent a conserved T cell sublineage and appear to play 
an important immunoregulatory role in the immune system (141). Functionally 
different from conventional T cells, NKT cells possess an invariant TCRα chain 
associated with a heterogenous TCRβ chain (142). While an endogenous 
activating ligand is unknown, a synthetic glycolipid is capable of activating NKT 
cells when presented by the class I-like molecule, CD1d (143-145). Activated NKT 
cells rapidly produce a variety of cytokines including IL-4, TNF, IFN and GM-
CSF (146, 147) and are capable of interacting with DCs, NK cells, T and B cells 
(141). Interestingly, NKT cells are associated with the onset of diabetes in 
humans, tumor clearance, allograft survival and as mediators of anterior 
chamber acquired immune deviation (ACAID) in which specific tolerance is 
generated to antigens introduced into the anterior chamber of the eye (98). 
 
NKT cells comprise 0.48% of the CD3+ T cells population in first trimester 
decidua (98). While comprising a small leukocyte population in the decidua, they 
are present at a frequency ten times greater than that in peripheral blood. These 
cells also exhibit a marked TH1-like cytokine bias with IFN-γ but also can produce 
IL-4 and GM-CSF (98, 148). Fetal trophoblasts express CD1d, suggesting that 
decidual NKT cell interactions with CD1d-expressing trophoblasts play a specific 
role at the maternal-fetal interface, possibly in the acceptance of the fetal 
allograft and/or in placental development (98). 
 
Dendritic cells 
Dendritic cells present in decidua may play a pivotal role in sampling, processing 
and presenting fetally derived trophoblast antigens to the maternal immune 
system (100). These cells comprise approximately 1.7% of CD45+ cells in the 
isolates of first trimester decidual tissue and have the phenotype of myeloid 
immature DCs (100). First trimester decidua also contains DCs with 
morphological and functional features of typical mature DCs including co-
stimulatory molecule expression of CD40, CD45, CD83 and HLA-DR (149). Cells 
with dendritic processes are found scattered through both the decidua basalis and 
decidua parietalis as well as in endothelial-lined spaces (100). It is suggested that 
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a bi-directional cross-talk between decidual CD56bright uterine NK cells and 
decidual CD83+ DCs results in activation and proliferation of autologous NK cells 
(150, 151). Furthermore, it is suggested that immature DCs in the decidua have 
the potential to capture fetal antigens from extravillous trophoblasts and present 
to local maternal T cells, thus inducing tolerance to those antigen peptides (118). 
 
Changes in cells during the menstrual cycle and pregnancy 
The cellular composition changes throughout the menstrual cycle and pregnancy. 
Changes in CD56brightCD16− NK cells occur throughout the menstrual cycle and 
pregnancy. In the late secretory phase of the menstrual cycle, these cells become 
a prominent population of endometrial leukocytes in preparation for a possible 
conception (94, 96, 101, 103). When pregnancy occurs, CD56brightCD16− NK cells 
account for up to 70% of the leukocytes at the decidua basalis (93, 152). The 
characteristic accumulation and predominance of these cells at the maternal-fetal 
interface at the beginning of the first trimester implies a putative role in the 
control of implantation and placentation. It is often stated that as pregnancy 
progresses, the number of uterine NK cells in the decidua basalis gradually 
declines or becomes virtually absent by term pregnancy (114, 153). Histologic 
studies in mice also indicate that the high proportion of uterine NK cells is 
limited only to early pregnancy (154, 155). 
 
T cells, on the other hand, show a reciprocal distribution during the menstrual 
cycle and pregnancy. In the early proliferative phase of the menstrual cycle, T 
cells are an abundant leukocyte population accounting for approximately 4560% 
of the leukocytes in the endometrium (96, 124). As the endometrium prepares for 
the possible reception of a fertilized ovum during the secretory phase, the 
percentage of T cells progressively decreases. An additional decline characterizes 
the first trimester transformation of endometrium into decidua, in which the 
total T-cell population represents only 6-30% of the decidual leukocytes (93, 95, 
96, 116, 124). However, by term pregnancy, 45-50% of the leukocytes in the 
decidua basalis are CD3+, accounting for the most abundant leukocyte population 
(116, 125). 
 
Lastly, macrophages remain a stable population of cells throughout the 
menstrual cycle and pregnancy. Macrophages account for 20-30% of the decidual 
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leukocyte population and do not fluctuate in proportion like NK and T cells (95, 
116). Studies of NKT cells and DCs cells have focused on early first trimester 
decidua; little is known about the change in these cells during the menstrual 
cycle and pregnancy. 
 
CYTOKINES 
Cytokines play a significant role in the immunological mechanisms involving 
placental growth and the maintenance of pregnancy (156). It was originally 
proposed by Wegmann that pregnancy requires a dominance of TH2 cytokines 
and that an established successful pregnancy is characterized by low levels of 
TH1 cytokines and by a shift in the cytokine pattern from TH1 to TH2 (157). This 
TH1/TH2 paradigm of reproduction suggests that pregnancy rejection is mediated 
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Figure 8. Changes in NK cells, macrophages and T cells throughout the menstrual 
cycle and pregnancy based on a review of the current literature (91-94, 100, 106, 116, 
124, 125, 152, 153). 
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cytokines (35, 158). Current research has altered this paradigm to suggest that 
the TH1/TH2 paradigm may be an oversimplification of role of cytokines in 
reproduction (159). For example, mice lacking TH2 cytokines, including IL-4, IL-5, 
IL-9, IL-10 and IL-13 undergo normal allogeneic pregnancy with unaffected litter 
size (160, 161). TH1 cytokines may in fact serve an essential role very early in 
embryonic development and then again during labor (124). Regardless of the 
precise balance of cytokines, there is a complex network of cytokines at the 
maternal-fetal interface involved in regulation of immune responsiveness. 
 
MOUSE MODEL IN REPRODUCTIVE IMMUNOLOGY 
The mouse model has proven to be essential for the characterization of human 
decidual leukocytes by allowing manipulative studies that are not possible in 
humans. Mice and humans both have hemochorial placentas in which there is 
direct contact between maternal blood and trophoblasts. Importantly, analogous 
cell types, such as trophoblasts and NK cells, as well as correlate surface markers 
and receptors have been identified. There are differences, however, in 
implantation, placental morphogenesis and endocrine function (115). In mice, the 
trophoectoderm of the blastocyst develops into an ectoplacental cone to become 
the placenta. NK cells are not present in non-pregnant murine endometrium, 
with decidualization occurring only after implantation. In pregnancy, NK cells 
are confined to the central decidua basalis and  mesometrial region of the uterine 
musculature where there is minimal trophoblast invasion (115, 155). Although 
human and mice placentas differ, common features allow for valuable studies. 
 
 
IMMUNE MECHANISMS AT THE MATERNAL-FETAL INTERFACE 
When the paradox of pregnancy first was proposed, four hypotheses were 
presented by Medawar and Billingham to explain maternal tolerance of the fetus 
(1, 162). It was suggested that the fetus lacks immunogenecity; that the maternal 
immune system is suppressed during pregnancy; that there is the elaboration of 
an immune barrier by the placenta; and that the uterus is an immunoprivileged 
site. Since 1953, many advances in the field of reproductive immunology have 
changed the opinion on and reliability of these hypotheses. With the research 
amassed throughout the last fifty years, several new mechanisms have emerged 
to explain the paradox of pregnancy and maternal tolerance toward the fetus.  
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The direct contact between fetal trophoblasts that invade the decidua and 
maternal immunocompetent cells in the decidua suggests that mechanisms of 
immunosuppression or tolerance must exist to avoid of rejection the fetus. 
According to the classic laws of transplantation immunology, foreign fetal 
antigens should be recognized and induce a response by the maternal immune 
system. It therefore would seem logical that nonrecognition of the fetus is 
advantageous. It is now proposed, however, that immune recognition of 
pregnancy is important for the maintenance of pregnancy. In fact, inadequate 
recognition may result in failed pregnancy (139). This is in contrast to the 
successful maintenance of an organ transplant. It has been noted that the 
comparison of pregnancy with tissue transplantation is inaccurate and a 
misleading framework (123, 163). Unlike pregnancy, a blood or organ allograft 
requires medical or surgical placement, acutely exposing the recipient to a 
significant amount of foreign antigen and generally will be rejected following 
antigen presentation by antigen presenting cells (123). The immunological 
relationship between the mother and the fetus is a delicate balance between fetal 
antigen presentation and recognition and response by functionally intact 
maternal immune system (139). 
 
There is evidence that fetal recognition occurs during pregnancy. Beginning at 4-
6 weeks gestation, the transfer of fetal cells into the maternal circulation occurs 
in most pregnancies and continues until delivery, leading to microchimerism 
(164). Interestingly, fetal cells in maternal circulation have been shown to persist 
27 years after pregnancy (165). Conversely, maternal cells also have been 
detected in human fetal umbilical cord blood at birth (166) and within primary 
lymphoid organs in the murine system (167). Anti-paternal antibodies are 
detectable in sera of women with successful pregnancies (168). Studies 
investigating the presence of anti-paternal antibodies and the outcome of 
subsequent pregnancies demonstrate that these antibodies are positively 
associated with a higher live birth rate, whether induced by immunization or 
previous pregnancies. Decreased anti-paternal alloantibody production is 
associated with recurrent spontaneous abortion (168). Semen also may play an 
essential role in recognition. Studies in mice indicate that factors in seminal fluid 
can initiate a maternal immune response by providing the necessary antigenic 
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and environmental signals (169). Furthermore, HLA matching between couples is 
associated with spontaneous abortion (170, 171), suggesting that the lack of 
immune recognition is deleterious to pregnancy. Maternal recognition does not 
appear to compromise pregnancy, but rather promote pregnancy. 
 
There is evidence that the maternal immune system is altered during pregnancy. 
Systemically, the innate immune system is enhanced and activated (123), while 
acquired cell-mediated immunity is diminished (172). Beginning at the first 
trimester, there is a progressive relative lymphopenia and neutrophilia (173, 
174). Specifically, there is an increase in the percentage of circulating monocytes 
and granulocytes. By the third trimester these cells express an activated 
phenotype, with cell surface marker expression similar to those during systemic 
sepsis and also display increased phagocytosis and intracellular reactive oxygen 
species (175-177). Resulting from the alteration of the maternal immune system, 
the risk of specific intracellular infections in pregnancy, such as malaria, 
pneumonia and influenza may be increased, while certain cell-mediated 
autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis 
improve (178). 
 
Immune tolerance is the mechanism by which the host is protected against self-
reactive T cells that escape the thymus. Although tolerance is normally defined in 
terms of the prevention of responses against self-antigens, there is also tolerance 
induced to foreign antigen as in the setting of transplantation. In the setting of 
pregnancy, there is recent evidence in the murine model that there is systemic 
tolerance of the fetus. It has been shown that maternal T cells acquire a transient 
state of tolerance to paternal antigens during pregnancy. Fetal antigen-specific T 
cells downregulate CD8 co-receptors during pregnancy, resulting in reversible 
functional unresponsiveness to paternal antigens (179). T cells specific for fetal 
antigens decrease in an antigen-specific manner during pregnancy and remain 
low postpartum (180). Furthermore, maternal regulatory T cells are expanded 
systemically during pregnancy in alloantigen-independent manner, suggesting 
that this population of cells is essential for the suppression of maternal immune 
aggression directed against the fetus (131). Importantly, maternal recognition of 
fetal antigens can lead to tolerance. 
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OUTLINE OF THESIS 
To gain a better understanding of the immunoregulatory mechanisms of 
pregnancy, studies of leukocytes in human decidua generally have focused on 
early first trimester decidua, the stage in which implantation and placentation 
are established. Leukocytes in human term decidua have been the focus of fewer 
studies. The third trimester, however, represents the stage in which pregnancy 
and placentation are maintained. Furthermore, those studies of term decidua 
mainly have focused on leukocytes derived from decidua basalis, the site of 
implantation. The decidua parietalis, lining the remainder of the uterine cavity is 
another important region of the maternal-fetal interface which forms contact 
with fetal tissue at the end of the first trimester. 
 
The aim of this thesis was to study the distribution of decidual leukocytes, 
specifically uterine NK cells and T cells, in the decidua basalis and parietalis in 
the setting of normal term pregnancy, following elective cesarean section or 
spontaneous vaginal delivery, in the setting of complicated pregnancy, and in the 
setting of assisted reproduction, and to study the function of term decidual 
leukocytes, specifically proliferation and cytokine production, in response to fetal 
and allogeneic blood leukocytes. Techniques involving flow cytometry, 
immunohistochemistry and mixed lymphocyte cultures were used to perform 
these studies.  
 
In Chapter 2, the expression of CD16 and CD56 on leukocytes by flow cytometry 
and immunohistochemistry in normal term decidua basalis and parietalis is 
compared and quantified. The focus of Chapter 3 is on T cells, specifically the 
expression of activation markers, in term decidua basalis and decidua parietalis. 
Importantly, it must be noted that the twenty placentas from women undergoing 
elective cesarean section in Chapter 3 were also included in part of the subject 
groups in Chapters 2, 4 and 7. 
 
In Chapter 4, the effect of labor on decidual leukocytes is determined by 
quantifying leukocyte subpopulations and the activation state of T cells in term 
decidua basalis and decidua parietalis obtained from spontaneous vaginal 
delivery and comparing the results with those of elective cesarean section. 
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The function of leukocytes in the decidua basalis and parietalis, including their 
ability to proliferate in response to fetal or allogeneic cells and their ability to 
produce cytokines is an important focus in order to understand the role of these 
cells in the maintenance of pregnancy. The aim of Chapter 5 was to examine the 
function of leukocytes isolated from term decidua basalis and parietalis by 
measuring their proliferation and cytokine production in response to various 
stimuli including fetal and allogeneic blood leukocytes in a one-way mixed 
lymphocyte culture and by comparing it to the responses from maternal and 
allogeneic peripheral blood leukocytes. 
 
In Chapters 6 and 7, decidual leukocytes were studied in the setting of 
complicated pregnancy and of assisted reproduction to provide new insight into 
the immunology of the maternal-fetal interface. Preeclampsia (PE) and 
intrauterine growth restriction (IUGR) are significant complications of pregnancy 
associated with high perinatal morbidity and mortality and with varying 
morphologic placental development. In assisted reproduction, specifically 
gestational surrogacy, the surrogate typically has no genetic link to the fetus and 
is presented with two sets of mismatched histocompatibility antigens. It provides 
a unique model to investigate the field of reproductive immunology and seems to 
more accurately characterize the setting of organ transplantation. 
 
In Chapter 8, future plans are suggested, conclusions are summarized and a 
discussion is presented. In conclusion, the human placenta and fetal membranes 
are of elegant design, comprised of a multitude of cells, containing a variety of 
molecular messengers, allowing for the maintenance of pregnancy and directing 
the complex physiology of the mother and fetus.  While research in this field has 
impacted immunology, obstetrics and transplantation, future research is 
essential to further promote translation into the clinical setting.   
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ABSTRACT 
As pregnancy progresses, a characteristic decline in the percentage of 
CD56brightCD16- uterine NK cells occurs. Studies of term decidua, however, have 
focused only on leukocytes derived from decidua basalis, the site of implantation. 
The decidua parietalis, lining the remainder of the uterine cavity is another 
important region of the maternal-fetal interface which forms contact with fetal 
tissue at the end of the first trimester. The aim of this study was to evaluate 
possible differences in expression of CD16 and CD56 on leukocytes from normal 
term decidua basalis and decidua parietalis. 
 
Decidua basalis and parietalis samples were obtained from 30 placentas collected 
after elective cesarean section. Percentages of leukocyte subpopulations and NK 
cell subsets within the CD45+ cell fraction were determined by flow cytometry. In 
six decidual samples, concurrent immunohistochemical staining was performed. 
 
Higher percentages of CD56dimCD16+ NK cells and CD56-CD16+ cells were found 
in decidua basalis in comparison to decidua parietalis. In contrast, the 
percentage of CD56brightCD16- uterine NK cells was significantly higher in 
decidua parietalis. Immunohistochemical quantification supported flow 
cytometric results. 
 
We conclude that significant differences exist with respect to the distribution of 
NK cells in term decidua basalis and parietalis. Future functional studies may 
improve our understanding of their role at the maternal-fetal interface. 
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INTRODUCTION 
Natural killer (NK) cells represent an important effector component of the innate 
immune system, able to produce immunoregulatory cytokines and to recognize 
and kill target cells (1). Phenotypically characterized by the expression of CD56 
and the lack of expression of CD3, there are two distinct subsets of NK cells 
defined as CD56dimCD16+CD3- and CD56brightCD16-CD3-. Ninety percent of NK 
cells in normal circulating peripheral blood have the classical phenotype of 
CD56dimCD16+CD3-, and the remaining 10% are CD56brightCD16-CD3- (2). 
 
In contrast to peripheral blood, CD56brightCD16-CD3- cells represent the major 
subset of NK cells in the uterus and are termed large granular lymphocytes or 
uterine NK cells (3-8). Representing a unique population of cells in the non-
pregnant and pregnant endometrium, these CD56brightCD16- cells have prominent 
cytoplasmic granules (9, 10), are minimally cytotoxic yet highly proliferative (11, 
12), produce a number of cytokines (13-16) and express a wide variety of NK and 
cytokine receptors and adhesion molecules (17). Although the specific role of 
these cells is still unknown, it is suggested that they regulate placental 
development by mediating maternal mucosal and arterial function and fetal 
extraembryonic trophoblast invasion (18). 
 
Changes in CD56brightCD16- NK cells occur throughout the menstrual cycle and 
pregnancy. In the late secretory phase of the menstrual cycle, these cells become 
a prominent population of endometrial leukocytes in preparation for a possible 
conception (4-7). Concurrently, the uterine mucosa begins to undergo 
decidualization, a hormone-dependent process in which endometrial stromal cells 
enlarge and become capable of producing growth factors and matrix components 
to support implantation and placental growth (19). When pregnancy occurs, 
CD56brightCD16- NK cells account for up to 70% of the leukocytes at the site of 
implantation, identified as the decidua basalis (3, 20). The characteristic 
accumulation and predominance of these cells at the maternal-fetal interface at 
the beginning of the first trimester implies a putative role in the control of 
implantation and placentation. It is often stated that as pregnancy progresses, 
the number of uterine NK cells in the decidua basalis gradually declines or 
becomes virtually absent by term pregnancy (21). Histological studies in mice 
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also indicate that the high proportion of uterine NK cells is limited only to early 
pregnancy (22, 23). 
There are two distinct regions of the maternal-fetal interface where maternal 
decidua comes into direct contact with fetal extraembryonic tissue – one between 
decidua basalis and the invading interstitial trophoblasts and the other between 
tissue lining the remainder of uterine cavity, identified as the decidua parietalis 
and the amniochorion (Figure 1). While the decidua basalis encounters fetal 
tissue on the first day of implantation, contact between the decidua parietalis 
and fetal tissue does not occur until the end of the first trimester when fetal 
growth obliterates the uterine cavity. The focus of most immunological studies 
has centered primarily on the decidua basalis, where immune interaction is 
expected to take place. Remarkably, the decidua parietalis has not been as well 
studied as the decidua basalis, yet it is an important site of the maternal-fetal 
interface. Our recent studies revealed that there are, in fact, significant 
differences in term decidua basalis and parietalis. Flow cytometric quantification 
of term decidual leukocytes showed a significantly higher percentage of T cells 
expressing CD25, HLA-DR, CD45RO and CD69 activation markers in decidua 
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Figure 1. The decidua basalis and 
decidua parietalis in relation to 
other uterine tissues after the 
fourth month of pregnancy 
(Adapted from Cunnigham FG, 
Gant NF, Leveno KJ, Gilstrap LC, 
Hauth JC, Wenstrom KD: Williams 
Obstetrics 21st edition. New York, 
McGraw-Hill, 98, 1997). 
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The aim of the present study was to quantify and compare the expression of 
CD16 and CD56 on leukocytes by flow cytometry and immunohistochemistry in 
normal term decidua basalis and parietalis. 
 
MATERIALS AND METHODS 
Tissue specimens 
Paired normal term decidua basalis and parietalis samples were obtained from 
30 placentas following uncomplicated pregnancy. To exclude the effects of labor 
or vaginal delivery on the decidual cells, only placentas from pregnant women 
delivered by elective cesarean section prior to the onset of labor were selected. All 
women received spinal anesthesia prior to cesarean section. All cesarean sections 
were performed for breech presentation and resulted in the birth of a non-growth 
restricted healthy neonate. Term decidua basalis tissue was macroscopically 
dissected from the central region of the maternal-facing surface, and term 
decidua parietalis tissue was collected by removing the amnion and delicately 
scraping the tissue from the chorion. Areas of ischemia or necrosis were avoided. 
Data from 20 of the 30 placentas were used in our concurrent study previously 
published (24). Additionally, 10 ml of maternal peripheral blood were collected 
from six of the patients prior to the cesarean section into heparinized tubes. 
Informed consent was obtained from all patients. 
 
Cell isolation for flow cytometric analysis 
For flow cytometric analysis, decidual tissue was prepared into a single cell 
suspension. To avoid selective cell death or selective loss of surface proteins, 
mechanical disaggregation rather than enzymatic digestion was used to process 
the decidual tissue and to isolate the decidual leukocytes. The obtained tissue 
was washed and finely minced between two scalpel blades in a small volume of 
PBS. Minced decidual fragments were gently worked through an open filter 
chamber (NPBI International BV; Emmer Compascuum, the Netherlands, and 
Beldico; Marche-en-Famenne, Belgium) with PBS. The resultant suspension was 
filtered through a 70µm sieve (Becton Dickinson Labware; Franklin Lakes, New 
Jersey), washed in PBS and layered on an equal volume of ficoll hypaque (Leiden 
University Medical Center Pharmacy; Leiden, the Netherlands) at room 
temperature for density gradient centrifugation for 20 minutes at 800g. 
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Mononuclear cells were collected from the interface, washed twice and 
resuspended in PBS for cell staining. Maternal peripheral blood mononuclear 
cells were similarly isolated by density gradient centrifugation and collected. 
 
Flow cytometric staining of leukocytes 
Directly conjugated fluorescent antibodies directed against a variety of leukocyte 
antigens (Table 1) were used for two- and three-color immunofluorescence 
staining to determine leukocyte subpopulations within decidua basalis and 
decidua parietalis. Cells were stained with monoclonal antibodies at a density of 
106 cells/ ml in PBS (100µl/ sample) and incubated for 30 minutes at 40C in the 
dark. Following two washes with PBS, cells were resuspended and fixed with 
PBS containing 1% paraformaldehyde. Cells were then analyzed on a Becton-
Dickinson FACScan flow cytometer. The double-labeled CD45 and CD14 sample 
was used to establish the optimal lymphocyte gate based on light scattering 
profile and immunofluorescence (25). Directly labeled isotype-control antibodies 
were used for the exclusion of non-specific binding. Approximately 5,000 events 
were acquired in the gating window. The acquired data were then analyzed using 
Becton-Dickinson CellQuest softwareTM (San Jose, CA, USA). 
 
The percentages of CD16+, CD56+, CD14+, CD19+, CD3+, CD4+ and CD8+ and cells 
in decidua basalis and decidua parietalis were determined and calculated as a 
percentage of the CD45+ cell fraction. To precisely characterize the expression of 
CD16 and CD56, the percentages of CD56dimCD16+ NK cells, CD56brightCD16- 
uterine NK cells and CD56-CD16+ cells were established by delineating regions 




As a control, one 19 week decidual sample was analyzed. This tissue was 
obtained after an elective abortion on social grounds of a normally developing 
pregnancy. From this sample, decidua basalis tissue was microscopically 
separated from fetal tissue, leukocytes were isolated, and flow cytometric 
analysis was performed as previously described. In comparison to previous 
studies (3, 20), similar percentages of leukocyte subpopulations were found, 
specifically a high percentage (66.7%) of CD56brightCD16- cells (data not shown). 
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Immunohistochemical staining 
Six of the tissue specimens of decidua basalis and parietalis were concurrently 
embedded in paraffin for immunohistochemical labeling of leukocytes using 
antibodies listed in Table 2. Serial 3 µm thick tissue sections were mounted on 
slides coated with 3-aminopropyltriethoxysilane and glutaraldehyde (Sigma; 
Zwijndrecht, Netherlands). Tissue sections were deparaffinized using xylene and 
100% ethanol. Endogenous peroxidase activity was blocked with methanol 
containing 0.3% H202 (Sigma; Zwijndrecht, Netherlands) for 20 minutes. Sections 
were then rehydrated with 70% and 50% ethanol. Antigen retrieval pre-
treatment was performed by two different methods depending on the primary 
antibody. Tissue sections were pre-treated by microwaving the sections for 10 
minutes in boiling citrate buffer (10 mmol/L, pH 6.0) or in boiling Tris/EDTA 
Table 1. Monoclonal antibodies for flow cytometry. 
Antigen 
Specificity 
Antibody Cell Type Fluorochrome Type of 
Labeling 
Sourcea 




PE Direct BD 
CD19 Leu-12 B cell FITC Direct BD 
CD3 Leu-4 T cell APC 
PerCP-Cy5 
Direct BD 
CD4 Leu-3a T cell subset FITC 
PE 
Direct BD 












CD56 Leu-19 NK cell FITC Direct BD 
aBecton-Dickinson (BD) Immunocytometry Systems (San Jose, CA, USA) 
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buffer (1 mmol/L, pH 9.0). Following two washes in PBS, tissue sections were 
incubated with primary antibodies at the appropriate dilutions in PBS with 1% 
BSA (Sigma; Zwijndrecht, Netherlands) overnight in a moist chamber. Sections 
were washed three times in PBS and further incubated for 30 minutes with the 
secondary biotinalyted anti-mouse IgG immunoglobulin (Dako; Glostrup, 
Denmark) diluted 1:100 in PBS with 1% BSA. Following three washes in PBS, 
sections were incubated for 30 minutes with a biotinylated horse radish 
peroxidase/ streptavidin complex (Dako; Glostrup, Denmark) diluted 1:100 in 
PBS with 1% BSA. The reaction was developed in a 10-minute incubation period 
with 0.5 mg/ml diaminobenzidene tetrahydrocholoride (Sigma; Zwijndrecht, 
Netherlands), 0.3% H202 in 0.05M Tris-HCL (pH 7.6). Sections were then 
counterstained with Mayer’s hematoxylin (Klinipath; Duiven, Netherlands) for 
15 seconds and then washed for 5 minutes with demiwater. 
Quantification of immunohistochemistry 
The number of positive cells in 10 high-power fields (400x magnification) was 
quantified for each specimen by two independent observers (A.P.S.-T. and J.J.S.). 
Fields were selected to contain only decidua, and cells within blood vessels were 




To compare differences in decidual leukocyte subsets in the decidua basalis and 
decidua parietalis, the Wilcoxon signed rank test, a non-parametric paired t-test, 
was performed. The value of p<0.05 was defined as significant. 
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Table 2. Monoclonal antibodies for immunohistochemistry. 
Antigen 
Specificity 
Antibody Cell Type Pre-
treatment 
Dilution Sourcea 




Microwave -  
Citrate 
1:10 Lab Vison 
Neomarkers 
CD56 NCAM NK cell Microwave - 
EDTA 
1:200 Sanbio 
aLab Vison Neomarkers (Duiven, the Netherlands) 
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RESULTS 
Expression of CD16 and CD56 in normal term decidua basalis and 
parietalis 
The percentage of several leukocyte subpopulations was examined in normal 
term decidua basalis and parietalis by flow cytometry (Figure 2) and summarized 
in Table 3. Comparison of the expression of CD16 and CD56 on leukocytes in 
these two tissue sites showed a differential distribution (Figure 2). In decidua 
basalis, the percentage of CD56+ cells was significantly lower (22.8%, p<0.0001) 
in comparison to that of decidua parietalis (41.2%). In contrast, the percentage of 
CD16+ cells was significantly higher (16.1%, p=0.0015) in decidua basalis in 
comparison to that of decidua parietalis (9.8%). To characterize NK cells subsets, 
regions were defined around populations of CD56dimCD16+ NK cells, 
CD56brightCD16- uterine NK cells and CD56-CD16+ cells based on maternal 
peripheral blood samples (Figure 3). Analysis of the decidua basalis and 
parietalis showed that there was a significant increase in the percentage of CD56-
CD16+ cells and CD56dimCD16+ cells in decidua basalis (p=0.0069 and p=0.0009, 
respectively). Most importantly, the percentage of CD56brightCD16- uterine NK 
cells was 22.1% in decidua parietalis, significantly higher in comparison to 5.6% 
found in decidua basalis (p<0.0001). 
 
Quantification of CD16 and CD56 expression (Figure 4) in decidua tissue sections 
stained by immunohistochemistry confirmed results between decidua basalis and 
parietalis found by flow cytometric analysis (Table 4). In decidua basalis, the 
mean number of CD56+ cells was significantly lower (1.6; p=0.0005) in 
comparison to that of decidua parietalis (6.0). In contrast, the mean number of 
CD16+ cells per high power field was significantly higher (8.0; p=0.01) in decidua 
basalis in comparison to that of decidua parietalis (5.5). 
 
Expression of additional markers in normal term decidua basalis and 
parietalis 
The percentages of CD45+ leukocytes, CD14+ macrophages, CD19+ B cells, CD3+ 
T cells and CD8+ cells were similar in decidua basalis and parietalis (Figure 1 
and Table 3). A higher percentage of CD4+ cells was found in the decidua basalis 
in comparison to that of the decidua basalis (p=0.023). 
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Figure 2. CD16 and CD56 expression in normal term decidua basalis and parietalis. 
Column error bars represent the standard error of the mean (SEM). *p<0.05; 
**p<0.005. 
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Figure 4. Representative immunohistochemical staining for CD56 on term decidua 
basalis (4A) and parietalis (4B) samples. Original magnification X100. 
Figure 3. Representative two-color flow cytometric analysis of CD56brightCD16- [1],  
CD56dimCD16+ [2] and CD56-CD16+ [3] cell populations in one decidua basalis [a] and 
decidua parietalis [b]. Regions were defined around these cell populations based on 
the maternal peripheral blood sample [c]. Percentages of these cell populations 
within the CD45+ cell fraction were: 1a: 2.88%, 1b: 29.06%, 1c: 0.43%; 2a: 13.82%, 2b: 
4.42%, 2c: 3.42%; 3a: 3.92%, 3b: 0.37%, 3c: 1.08%. 
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Table 3. Mean percentage of leukocytes in normal term decidua basalis and 








CD45+ 36.0 31.5 NS 
CD56+/CD45+ 22.8 41.2 p<0.0001 
CD14+ /CD45+ 14.4 17.4 NS 
CD19+/CD45+ 5.5 3.8 NS 
CD3+/CD45+ 56.5 52.7 NS 
CD4+/CD45+ 27.4 18.6 p=0.023 
CD8+/CD45+ 31.6 31.5 NS 
CD16+/CD45+ 16.1 9.8 p=0.0015 
CD16+CD56-/
CD45+ 
5.5 3.7 p=0.0069 
CD56dimCD16+/
CD45+ 




5.6 22.1 p<0.0001 
Table 4. Mean number of positive leukocytes per high power field in normal 








CD16+ 8.0 [2.0-11.9] 5.5 [3.0-7.5] p=0.01 
CD56+ 1.6 [0-7.7] 6.0 [0.5-13.2] p=0.0005 
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DISCUSSION 
This study indicates that there are regional differences in the expression of CD16 
and CD56 on leukocytes in term decidua basalis and parietalis. By precisely 
defining NK cell subsets, an analysis of NK cells in both term decidua basalis and 
term decidua parietalis was performed using flow cytometry and confirmed by 
immunohistochemistry. A higher percentage of CD56brightCD16- uterine NK cells 
was found in decidua parietalis in comparison to decidua basalis. In contrast, the 
percentage of CD56dimCD16+ NK cells was significantly increased in decidua 
basalis. These results show that uterine NK cells account for a substantial 
proportion of leukocytes in term decidua parietalis, thus indicating that the 
presence of uterine NK cells, contrary to current belief, is not only restricted to 
early pregnancy.  
 
The factors leading to the unequal distribution of NK cells in the decidua are 
unknown. A possible mechanism to explain the lower number of uterine NK cells 
in the decidua basalis may involve the classical and non-classical MHC class I 
molecules expressed in the placenta. HLA-C, HLA-E and HLA-G are expressed 
by the population of extravillous trophoblast that invade the uterus (26-30) and 
interact with receptors, such as CD94/NKG2A and killer-cell immunoglobulin-
like receptors, expressed by uterine NK cells leading to activation or inhibtion 
(31-35). The abundant presence of HLA-C, HLA-E and HLA-G in tissue adjacent 
to decidua basalis may account for the decreased percentage of uterine NK cells 
in that region compared to that of decidua parietalis. 
 
Another mechanism to account for the higher number of CD56brightCD16- uterine 
NK cells in the decidua parietalis and the increased percentage of CD56dimCD16+ 
in the decidua basalis may involve homing of CD56bright cells from the maternal 
circulation to the decidua or may involve maturation from a uterine NK cell 
precursor. A recent study on trafficking of NK cells shows that cells from 
secondary lymphoid tissues of pregnant mice can reconstitute uterine NK cells in 
NK-cell-deficient mice and that human peripheral blood CD56bright cells can 
adhere selectively to mouse uteri (36). Homing and recruitment of uterine NK 
cells to the maternal-fetal interface may be mediated by adhesion molecules (36-
38), by molecules expressed by trophoblasts, such as monocyte inflammatory 
protein (39), and by molecules expressed by uterine NK cells, such as very late 
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antigen-1 or CD49a (40). There is perhaps increased homing of uterine NK cells 
to term decidua parietalis. Future studies are necessary to determine 
mechanisms involved in the regional difference of uterine NK cells in term 
decidua. 
 
Although it is often stated that there is a progressive decrease in or even an 
absence of uterine NK cells in term decidua, current references that clearly 
illustrate such data are lacking. In general, studies on human term decidual 
leukocytes are limited. A few publications report substantial reductions or low 
percentages in CD56+ cells isolated from term decidua, depending on the tissue 
examined and the techniques used (42-44). However, these studies do not clearly 
distinguish CD56dimCD16- and CD56brightCD16- NK cell subsets, but rather 
simply evaluate CD56+ cells.  In studies on term decidua basalis, the percentage 
of CD56+ cells, as determined by flow cytometry, was generally similar, ranging 
between 12% and approximately 24%, to that of the current study. In a study by 
Vince et al. (42), leukocytes in term decidua parietalis were analyzed.  The 
percentage of CD56+ cells, however, was substantially lower compared to that of 
the current study. There are several important differences between the two 
studies that may account for this disparity, including the use of enzymatic 
digestion to isolate decidual cells, the CD56 monoclonal antibody specificity, the 
use of indirect immunofluorescence staining, and the method to calculate the 
percentage of positive cells. 
 
The aim of the current study was to compare differences in decidua basalis and 
parietalis from term pregnancy. In a study by Haller et al. (45), decidua basalis 
and parietalis from first trimester pregnancy obtained under ultrasonic guidance 
was compared and analyzed by immunohistochemistry. The mean number of 
CD56+ cells was higher in first trimester decidua parietalis compared to early 
decidua basalis, analogous to findings of the present study. The difference, 
however, was not significant and may have been a result of the small sample size 
(n=6) or the gestational age of the decidua. 
 
In the present study, a significantly increased percentage of CD56-CD16+ cells 
was found in decidua basalis in comparison to decidua parietalis. Although 
further phenotypic analysis is required, these cells are most likely granulocytes. 
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It is suggested, however, that the precise phenotype of the CD16+ cells in term 
decidua is unclear (43). By flow cytometric analysis, fewer CD16+ cells as 
compared to CD56+ cells were found in decidua basalis and parietalis. On the 
other hand, more CD16+ cells as compared to CD56+ cells were found by 
immunohistochemical analysis, similar to results reported by Vargas. Several 
studies indicate that trophoblasts in early and term placental tissue express 
CD16 (46-48). Recognizing the IgG Fc receptor III, CD16 is suggested to be 
involved in the transport of IgG across the placenta. Some CD16+ trophoblasts 
were possibly included in immunohistochemical quantification, but by flow 
cytometric analysis, these cells were excluded by gating. Furthermore, the 
difference also may be due to variation in monoclonal antibodies used for flow 
cytometry or immunohistochemistry. 
 
Our findings also indicate that the percentages of CD45+ leukocytes, CD14+ 
macrophages, CD19+ B cells, CD3+ T cells and CD8+ cells are similar in decidua 
basalis and parietalis. While there are similar percentages of CD8+ cells in 
decidua basalis and parietalis, a significantly higher percentage of CD4+ cells is 
found in decidua basalis. Including both CD3+ and CD3- cells, the CD8+ 
population likely includes both cytotoxic T cells and NK cells. Our study on CD3+ 
cells in term decidua further characterizes CD4 and CD8 expression on and the 
activation state of T cells (24). To confirm that our method for quantification of 
the various leukocyte subpopulations calculated within the CD45+ cell fraction 
was accurate, these percentages were also determined by concurrent three-color 
staining with CD45 in APC in combination with the various leukocyte markers in 
FITC and PE in two of the decidua basalis and parietalis samples and compared. 
Equivalent percentages of CD14+, CD19+, CD3+, CD4+, CD8+, CD16+ and CD56+ 
cells were obtained by both methods of flow cytometric staining and analysis 
(data not shown). 
 
It is unlikely that contamination of decidual samples by maternal peripheral 
blood or umbilical cord blood accounts for the regional differences in the two 
decidual sites. Primarily, tissue samples were carefully collected and thoroughly 
washed with PBS prior to cell isolation. This is the described method to remove 
possibly contaminating maternal or fetal blood from the tissue (44). Secondly, 
flow cytometric results were confirmed by immunohistochemical analysis, in 
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which only cells located in the tissue and not in vessels were quantified. Using 
immunohistochemistry, differences between the decidua basalis and parietalis 
were similar to those found by flow cytometry. Additionally, the minor 
percentage of B cells found in both decidua basalis and parietalis and the lack of 
a significant difference between the percentages of B cells in the decidual sites 
suggests that circulating blood, which contains a higher percentage of B cells, did 
not appreciably contaminate decidual samples. 
 
In summary, this study establishes that there are significant differences in the 
distribution of NK cells in term decidua basalis and decidua parietalis. Although 
decidual leukocytes have been well characterized, their role in the maintenance 
of pregnancy and in the development of obstetrical pathologies, such as fetal 
growth restriction and pre-eclampsia, remains unknown. To improve our 
understanding, future studies should focus on the mechanism involved in the 
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ABSTRACT 
PROBLEM: The aim of this study was to quantify and compare activated T cells 
in term decidua basalis and parietalis using flow cytometry. 
 
METHOD OF STUDY: Term decidua basalis and parietalis samples were 
obtained from 20 placentas collected after elective caesarean section. Percentages 
of leukocyte subclasses within the CD45+ cell fraction and activated T cells were 
determined by flow cytometry. 
 
RESULTS: There was no significant difference in CD45+, CD14+, CD19+, and 
CD3+ cell percentages. However, within the CD3+ population, there were 
significantly more TCRγδ+ and CD8+ cells in decidua parietalis compared to 
decidua basalis. More importantly, percentages of T cells expressing CD25, HLA-
DR, CD45RO, and CD69 markers were significantly increased in decidua 
parietalis. 
 
CONCLUSION: These findings suggest that there are more activated T cells in 
decidua parietalis than in decidua basalis. Further investigation into differences 
between the two decidual sites may expand our understanding of the 
immunology of the maternal-fetal interface. 
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INTRODUCTION 
T cells, macrophages, and CD56+CD16- decidual NK cells are the three primary 
leukocyte subclasses in non-pregnant and pregnant decidualized endometrium 
(1-8). In the early proliferative phase of the menstrual cycle, T cells are an 
abundant leukocyte population accounting for approximately 45% to 60% of the 
leukocytes in the endometrium (6, 9). As the endometrium prepares for the 
possible reception of a fertilized ovum during the secretory phase, the percentage 
of T cells progressively decreases (6, 9). An additional decline characterizes the 
first trimester transformation of endometrium into decidua, in which the total T-
cell population represents only 6% to 30% of the decidual leukocytes (5, 6, 9-11). 
This progressive decline in T cells in early pregnancy suggests that T cells may 
not be critical to trophoblast invasion (12). However, in term pregnancy, 45% to 
50% of the leukocytes in the decidua basalis, the site of trophoblast invasion, are 
CD3+, accounting for the most abundant leukocyte population (11, 13). 
Furthermore, it is also shown that T cells in term pregnancy decidua basalis 
express cell surface markers indicating activation, such as CD25, CD69, and 
HLA-DR (13). The reappearance of T cells during term pregnancy and their 
expression of activation markers imply that these cells play a more important 
role in the maintenance of pregnancy. 
 
There are two distinct regions of direct contact between the maternal decidua 
and tissue of fetal origin – one between decidua basalis and the invading 
interstitial trophoblasts and the other between the tissue lining the remainder of 
uterine cavity, identified as the decidua parietalis, and the amniochorion (Figure 
1). The decidua parietalis is the focus of far fewer studies as compared to the 
decidua basalis. Our earlier data revealed that there are, in fact, significant 
differences in the proportion of NK cell populations in the decidua basalis and 
parietalis. Our flow cytometric quantification of term decidual leukocytes showed 
a significantly increased percentage of CD56+CD16- NK cells in the decidua 
parietalis as well as a significantly increased percentage of CD16+ cells, which 
included the CD56+CD16+ NK cell population, in the decidua basalis (14). To our 
knowledge, no study has examined the differential expression of activation 
markers in the decidua parietalis. The aim of this study was to quantify and 
compare the percentage of activated T cells in term decidua basalis and parietalis 
using flow cytometry. 
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MATERIALS AND METHODS 
Isolation of decidua basalis and parietalis cells 
Normal term decidua basalis and parietalis samples were obtained from 20 
placentas collected after elective caesarean section following uncomplicated 
pregnancy. All caesarean sections were performed for breach presentation and 
resulted in the birth of a non-growth restricted healthy neonate. Term decidua 
basalis tissue was macroscopically dissected from the maternal-facing surface, 
and term decidua parietalis tissue was collected by removing the amnion and 
delicately scraping the tissue from the chorion. Areas of ischemia or necrosis 
were avoided. The obtained tissue was washed and finely minced between two 
scalpel blades in a small volume of phosphate buffered saline (PBS). Minced 
decidual fragments were gently worked through an open filter chamber (NPBI 
International BV; Emmer Compascuum, the Netherlands) with PBS. The 
resultant suspension was filtered through a 70µm sieve (Becton Dickinson 
Labware; Franklin Lakes, New Jersey), washed in PBS, and layered on an equal 
volume of ficoll hypaque (Leiden University Medical Center Pharmacy; Leiden, 
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Figure 1. Relationship of the fetus 
and the decidua basalis and parietalis 
after the fourth month of pregnancy 
(Adapted from Tuchmann-Duplessis 
H, David G, Haegel P: Illustrated 
Human Embryology. Vol 1. Paris, 
Masson and Company Paris, 1971, 
p.71). 
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the Netherlands) at room temperature for density gradient centrifugation (for 
20min at 800g). Mononuclear cells were collected from the interface, washed 
twice, and resuspended in PBS for cell staining. 
 
Cell Staining 
Directly conjugated fluorescent antibodies directed against the following antigens 
were used for two- and three-color immunofluorescence staining: CD45 [HLe-1; 
Fluorescein isothyocyanate (FITC)], CD14 [Leu-M3; Phycoerythrin (PE)], CD3 
[Leu-4; Allophycocyanin (APC) or Peridinin Chlrophyll-a Protein-Cytochrome 5.5 
(PerCP-Cy5)], CD8 (Leu-2a; FITC), CD4 (Leu-3a; PE), CD19 (Leu-12; FITC), 
CD56 (Leu-19; FITC), CD16 (Leu-11a; PE), CD25 (Anti-IL-2R; FITC), HLA-DR 
(Anti-HLA-DR; PE), CD45RA (Leu-18; FITC), CD45RO (UCHL1; PE), CD69 
(Leu-23; FITC), and TCRαβ (WT31; FITC) all from Becton-Dickinson 
Immunocytometry Systems (San Jose, CA, USA) and TCRγδ (5A6.E9; FITC, 
Serotec, Oxford, England). Sixteen to 20 of the decidual samples were analyzed 
for expression of all abovementioned except for CD69, which was only analyzed in 
7 samples. 
 
All cells were stained at densities of 106 cells/ ml in PBS and incubated for 30 
minutes at 40C in the dark. Following two washes with PBS, cells were 
resuspended and fixed with PBS containing 1% paraformaldehyde. Cells were 
then analyzed on a Becton-Dickinson FACScan flow cytometer. The double-
labeled CD45 and CD14 sample was used to establish the optimal lymphocyte 
gate based on light scattering profile and immunofluorescence (15). 
Approximately 3,000 events were acquired in the gating window. The acquired 
data were then analyzed using CellQuestTM software (Becton-Dickinson, San 
Jose, CA, USA). The percentages of CD14+, CD19+, CD3+, CD56+CD16- , and 
CD16+ cells were calculated within and represented as a percentage of the CD45+ 
cell fraction. To determine the expression of activation markers on T cells, cells 
that were within the leukocyte gate and that were also positive for CD3 were 
gated based on these two parameters and analyzed for the expression of the 
activation marker of interest. 
 
Effect of maternal peripheral blood 
To confirm that maternal peripheral blood was not preferentially contaminating 
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the decidua basalis or parietalis samples or possibly affecting the results, a 
peripheral blood sample drawn from the mother prior to collection of four of the 
20 placental samples was compared to its corresponding decidual basalis and 
parietalis samples. Peripheral blood mononuclear cells were isolated by density 
gradient centrifugation, stained at a density of 106 cells/ ml and analyzed for the 
expression of the same markers simultaneously with isolated decidual cells. 
 
Statistical Analysis 
To compare differences in decidual leukocyte subsets in the decidua basalis and 
decidua parietalis, the Wilcoxon signed rank test was performed. The 




The isolated leukocytes from normal term decidua basalis and parietalis were 
analyzed by flow cytometry and compared. The results of this comparison are 
summarized in Table 1. As established in our previous study (14), the percentage 
of decidual NK cells, defined as CD56+CD16- cells, was significantly increased in 
the decidua parietalis in comparison with the decidua basalis, 28.2% and 11.0%, 
respectively (p<0.001). On the other hand, the percentage of CD16+ cells, which 
included CD56+CD16+ and CD56-CD16+ cells, was significantly increased in the 
decidua basalis in comparison with the decidua parietalis. There was no 
significant difference in the percentages of CD45+, CD14+, and CD3+ cells in the 
decidua basalis and parietalis. In the present study, we also confirmed that there 
was no significant difference in the percentage of CD19+ B cells in the two 
decidual sites. Furthermore, the CD19+ cells in the decidua basalis and parietalis 
composed only a minor percentage of cells within the total CD45+ fraction, 6.1% 
and 3.8%, respectively (p=0.057). This data is summarized in Figure 2. 
 
Although the percentage of CD3+ T cells was similar in the decidua basalis and 
parietalis, there were slightly but significantly more TCRγδ+ cells within the 
CD3+ cell population in the decidua parietalis than in the decidua basalis, 13.9% 
and 8.2%, respectively (p=0.001). Furthermore, the percentage of CD3+CD8+ cells 
was slightly but significantly greater in the decidua parietalis than in the 
decidua basalis, 43.2% and 53.8%, respectively (p=0.001). Conversely, the 
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percentage of CD3+CD4+ cells was greater in the decidua basalis than in the 
parietalis, 52.6% and 42.2%, respectively (p=0.003). These results are graphically 
summarized in Figure 3. 
 
 
T-CELL ACTIVATION IN TERM DECIDUAL LEUKOCYTES 
Table I. Mean percentage of leukocytes in normal term decidua basalis and 
parietalis. 





CD45+ 35.3 28.8 0.103 
CD3+CD69+ 18.8 60.5 0.008 
CD14+/CD45+ 17.7 21.0 0.301 
CD3+/CD45+ 55.4 60.6 0.195 
CD19+/CD45+ 6.1 3.8 0.057 
CD16+/CD45+ 15.9 10.9 0.010 
Decidual NK cells 
CD56+CD16-/CD45+ 
11.0 28.2 <0.001 
CD3+CD4+ 52.6 42.2 0.003 
CD3+CD8+ 43.2 53.8 0.001 
CD3+CD4+ / 
CD3+CD8+ ratio 
1.4 0.9 0.001 
CD3+TCRαβ+ 89.8 86.4 0.020 
CD3+TCRγδ+ 8.2 13.9 0.001 
CD3+TCRαβ+ /
CD3+TCRγδ+ ratio 
14.0 8.0 0.002 
CD3+CD25+ 15.9 28.7 <0.001 
CD3+HLA-DR+ 29.5 69.7 <0.001 
CD3+CD45RA+ 47.9 29.3 <0.001 
CD3+CD45RO+ 53.8 72.9 <0.001 
CD3+CD45RA+ /
CD3+CD45RO+ ratio 
1.1 0.4 <0.001 
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More remarkably, the percentage of activated T cells, expressing four different 
markers implying T-cell activation, CD25, HLA-DR, CD45RO, or CD69 within 
the CD3+ cell population, was consistently and significantly increased in the 
decidua parietalis when compared to that of the decidua basalis (Figure 4). An 
illustrative flow cytometric profile of the activation marker, HLA-DR, expressed 
on CD3+ cells is shown in Figure 5. Furthermore, the percentage of naïve T cells, 
as defined by co-expression of CD3 and CD45RA, was significantly greater in the 
decidua basalis than in the decidua parietalis, 47.9% and 29.3%, respectively 
(p<0.001). 
 
Results of the comparison between maternal peripheral blood and decidua basalis 
and parietalis samples did not suggest that peripheral blood was preferentially 
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Figure 2. Mean percentage of leukocytes in normal term decidua basalis and 
parietalis. Column error bars represent the standard error of the mean (SEM). 








































































Figure 4. Mean percentage of CD3+ leukocytes in normal term decidua basalis and 
parietalis. Column error bars represent the SEM. 


































Figure 3. Mean percentage of CD3+ leukocytes in normal term decidua basalis and 
parietalis. Column error bars represent the SEM. 
         Normal decidua basalis             Normal decidua parietalis 




Flow cytometric quantification and comparison of leukocytes of term decidual 
basalis and parietalis confirms that there are distributional differences between 
the two decidual sites. The significantly higher percentage of cells expressing 
CD25, CD69, HLA-DR, and CD45RO on CD3+ cells in the decidua parietalis 
indicates that T cells in this site are activated in term pregnancy. Cells in term 
decidua basalis also have been shown to express CD25, CD69, and HLA-DR 
activation markers (13). In the present study, we confirm the finding, but also 
extend the finding to show that there are more activated T cells in term decidua 
parietalis than in term decidua basalis. 
 
The markers, CD25, CD69, HLA-DR, CD45RO, and CD45RA were applied in this 
study to evaluate T-cell activation. CD25, the alpha chain of interleukin-2 
receptor, is an early universal T-cell marker that increases upon activation (16). 
CD69, another early activation marker, is present on activated T, B and NK cells 
(17). Although the function of CD69 is unknown, the induction of CD69 
expression on T cells is shown to be very rapid (18, 19). HLA-DR is a relatively 
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Figure 5. A typical flow cytometric dot plot of the expression of the activation 
marker anti-HLA-DR on CD3+ cells. There is significantly higher HLA-DR 
expression on CD3+ cells in the decidua parietalis compared to those in the decidua 
basalis, with mean percentages of 68.7 and 29.5, respectively (p<0.001). 
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late activation marker, expressed by B cells, monocytes, macrophages, and 
activated T and NK cells (20, 21). CD45RA, an isoform of the leukocyte common 
antigen, is expressed by naïve T lymphocytes, and upon activation, antigen 
density decreases (22). On the contrary, CD45RO is present at low density early 
in T lymphocyte maturation cycle. Upon activation, naïve T lymphocytes first 
acquire CD45RO and then lose CD45RA. CD45RO+ cells are considered to be a 
primed population of memory T cells (23-25). Thus, the phenotype of cells in the 
term decidua parietalis determined using these markers indicates that these 
cells are in an activated state. 
 
Immunohistological and flow cytometric studies focusing on decidua of the first 
trimester have shown that various types of lymphocytes are activated and 
produce cytokines (26-35). Previous studies of decidua basalis samples from first 
trimester pregnancy demonstrate that T cells express CD25, CD69, HLA-DR, and 
CD45RO activation markers (29-31, 33-35). CD25 surface antigen was detected 
on 6 to 27% of first trimester decidual T cells. CD69 expression was found on 58 
to 73% of these cells, and 32% to 70% expressed HLA-DR (29, 31, 34, 35). 
Approximately, 85% of CD4+ T cells and 59% of CD8+ T cells expressed CD45RO 
antigen (33). The percentages of activated T cells in first trimester decidua 
basalis measured in these studies appear to be higher than those found in term 
decidua basalis, and yet similar to those found in our term decidua parietalis, 
suggesting that the proportion of activated T cells declines in the decidua basalis 
during pregnancy. In general, immune activation appears paradoxical at a site in 
which immunosuppression should predominate in order to guarantee maternal 
tolerance toward the fetus. It is suggested, however, that maternal T cells 
promote and contribute positively to placental growth and trophoblast invasion 
(36). These studies imply that regionally activated T cells in the decidua basalis 
of early pregnancy may play an important role and that their balance with other 
leukocyte subsets may be essential to the maintenance of pregnancy. 
 
Factors leading to the unequal distribution and activation of T cells in the 
decidua are unknown. Mediators, such as prolactin or indoleamine 2,3-
dioxygenase (IDO), may be plausible candidates involved in the activation 
process. Prolactin, known to be produced in the decidualized human 
endometrium, transported through fetal membranes, and secreted into amniotic 
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fluid (37-39), induces cell proliferation and activation and is involved in the 
maintenance of immunocompetence (40, 41). Furthermore, prolactin receptors 
have been identified in the placenta and amnion (42). It is suggested, yet not 
fully clear, that there are regional and periodic differences in prolactin gene 
expression in the decidual cells during pregnancy (43). Perhaps there is 
increased prolactin expression in the decidua parietalis leading to T-cell 
activation. IDO, on the other hand, is synthesized and secreted by 
synctiotrophoblasts and catabolizes and degrades tryptophan (44). Present in 
human placental villous explants, IDO has been shown to inhibit lymphocyte 
proliferation via tryptophan depletion (45-47). Increased IDO enzymatic levels 
or activity or lower levels of tryptophan in the decidual basalis are possible 
mechanisms for the detected differences in T-cell activation. In a study by 
Sedlmayr, IDO was irregularly localized in term placental samples to the 
mesenchymal core and found in isolated areas of the synctiotrophoblast (48). 
Further investigation into prolactin, IDO, and tryptophan localization in the 
decidua basalis and parietalis seems warranted. 
 
Activation by fetal trophoblasts followed by selective Fas mediated apoptosis is 
another plausible mechanism to explain the decreased percentage of activated T 
cells in the decidua basalis. Fas, a cell surface receptor of the tumor necrosis 
factor family (CD95), mediates apoptosis by binding FasL (49, 50). In a study by 
Hammer et al, apoptotic nuclei arising from CD45+ leukocytes were detected 
scattered within the whole functional stroma of the non-invaded decidua 
parietalis. In the decidua basalis, the apoptotic leukocytes were irregularly 
distributed and concentrated in the area around necrotic nuclei and especially in 
the primary fetal-maternal contact zone where trophoblasts from the cell 
columns began to invade the maternal tissue (51). In light of this study, our 
study suggests that there are less activated cells in the basalis because these 
cells have been activated and then selectively programmed to die by the 
invading trophoblasts. In the decidua parietalis, where there is less invasion by 
trophoblasts, but simply contact, the activated cells are not killed to the same 
extent by trophoblastic FasL. It is also plausible that there is perhaps a lower 
expression of Fas on T cells in the decidua parietalis or higher expression of 
FasL in the trophoblasts of the decidua. 
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Another conceivable explanation is that the T-cell activation is related to 
inflammation and infection in a fraction of the decidua parietalis samples. 
Ascending infection into the lower uterine segment can occur in term pregnancy 
prior to labor, and such an infection could potentially affect the decidua 
parietalis. However, the increased percentage of activated T cells in the decidua 
parietalis was consistently detected in every sample, not in just a few outlying 
samples, implying a highly improbable situation in which infection and 
inflammation was present in every pregnancy. Furthermore, the percentage of 
cells expressing CD16, a marker associated not only with classical NK cells but 
also with neutrophils and inflammation, was significantly increased in the 
decidua basalis and not the decidua parietalis. Therefore, it is highly unlikely 
that the significantly increased percentage of activated T cells in the decidua 
parietalis was due to an inflammatory response in a number of cases. 
 
Additionally in this study, we confirm our previous findings that there are 
significantly increased CD56+CD16- decidual NK cells in the decidual parietalis, 
while there are significantly increased CD16+ cells, which includes CD56+CD16+ 
and CD56-CD16+ populations, in the decidua basalis. We also confirm that there 
is no difference in CD14+, CD45+, and CD3+ cell populations in the two decidual 
sites.14 In this study, the finding is extended to show that similar percentages of 
CD19+ B cells are found in both decidual sites. The minor percentage of B cells 
and the lack of a significant difference between the percentages of B cells 
detected in the decidua basalis and parietalis also indicates that maternal 
peripheral blood, which has a substantially higher percentage of B cells, did not 
appreciably contaminate our samples. 
 
The results of our present study also indicate that there are significantly more 
CD3+CD4+ cells in the decidua basalis than CD3+CD8+ cells, while the opposite 
is true for the decidua parietalis. The proportion of CD4+ and CD8+ T cells may 
reflect an inherent difference in activity of the two decidual sites, but both CD4+ 
and CD8+ T cells can be involved in a destructive immune response and in 
regulation. It is important to indicate that comparable to other previous studies 
(11-14), the total percentage of CD8+ cells, including those that are CD3+ and 
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CD3-, however, was higher than the total percentage of CD4+ cells in both the 
decidua basalis and parietalis (data not shown). Furthermore, in agreement 
with the study by Abadia-Molina et al., CD3+ lymphocytes were the most 
abundant lymphocyte in the term decidua basalis (13). We showed that this 
finding also applies to the decidua parietalis. 
 
In this study, slightly yet significantly more γδ T cells were found in the decidua 
parietalis than in the decidua basalis. There has been considerable controversy 
concerning the expression of the γδ T-cell receptor on decidual T cells. Although 
the function of these cells is not clearly identified, they may have a regulatory 
role in the decidua (52, 53). The study by Mincheva-Nilsson et al. suggests that 
the extrathymic T-cell maturation occurs in the decidua of early pregnancy and 
that CD56+CD16- decidual NK cells are immature progenitors for T cells (54). In 
consideration of these studies, the significant increase in TCRγδ+ and 
CD56+CD16- decidual NK cells further suggests the potential and unique 
immunologic role of these cells in the decidua parietalis. 
 
The findings of this study extend our understanding of the many events 
occurring at the maternal-fetal interface and suggest that there may be 
particular inherent differences in the nature and function of the decidua basalis 
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ABSTRACT 
The aim of this study was to quantify and compare leukocyte populations in 
term decidua basalis and parietalis obtained after spontaneous vaginal delivery 
(SVD) or elective cesarean section (CS) without labor. Decidua basalis and 
parietalis samples were obtained from placentas after SVD (n=20) and after CS 
(n=30). Following mechanical disaggregation, leukocytes were purified and 
stained with monoclonal antibodies. Percentages of leukocyte subclasses within 
the CD45+ cell fraction and activated T cells were determined by flow cytometry. 
No differences were found in the percentages of CD45+ cells or CD56brightCD16- 
uterine natural killer (NK) cells between decidua basalis from SVD and CS or 
between decidua parietalis from SVD and CS. In decidua basalis and parietalis 
from SVD, a significantly higher number of CD56dimCD16+ NK cells was found 
compared to CS. In decidua basalis from SVD, there was a significantly lower 
percentage of CD14+ cells and higher percentage of CD19+ cells compared to CS. 
The percentage of CD3+ T cells expressing CD25 or human leukocyte antigen 
(HLA)-DR was significantly decreased in decidua basalis and parietalis from 
SVD compared to CS. Comparison of decidua collected after SVD or CS suggests 
that labor is associated with dynamic changes in the distribution of decidual 
leukocytes, specifically NK and T cell subpopulations. In particular, the 
disappearance of the CD4+CD25+ T cell population, which possibly contains a 
subpopulation of regulatory T cells, may contribute to the initiation of labor. 
Further investigation into factors affecting decidual leukocytes may expand our 
understanding of the immunological events at the maternal-fetal interface. 
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INTRODUCTION 
In the late secretory phase of the menstrual cycle, the mucosal lining of the 
uterus transforms from the endometrium into the decidua in preparation for 
pregnancy. During this hormone-dependent process, endometrial glands 
enlarge, spiral arteries become tortuous, and stromal cells differentiate into 
large glycogen-filled decidual cells to support placental implantation and growth 
(1, 2). Importantly, leukocytes become a prominent cell population in the 
decidua, including CD56brightCD16- uterine natural killer (NK) cells, 
macrophages and T cells (3-5). The cellular composition of the decidua, however, 
is dynamic and changes in proportion and distribution during the menstrual 
cycle and throughout pregnancy. (4, 6-14). Serving as an immunologically 
specialized tissue, the decidua and its components carry out multiple functions 
and play an essential role in implantation and in the maintenance of pregnancy 
(1, 15). Decidual leukocytes may contribute both directly and indirectly by 
expressing receptors that potentially mediate fetal trophoblast recognition and 
invasion and by producing cytokines that modulate and regulate maternal 
immune and vascular function (16, 17). 
 
Upon implantation, the decidua is in direct contact with fetal extraembryonic 
tissue, thus establishing the maternal-fetal interface. By term pregnancy, there 
are two distinct regions of the maternal-fetal interface: one in the placenta 
between the decidua basalis and the invading interstitial trophoblasts, and the 
other at the fetal membranes between the decidua parietalis and the 
amniochorion. While direct cell-to-cell contact between decidua basalis and fetal 
tissue occurs just six days after fertilization, direct contact between decidua 
parietalis and fetal tissue occurs only in the second trimester of pregnancy as 
fetal growth obliterates the chorionic and uterine cavities (1). Our recent studies 
on decidua collected after elective cesarean section revealed that there are 
significant differences between term decidua basalis and decidua parietalis. 
Flow cytometric quantification of decidual leukocyte subpopulations showed a 
significantly higher percentage of CD56brightCD16- NK cells and of CD3+ T cells 
expressing activation markers CD25, human leukocyte antigen (HLA)-DR, 
CD45RO, or CD69 in the decidua parietalis in comparison to the decidua basalis 
indicative for a differential immunoregulation in these two regions of the 
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maternal-fetal interface (18, 19). 
 
Spontaneous labor at term is associated with specific changes in the distribution 
and proportion of leukocyte subpopulations and in various immunologic 
mediators found in gestational tissues, including cervix,  myometrium, and 
decidua, and also in umbilical cord blood and maternal peripheral blood when 
compared to cesarean section without labor (20-35). The changes suggest that 
the stress of labor possibly has an important effect on immunoregulatory 
processes in gestational tissues. The aim of this study, therefore, was to 
determine the effect of labor on decidual leukocytes by quantifying decidual 
leukocyte subpopulations and the activation state of T cells in term decidua 
basalis and decidua parietalis obtained from spontaneous vaginal delivery 
(SVD) and comparing the results with those of elective cesarean section (CS). 
 
 
MATERIALS AND METHODS 
Subjects 
The study population consisted of 50 pregnant women from the Leiden 
University Medical Center in Leiden, the Netherlands undergoing delivery in a 
one and a half year period between October 2001 and April 2003. Paired normal 
term decidua basalis and parietalis samples were obtained from two groups of 
term deliveries: term SVD (gestational age range: 38-42.1 weeks; maternal age 
range: 20.5-40.4 years; n=20) and term elective CS before the onset of labor 
indicated for breech presentation (gestational age range: 38-41.6 weeks; 
maternal age range: 21.4-42 years; n=30). All women in the CS group received 
combined spinal epidural anesthetia prior to the procedure. Although such 
anesthesia can cause minimal changes in systemic maternal blood pressure, a 
significant effect caused by a difference in the use of anesthesia on decidual 
leukocytes is unlikely due to, firstly its regional use and secondly to the low dose 
of the anesthetic used. No general anesthesia was administered to this group. 
The incidence of the use of epidurals in the SVD group is 15%. Some samples 
from the CS study group were used in previous publications (18, 19). Women in 
which a caesarean was performed after having labour were excluded from the 
study  as the proportion of lymphocyte subsets in decidua obtained could have 
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potentially affected by other factors as prolonged duration of labor or fetal 
distress, for which we could not control. All deliveries followed uncomplicated 
pregnancies and resulted in the birth of a non-growth restricted healthy 
neonate. Informed consent was obtained from all women, and the study received 
the appropriate ethical approval by the Leiden University Medical Ethics 
Committee. 
 
Isolation of decidua basalis and parietalis cells 
Term decidua basalis tissue was macroscopically dissected from the central 
region of the maternal-facing surface, and term decidua parietalis tissue was 
collected by removing the amnion and delicately scraping the tissue from the 
chorion. Areas of ischemia or necrosis were avoided. The obtained tissue was 
thoroughly washed and finely minced between two scalpel blades in phosphate 
buffered saline (PBS). Minced decidual fragments were gently worked through 
an open filter chamber (NPBI International BV, Emmer-Compascuum, the 
Netherlands, and Beldico, Marche-en-Famenne, Belgium) with PBS. The 
resultant suspension was filtered through a 70µm sieve (Becton Dickinson, 
Labware; Franklin Lakes, New Jersey), washed in PBS, and layered on an equal 
volume of ficoll hypaque (Leiden University Medical Center Pharmacy; Leiden, 
the Netherlands) at room temperature for density gradient centrifugation (for 
20 minutes at 800g). Mononuclear cells were collected from the interface, 
washed twice, and resuspended in PBS for cell staining. 
 
Cell Staining 
Directly conjugated fluorescent antibodies directed against the following 
antigens were used for two- and three-color immunofluorescence staining: CD45 
[HLe-1; Fluorescein isothyocyanate (FITC)], CD14 [Leu-M3; Phycoerythrin 
(PE)], CD3 [Leu-4; Allophycocyanin (APC) or Peridinin Chlrophyll-a Protein-
Cytochrome 5.5 (PerCP-Cy5)], CD8 (Leu-2a; FITC), CD4 (Leu-3a; PE), CD19 
(Leu-12; FITC), CD56 (Leu-19; FITC, Leu-19; PE), CD16 (Leu-11a; FITC, Leu-
11c; PE), CD25 (Anti-IL-2R; FITC), HLA-DR (Anti-HLA-DR; PE), CD45RA (Leu-
18; FITC), CD45RO (UCHL1; PE), CD69 (Leu-23; FITC), and TCRαβ (WT31; 
FITC) all from Becton-Dickinson Immunocytometry Systems (San Jose, CA, 
USA) and TCRγδ (5A6.E9; FITC, Serotec, Oxford, England and Biocarta, 
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Hamburg, Germany).  
 
Cells were stained with monoclonal antibodies at a density of 106 cells/ ml in 
PBS (100µl/ sample) and incubated for 30 minutes at 40C in the dark. Following 
two washes with PBS, cells were resuspended and fixed with PBS containing 1% 
paraformaldehyde. Cells were then analyzed on a Becton-Dickinson FACScan 
flow cytometer. The double-labeled CD45 and CD14 sample was used to 
establish the optimal lymphocyte gate based on the light scattering profile and 
immunofluorescence (36). Although a leukocyte gate was established, the 
percentage of CD45+ cells was often not high in this gate presumably due to red 
blood cells or dead cells that were also present in this gate. The purpose of this 
gate was simply to better define the leukocyte population and to exclude most of 
the cells with high forward and side scatter from the flow cytometric analysis. 
Approximately 5,000 events were acquired in the gating window. The acquired 
data were then analyzed using Becton-Dickinson CellQuestTM software (San 
Jose, CA, USA). The percentages of CD14+, CD19+ and CD3+ cells were 
calculated within and represented as a percentage of the CD45+ cell fraction. To 
characterize the expression of CD16 and CD56, the percentages of CD56-CD16+ 
cells, CD56dimCD16+ NK cells and CD56brightCD16- uterine NK cells were 
established by delineating regions around these various populations. To 
determine the expression of activation markers on T cells, cells that were within 
the leukocyte gate and that were also positive for CD3 were gated based on 
these two parameters and analyzed for the expression of the activation marker 
of interest. For 10 samples in each study group, the co-expression of CD4 or CD8 




The Mann-Whitney test, a non-parametric non-paired t-test, was performed to 
identify differences in decidual leukocyte subsets between the two study groups. 
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RESULTS 
Leukocytes subpopulations in term decidua basalis and parietalis after 
SVD or CS 
Leukocytes isolated from normal term decidua basalis and parietalis obtained 
following SVD and CS were analyzed by flow cytometry. No significant 
differences were found between CD45+ cell percentages in decidua basalis or 
decidua parietalis from SVD and CS. Specific subpopulations of leukocytes, 
however, significantly differed within the CD45+ cell fraction. In decidua basalis 
from SVD, there was a significantly decreased percentage of CD14+ 
macrophages and increased percentage of CD19+ B cells in comparison to 
decidua basalis from CS (Fig 1a). In decidua parietalis from SVD, the 
percentage of CD14+ cells was also significantly decreased in comparison to 
decidua parietalis from CS, while there was no significant difference in the 
percentage of CD19+ cells in the decidua parietalis from SVD and CS (Fig. 1b). 
 
CD56 and CD16 expression on term decidua basalis and parietalis 
leukocytes after SVD or CS 
In decidua parietalis from SVD and CS, there were similarly high percentages of 
CD56brightCD16- uterine NK cells (17.6% and 22.1%), while in decidua basalis 
from SVD and CS, there were equally low percentages of uterine NK cells (4.5% 
and 5.6%).  The differential distribution of CD56brightCD16- uterine NK cells in 
decidua parietalis and basalis was not affected by labor. No significant 
differences were found in the percentage of CD56-CD16+ cells in decidua basalis 
from SVD and CS or decidua parietalis from SVD and CS. In contrast, decidua 
basalis and decidua parietalis from SVD contained significantly higher 
percentages of CD56dimCD16+ NK cells (13.8% and 10.4%) respectively compared 
to decidua basalis (9.8%; p=0.0415)  and decidua parietalis from CS (5.3%; 
p=0.0203) (Fig. 1a; Fig. 1b). 
 
 
T cells in term decidua basalis and parietalis after SVD or CS 
Within the CD3+ T cell population (Table 1), there were no significant 
differences in the percentages of CD4+, CD8+, TCRαβ+ and TCRγδ+ cells in 
decidua basalis from SVD and CS. In decidua parietalis from SVD, there was a 
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significant increase in the percentage of CD3+CD4+ cells and a significant 
decrease in the percentage of CD3+CD8+ cells in comparison to that of decidua 
parietalis from CS (p=0.0066 and p=0.0420, respectively). T cells expressing 
activation markers, CD25, HLA-DR, CD45RO and CD69, and expressing a naïve 
T cell marker, CD45RA, were determined in decidua basalis and parietalis from 
SVD and CS. There were no significant differences in the percentages of 
CD3+CD45RA+, CD3+CD45RO+ and CD3+CD69+ cells when comparing decidua 
basalis from SVD and CS and decidua parietalis from SVD and CS. Importantly, 
the percentage of CD3+ cells expressing the markers of activation, CD25 and 
HLA-DR, was significantly lower in the decidua basalis and parietalis from SVD 
when compared to decidua basalis and parietalis from CS (Fig. 2a; Fig. 2b). 
 
CD3+CD25+ and CD3+HLA-DR+ cells in term decidua basalis and 
parietalis after SVD or CS 
To characterize the CD3+ T cells expressing CD25 and HLA-DR, these 
populations were analyzed for their expression of CD4 and CD8 using three-
color immunofluorescence. The majority of CD3+CD25+ cells in decidua basalis 
and parietalis from SVD and CS expressed CD4, while the generally more 
CD3+HLA-DR+ cells in decidua basalis and parietalis from SVD and CS 
expressed CD8. Notably, the lower number of CD3+CD25+ cells in decidua from 
SVD was due to a lower number of CD3+CD4+CD25+ cells, while the lower 
number of CD3+HLA-DR+ cells was due to a lower number of both 










































































calculated within the CD45+ cell fraction
Figure 1b. Mean percentage of leukocytes in normal term decidua parietalis collected 
from SVD or CS. Column error bars represent the SEM. * p<0.05, ** p<0.005, Mann-
Whitney  test.  Decidua parietalis from SVD Decidua parietalis from CS 
Figure 1a. Mean percentage of leukocytes in normal term decidua basalis collected 
from spontaneous vaginal delivery (SVD) or elective cesarean section (CS). Column 
error bars represent the standard error of the mean (SEM). * p<0.05, ** p<0.005, Mann-


























calculated within the CD45+ cell fraction









































































































































































































Figure 2a. Mean percentage of CD3+ lymphocytes expressing activation markers, 
CD25, HLA-DR, CD45RO and CD69 in normal term decidua basalis collected from SVD 
or CS. Column error bars represent the SEM. * p<0.05, ** p<0.005, Mann-Whitney test.                  
        Decidua basalis from SVD             Decidua basalis from CS 
Figure 2b. Mean percentage of CD3+ lymphocytes expressing activation markers, 
CD25, HLA-DR, CD45RO and CD69 in normal term decidua parietalis collected from 
SVD or CS. Column error bars represent the SEM. * p<0.05, ** p<0.005, Mann-Whitney  
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Table 1. Comparison of the mean percentage of CD3+ lymphocytes expressing various 
T cell markers in normal term decidua basalis or decidua parietalis between sponta-
























CD3+CD4+ 53.9 52.5 NS 52.5 44.1 p=0.0066 
CD3+CD8+ 46.4 43.3 NS 48.3 52.8 p=0.0420 
CD3+TCR-αβ+ 89.8 90.2 NS 90.4 87.2 NS 
CD3+TCR-γδ+ 8.8 7.6 NS 9.9 12.5 NS 
CD3+CD25+ 5.5 14.0 p<0.0001 13.9 23.4 p=0.0123 
CD3+ 
CD4+CD25+ 
3.7 14.3 p=0.0260 7.4 17.7 p=0.0303 
CD3+ 
CD8+CD25+ 
0.6 0.6 NS 2.8 2.5 NS 
CD3+HLA-DR+ 17.7 25.1 p=0.0367 33.2 62.1 p<0.0001 
CD3+ 
CD4+HLA-DR+ 
5.6 10.3 p=0.0400 13.7 26.2 p=0.0193 
CD3+ 
CD8+HLA-DR+ 
6.2 11.2 p=0.0303 19.5 37.9 p=0.0101 
CD3+CD45RA+ 38.7 44.4 NS 24.4 30.1 NS 
CD3+CD45RO+ 55.7 54.4 NS 74.3 72.3 NS 
CD3+CD69+ 13.7 13.7 NS 51.9 50.8 NS 
aMann-Whitney test 
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DISCUSSION 
Comparison of decidua collected after SVD and CS suggests that labor is 
associated with significant differences in the distribution and proportion of 
specific subpopulations within the CD45+ cell fraction, including CD14+ 
macrophages, CD19+ B cells, CD56dimCD16+ NK cells, CD3+CD4+ cells, 
CD3+CD8+ cells and CD3+ T cells expressing CD25 or HLA-DR. 
 
Spontaneous labor at term can be described as a cascade of events that is 
associated with specific changes in leukocyte subpopulations, cell adhesion 
molecule expression and various immunologic mediators. In umbilical cord 
blood, neutrophils, monocytes, and NK cells are significantly increased following 
labor when compared to that after CS, while T cells are significantly decreased 
(33, 37). Enumeration of leukocyte subpopulations in maternal peripheral blood 
shows an increase in the total white blood cell count following labor (22). In the 
cervix, leukocytes, predominantly macrophages and neutrophils infiltrate 
concurrent with the process of cervical ripening and labor (20, 24, 29). In the 
myometrium, there is similarly a massive influx of macrophages and 
neutrophils as well as T cells in the lower uterine segment at the onset of labor 
at term (34). In the current study, it is established that the percentages of 
macrophages and CD56dimCD16+ NK cells increase and the percentages of 
CD3+CD4+CD25+ cells and CD3+CD4+HLA-DR+ and CD3+CD8+HLA-DR+ cells 
decrease in the decidua basalis and parietalis after SVD. 
 
A possible mechanism to account for the changes in decidual leukocytes 
following labor may involve migration of these cells to or from other tissue sites, 
such as to the cervix or myometrium or from peripheral blood. The decreased 
percentage of macrophages found in the decidua basalis and parietalis following 
labor in the current study may account for the presence of these cells in the 
cervix or myometrium. It has been suggested that cell adhesion molecules are 
involved in the control of leukocyte infiltration in the cervix and myometrium 
during late pregnancy, cervical dilation and labor (34, 38, 39). Cytokines such as 
Interleukin (IL)-1b, IL-6, IL-8, and Tumor Necrosis Factor-α are expressed in 
various gestational tissue sites and increase following spontaneous labor (29, 
35). The increased percentage of CD56dimCD16+ NK cells found in the decidua 
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basalis and parietalis following labor may be mediated by specific signaling 
mediators, such as cytokines or chemokines. CD56dimCD16+ NK cells express 
chemokine receptors CXCR1, CXCR2, CXCR3, CXCR4 and CX3CR1 (40). It is 
plausible that these cells are recruited from the peripheral blood where they 
represent the major NK cell subclass to the decidua during labor by chemokines. 
In the current study, there was a significantly higher percentage of CD19+ B 
cells in decidua basalis from SVD compared to that from CS. B cells, however, 
are virtually absent or found in very low percentages in decidua basalis and 
parietalis from term pregnancy following CS (6, 13, 14, 18). It is possible that 
the process of labor preferentially could attract and activate B cells in the 
decidua basalis. 
 
In several previous studies, placentas from uncomplicated pregnancies were 
examined for acute inflammation in the chorion-decidua parietalis by analyzing 
and grading histologic samples for the presence of polymorphonuclear 
leukocytes. Following the onset of labor, there was, in fact, a significant increase 
in polymorphonuclear leukocytes (26, 31). It is difficult, however, to clearly 
define leukocyte subpopulations by routine histology. In a study by Osman et al. 
(29), several leukocyte subpopulations in decidua parietalis were quantified and 
compared before and after labor using immunohistochemistry. Histological 
analysis demonstrated that the median density of CD45+ leukocytes, CD68+ 
macrophages, neutrophils, CD3+ T cells, CD20+ B cells was similar in decidua 
parietalis following CS without labor and CS with labor. Our findings in decidua 
parietalis are in general agreement with those of Osman et al. (29). We extend 
the findings by quantifying NK and T-cell subpopulations in decidua basalis and 
parietalis. Contrary to the study of Osman et al. (29), a decreased percentage of 
CD14+ in decidua parietalis was found following labor in the current study, the 
small disparity between the two studies could be due to differences in the labor 
study group (CS with labor and SVD), the antibody used to identify 
macrophages (CD68 and CD14), or the method of leukocyte quantification 
(immunohistochemistry and flow cytometry). 
 
Our previous studies on decidua collected after elective CS revealed that there 
are significant differences between term decidua basalis and decidua parietalis, 
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including a higher percentage of CD56brightCD16- NK cells and CD3+CD25+ cells 
in the decidua parietalis (18, 19). The current study extends our previous 
findings to establish that decidua parietalis contains a significantly higher 
percentage of CD56brightCD16- uterine NK cells regardless of the effect of labor. 
Importantly, the majority of CD3+CD25+ cells in decidua basalis and parietalis 
express CD4 and may represent a small population of regulatory T cells. 
Regulatory T cells are a unique cell population able to control the immune 
responsiveness to alloantigens via cell-to-cell contact and are essential for the 
active suppression of autoimmunity and for transplantation tolerance (41, 42). 
Recent studies have demonstrated that CD4+CD25+ regulatory T cells express 
CD25 at higher levels and more persistently than activated T cells (43, 44).
These CD4+CD25bright regulatory T cells are capable of inhibiting proliferation 
and cytokine secretion induced by TCR cross-linking of CD4+CD25- responder T 
cells in a contact-dependent manner (44). In a pilot study, we tried to 
distinguish CD4+CD25+ regulatory T cells from CD4+CD25+ activated T cells by 
the level of CD25 expression. These preliminary experiments showed a higher 
percentage of CD4+CD25bright T cells in the CD4+CD25 T cell population in the 
decidua parietalis in comparison to the decidua basalis. A reduction of this 
population of CD4+CD25bright T cells was observed when SVD samples were 
compared to CS samples. While regulatory T cells have not been described in the 
decidua, they could potentially serve as mediators in maternal tolerance of the 
fetal compartment by potently suppressing the activation and proliferation of 
CD4+CD25- T cells and also CD8+ T cells. The decrease or disappearance of 
regulatory T cells from the decidua potentially enables the activated alloreactive 
CD4+CD25- and CD8+ T cells to reach their effector status thus initiating the 
process of labor and delivery. To characterize these cells as regulatory T cells, 
determination of their expression of Foxp3, a unique and critical regulator in 
regulatory T cell development and function (45), or their expression of GITR, a 
member of the Tumor Necrosis Factor receptor superfamily that plays a key role 
in immunological self-tolerance (46, 47), is necessary for future studies. 
 
Identification and comparison of the effects of labor on leukocytes in the decidua 
basalis and parietalis suggests that labor significantly affects the distribution 
and proportion of certain leukocyte subpopulations. Further investigation into 
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the nature and function and into the regulation of these leukocytes at the 
maternal-fetal interface is necessary to understand the events occurring during 
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ABSTRACT 
In term placenta, contact between maternal and fetal tissue occurs between 
decidua basalis and invading trophoblasts and between decidua parietalis and 
amniochorion. In earlier studies, we found a higher percentage of uterine NK 
cells and activated T cells in decidua parietalis compared to decidua basalis. Our 
aim was to study the capacity of these maternal cells to produce an alloimmune 
response to the fetus. Samples of decidua basalis and parietalis, maternal 
peripheral blood (PB), and umbilical cord blood (UCB) were obtained from 10 
maternal-fetal pairs after elective cesarean section. Allogeneic PB was obtained 
from HLA-typed volunteers. Purified responder leukocyte populations were co-
cultured for 4 days in a mixed lymphocyte culture (MLC) with autologous 
maternal serum and irradiated stimulators including UCB, maternal, and 
allogeneic PB leukocytes (PBL). Furthermore, the cytokine production induced 
by this interaction with allogeneic cells was measured. A proliferative 
alloimmune response was observed in term decidual leukocytes both against 
UCB and allogeneic cells as stimulators. This proliferation was associated with 
the production of IFN-γ and IL-2. We conclude that maternal leukocytes present 
in term decidua basalis and parietalis are capable of producing an alloimmune 
response to UCB including the production of T helper 1 cytokines. 
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INTRODUCTION 
The mechanism by which the fetus avoids rejection and by which the 
functionally intact maternal immune system tolerates the fetus is the central 
question in reproductive immunology posed over fifty years ago by Medawar and 
Billingham (1, 2). The decidua, the maternal tissue in direct contact with fetal 
extraembryonic tissue, has been a focus of much investigation in an attempt to 
elucidate mechanisms involved in the delicate immunologic balance of 
pregnancy. This tissue originates from the mucosal lining of the uterus and 
establishes the maternal-fetal interface upon fertilization. By term pregnancy, 
there are two distinct regions of the maternal-fetal interface where maternal 
decidua contacts fetal tissue – one is at the placenta between the decidua 
basalis, the site of implantation, and the invading interstitial trophoblasts; and 
the other is at the fetal membranes between the decidual parietalis, the tissue 
lining the remainder of uterine cavity and the amniochorion. Focusing primarily 
on the decidua basalis, immunohistological and flow cytometric studies of first 
trimester and term pregnancy decidua have identified numerous cells of bone 
marrow origin, including macrophages, T lymphocytes, and uterine NK cells 
with a unique CD56brightCD16-CD3- phenotype (3-9). The proportions of these 
cell populations change throughout pregnancy (10); however, the role of these 
cells in implantation, placentation, and the maintenance of pregnancy is 
unclear. Our recent studies on decidual leukocytes revealed that there are 
significant differences in the distribution and proportion of these cells when 
comparing decidua basalis and decidua parietalis derived from placentas of 
uncomplicated term pregnancies following elective cesarean section. Flow 
cytometric quantification showed a significantly higher percentage of 
CD56brightCD16- NK cells and of CD3+ T cells expressing activation markers 
CD25, Human Leukocyte Antigen (HLA)-DR, CD45RO, or CD69 in the decidua 
parietalis in comparison to the decidua basalis (11, 12). This difference suggests 
that the regulation of leukocytes in these two regions of the maternal-fetal 
interface and their in vivo function may differ. 
 
The aim of this study was to examine the function of leukocytes isolated from 
term decidua basalis and parietalis by measuring their proliferation and 
cytokine production in response to various stimuli including fetal and allogeneic 
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blood leukocytes in a one-way mixed lymphocyte culture (MLC) and by 




MATERIALS AND METHODS 
Samples 
Samples of maternal peripheral blood (PB), decidua basalis and parietalis and 
umbilical cord blood (UCB) were obtained at the time of delivery from ten 
maternal-fetal pairs following uncomplicated term pregnancies which were 
selected on the basis that they had an HLA-DR mismatch. Because vaginal 
delivery is associated with changes in decidual leukocytes (13), only samples 
from pregnant women delivering by elective cesarean section prior to the onset 
of labor were selected. All cesarean sections were performed for breech 
presentation and resulted in the birth of a non-growth restricted healthy 
neonate. Informed consent was obtained from all women, and ethical approval 
was received from the Leiden University Medical Ethics Committee. Molecular 
typing was performed on DNA obtained from all maternal and fetal blood 
samples by polymerase chain reaction /sequence-specific oligonucleotide using a 
reverse dot-blot method (14). 
 
Decidua 
Term decidua basalis tissue was macroscopically dissected from the maternal-
facing surface, and term decidua parietalis tissue was collected by removing the 
amnion and delicately peeling the tissue from the chorion. Any areas of ischemia 
or necrosis were avoided. To avoid selective cell death or selective loss of surface 
proteins, mechanical disaggregation rather than enzymatic digestion was used 
to process decidual tissue and to isolate decidual leukocytes. The tissue was 
thoroughly washed and finely minced between two scalpel blades in phosphate 
buffered saline (PBS) (Leiden University Medical Center Pharmacy, Leiden, the 
Netherlands). Minced decidual fragments were gently worked through an open 
filter chamber (Beldico, Marche-en- Famenne, Belgium) with PBS. The 
resultant suspension was filtered through a 70µm sieve (Becton Dickinson 
Labware, Franklin Lakes, New Jersey, USA), washed in PBS and layered on an 
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equal volume of ficoll hypaque (Leiden University Medical Center Pharmacy, 
Leiden, the Netherlands) at room temperature for density gradient 
centrifugation for 20 minutes at 800g. Mononuclear cells were collected from the 
interface, washed twice, counted and resuspended for culture. 
 
Maternal Peripheral Blood and Umbilical Cord Blood 
For each maternal-fetal pair, maternal PB (20ml) was drawn before the 
cesarean section and collected into a heparinized tube for leukocyte isolation 
and also into a glass tube for isolation of maternal serum for later use in cell 
culture. UCB (10ml) was obtained from the umbilical vein after cord clamping 
and collected into a heparinized tube. Mononuclear cells were similarly isolated 
by density gradient centrifugation as abovementioned and resuspended for 
culture. 
 
Allogeneic Peripheral Blood 
Allogeneic PB was obtained from three random HLA-typed volunteers. PBL 
were isolated from heparinized blood by density gradient centrifugation and 
frozen in (RPMI) 1640 medium (Gibco, Paisley, Scotland) with 20% fetal calf 
serum (Greiner, Frickenhausen, Germany) and 10% dimethlysulfoxide (Fluka, 
Buchs, Switzerland) at -700C and stored in liquid nitrogen until use. For use in 
cell culture, cells were resuspended in 2ml of FCS, washed twice in RPMI 1640 
medium supplemented with 2mM L-glutamine (Gibco, Paisley, Scotland), 100U/
ml penicillin and 100 µg/ml streptomycin (Gibco, Paisley, Scotland), counted and 
resuspended at the appropriate cell concentration. 
 
One-way Mixed Lymphocyte Culture 
Cultures were established in triplicate in 96 well v-bottomed plates (Costar, 
Cambridge, MA, USA) in a total volume of 150µl of RPMI 1640 medium 
supplemented with 2mM L-glutamine, 100U/ml penicillin and 100 µg/ml 
streptomycin and 10% autologous maternal serum. Each well contained 1x 105 
responder cells in 100µl of culture medium and 1x 105 irradiated (3000 rad) 
stimulator cells in 50µl of culture medium. Combinations of responder and 
stimulator cells from each maternal-fetal pair were established. Responder cells 
included decidua basalis leukocytes, decidua parietalis leukocytes, maternal PB 
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leukocytes (PBL), and allogeneic (HLA-mismatched) PBL. Medium alone and 
anti-CD3 stimulation (see below) were used as controls for the responder cells. 
Stimulator cells included corresponding umbilical cord blood lymphocytes from 
the maternal-fetal pair and allogeneic PBL. Stimulator controls included 
decidua basalis leukocytes, decidua parietalis leukocytes, maternal PBL, and 
medium alone. Stimulator cells were irradiated at 3000 rads before culture to 
prevent their proliferation. Cultures were incubated for 96 hours at 370C in a 
humidified atmosphere of 5% CO2. Fifty µl of supernatant was removed from 
each triplicate well and pooled for cytokine analysis. Cultures were pulsed with 
1µCi/ well 3H thymidine diluted in RPMI 1640 medium, incubated for another 
18 hours at 370C in a humidified atmosphere of 5% CO2, and then harvested. 
Thymidine incorporation was measured by liquid scintillation counter (Wallac, 
Turku, Finland). Results were expressed as the median counts per minute (cpm) 
for each triplicate culture. 
 
Cytokine Analysis 
To analyze cytokine concentration in the supernatant, TH1 and TH2 Human 
Cytokine Becton-Dickinson Cytometric Bead Array (CBA) Kit II (San Jose, CA, 
USA) was used. The kit included six bead populations with distinct fluorescence 
intensities coated with capture antibodies specific for IL-2, IL-4, IL-6, IL-10, 
Tumor Necrosis Factor (TNF)-α, Interferon (IFN)-γ proteins. The CBA beads 
were then mixed with the phycoerythrin (PE)-conjugated detection antibodies 
and then incubated with recombinant standards or test samples to form 
sandwich complexes. Following acquisition of sample data using the Becton-
Dickinson FACScan flow cytometer, the sample results were generated in a 
graphical and tabular format using the Becton-Dickinson CBA Analysis 
Software (San Jose, CA, USA). 
 
Anti-CD3 Stimulation 
Anti-CD3 stimulation of responder cells was performed in triplicate in a 96 well 
flat-bottom plate (Costar, Cambridge, MA, USA). Fifty µl of anti-CD3 (OKT3, 
Orthoclone, Leiden University Medical Center Pharmacy, Leiden, Netherlands) 
diluted in PBS or RPMI at 1µg/ml concentration was added to coat each test well 
and incubated for 2 hours at 370C. The OKT3 suspension was pipeted out of the 
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wells, and wells were washed twice with PBS. Five x 104 responder cells in 
200µl of culture medium were then added. Responder cells included leukocytes 
from decidua basalis, decidua parietalis, maternal PB and allogeneic PB; culture 
medium was used as a control. The plate was incubated for 4 days at 370C in a 
humidified atmosphere of 5% CO2, and 100µl of supernatant was removed from 
each triplicate well and pooled for cytokine analysis. Cultures were pulsed with 
1 µCi/ well 3H thymidine diluted in RPMI 1640 medium, incubated for another 
18 hours at 370C in a humidified atmosphere of 5% CO2, and then harvested. 3H 
thymidine incorporation was measured by liquid scintillation counting. Results 
were expressed as the median cpm for each triplicate culture. 
 
Statistical Analysis 
To compare proliferative responses of decidual leukocytes and maternal and 
allogeneic PB with paired controls, the Wilcoxon signed rank test, a non-






The cultures of term leukocytes from decidua basalis produced significant 
proliferative response to anti-CD3 (p=0.031), as did leukocytes from decidua 
parietalis (0.031). Furthermore, in response to anti-CD3, significant 
proliferation was seen in cultures of maternal PBL (p=0.008). 
 
The proliferative responses of term decidua leukocytes and maternal PBL are 
summarized in Table I, which depict the analysis performed in the 10 maternal-
fetal pairs. A significantly higher proliferative response was seen in leukocytes 
from term decidua basalis and parietalis against both UCB cells (p=0.039 and 
p=0.014, respectively) and against allogeneic PBL as stimulators (p=0.004 and 
p=0.002, respectively). The response of decidual leukocytes against stimulator 
controls, including autologous cells from decidua and from maternal PB, was not 
significantly different from responses to medium alone. Comparing the response 
of decidua basalis leukocytes against UCB to that of decidua parietalis against 
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UCB revealed no statistically significant difference (p=0.301). There was, 
however, a significantly higher proliferation by decidua basalis leukocytes in 
response to allogeneic PBL (p=0.020) in comparison to proliferation by decidua 
parietalis leukocytes. 
 
Table I also depicts the responses of maternal and allogeneic PBL to the various 
stimuli. Predictably, maternal PBL showed a significant response to UCB cells 
(p=0.012) and to allogeneic PBL cells (p<0.0001). Furthermore, leukocytes from 
allogeneic PB proliferated in response to stimulation by decidua basalis 
(p=0.008) and decidua parietalis (p=0.016), and similarly in response to controls 
of UCB (p=0.002) and of maternal PB (p=0.003). 
 
Cytokine Analysis  
The proliferative response of leukocytes from decidua basalis, decidua parietalis 
or allogeneic PB when stimulated with UCB and allogeneic PB cell populations 
were associated with production of IFN-γ and IL-2 (Figure 1 and 2). There was a 
higher production of IFN-γ and IL-2 in cultures of decidua basalis or parietalis 
when these cells were stimulated with UCB in comparison to control autologous 
stimulation with decidua basalis or parietalis, respectively. Furthermore, there 
was a significantly higher production of IFN-γ (p=0.016) in cultures of decidua 
basalis with allogeneic PB as stimulator as compared to the control. IFN-γ and 
IL-2 production was also higher in cultures of decidua parietalis with allogeneic 
PB as stimulator. No significant production of TNF-α, IL-10 or IL-4 was 
observed in these experiments, whereas IL-6 was found in all cases (data not 
shown). In accordance with the proliferation data, a higher production of IFN-γ 
and IL-2 was found in cultures of maternal PBL as responder with allogeneic 
PBL or UCB as stimulator. There was no production of TNF-α, IL-10 or IL-4 
above background, whereas IL-6 was found in all cases (data not shown). 
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Table I. Proliferation measured in counts per minute (cpm) of decidua basalis, 
decidua parietalis, maternal PB, and allogeneic PB in response to decidua basa-
lis, decidua parietalis, maternal PB, UCB, allogeneic PB, and anti-CD3 statisti-
cally compared to the proliferation when cultured with medium alone (n=10). 
Responder Stimulator cpma (Range) P Valueb 
D. basalis Medium 1585 (133.8- 5341)  
 D. parietalis 1695 (160.7-6517) 0.438 (NS) 
 Maternal PB 1724 (411.8-4693) 0.910 (NS) 
 UCB 3584 (89.50- 9482) 0.039 
 Allogeneic PB 7522 (2347-14320) 0.004 
 Anti-CD3 87770 (22390-157600) 0.031 
D. parietalis Medium 1009 (143.4-3461)  
 D. basalis 1028 (266.1-2867) 0.578 (NS) 
 Maternal PB 980.8 (181.1-1877) 0.846 (NS) 
 UCB 1931 (130.6-6038) 0.014 
 Allogeneic PB 3154 (573.5-8360) 0.002 
 Anti-CD3 61090 (4197-111200) 0.031 
Maternal PB Medium 280.6  (102.1-908.8)  
 D. basalis 756.9 (102.1-2183) 0.156 (NS) 
 D. parietalis 205.7 (50.30-406.6) 0.938 (NS) 
 UCB 3057 (140.8-6113) 0.012 
 Allogeneic PB 8450 (992.1-18910) <0.0001 
 Anti-CD3 116300 (85060-157200) 0.008 
Allogeneic PB Medium 302.5  (55.70-1137)  
 D. basalis 10510 (131.6-27660) 0.008 
 D. parietalis 9645 (168.4-27460) 0.016 
 UCB 6619 (1444-20760) 0.002 
 Maternal PB 8000 (352.3-15690) 0.003 
 Anti-CD3 49900 (3335-115400) 0.008 














CHAPTER  5 
Figure 1. IL-2 cytokine production in MLC of decidua basalis (D. bas) or decidua parietalis 
(D. par) as responder with either autologous cells or UCB as stimulator. 
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The function of leukocytes in the decidua basalis and parietalis, including their 
ability to proliferate in response to fetal or allogeneic cells and their ability to 
produce cytokines is an important focus in order to understand the role of these 
cells in the maintenance of pregnancy. In the current study, we used a one-way 
MLC to assess these functions and compared it to maternal and allogeneic 
peripheral blood at term pregnancy. Furthermore, it was found that these 
decidual leukocytes proliferated and produced cytokines in response to fetal and 
allogeneic cells. These findings indicate that decidual leukocytes are capable of 
initiating and stimulating a classical alloimmune response. 
 
It has been well established that decidual leukocytes from both first trimester 
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Figure 2. IFN-gamma cytokine production in MLC of decidua basalis (D. bas) or decidua 
parietalis (D. par) as responder with either autologous cells or UCB as stimulator. 
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and term pregnancy decidua do not proliferate in response to extravillous 
trophoblasts from the chorion or chorionic laeve (9, 15, 16). Three MHC class I 
molecules have been detected on extravillous trophoblast, including HLA-C, 
HLA-G and HLA-E (17-22). These molecules interact with specific receptors, 
such as CD94/NKG2A and killer-cell immunoglobulin-like receptors (KIR) that  
are expressed by subpopulations of NK and γδ T cells and also by subpopulations 
of memory αβ T cells (23-28). It is suggested that the expression of KIR by 
decidual cells leads to the protection of fetal trophoblasts (29, 30) and that the 
stimulation of lymphocytes is essential at the placental interface (31, 32). 
 
To our knowledge, there are no previous studies that examine the proliferation 
of decidual leukocytes from early or term pregnancy in response to fetal UCB 
cells. In the current study, a significantly higher proliferative response was seen 
when leukocytes from term decidua basalis and parietalis were cultured with 
UCB cells, cells of fetal origin, as compared to controls. It has been shown that 
UCB cells are capable of eliciting a proliferative response as stimulators in a 
MLC comparable to that of irradiated adult PBL (33). Although UCB cells 
essentially do not come into direct physical contact with decidual leukocytes due 
to anatomical separation, fetal cells of hematopoietic origin such as nucleated 
red blood cells, lymphocytes, and stem cells enter the maternal circulation 
during all pregnancies (34-36). Furthermore, it is of scientific interest to confirm 
that term decidual leukocytes are capable of eliciting an immune response 
against cells of fetal origin, a finding not previously reported. In this study, we 
show that in the decidua (basalis and parietalis) alloreactive cells respond to 
HLA mismatched allogeneic PBL and also towards UCB of the fetus. The 
recognition of MHC alloantigens by T cells occurs via two distinct pathways, a 
direct and indirect pathway (37). In the direct pathway, T cells recognize 
alloantigens as intact molecules on allogeneic stimulator cells. In the indirect 
pathway, T cells recognize alloantigens presented by self MHC molecules. In the 
current study, it is plausible that the mechanism by which decidual leukocytes 
recognize and mount an immune response may occur via the indirect pathway of 
allorecognition.Although it is suggested that the fetus escapes rejection from the 
maternal immune system by mechanisms involving HLA, KIR, and cytokines, 
these data suggest that there is a local role for regulatory mechanisms 
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controlling the specific immune responsiveness to the fetus in which 
(CD4+CD25hi/bright) regulatory T cells may be involved. In a previous study, we 
have shown that the majority of CD3+CD25+ cells in decidua basalis and 
parietalis express CD4 (13). Our preliminary analysis confirms the presence of 
this population (38). CD4+CD25+ cells also have been described in term decidua 
parietalis, this population was not further characterized, however, as CD25hi/
bright nor proven to be functional by assay (39). Alternatively, it has been shown 
that early human pregnancy decidua contains functional CD4+CD25bright T cells 
(40). Although regulatory T cells have not been fully characterized in term 
decidua, they could potentially serve as mediators in maternal tolerance of the 
fetal compartment by potently suppressing the activation and proliferation of 
CD4+CD25- T cells, CD4+CD25+ T cells, and also CD8+ T cells. 
 
Interestingly, it has been shown that decidual leukocytes derived from first 
trimester decidua are not capable of proliferating in response to allogeneic PBL 
(15, 41, 42). In the study by King et al., no proliferative response was observed 
in decidual leukocytes from first trimester tissue cultured with irradiated 
allogeneic PBL as stimulators in a one-way MLC (16). In the present study, it is 
shown that decidual leukocytes from uncomplicated term pregnancy, in contrast 
to that described from early pregnancy, significantly proliferate in response to 
allogeneic PBL. The difference in the proliferative response of first trimester 
and term pregnancy decidua derived leukocytes against allogeneic PBL is likely 
due to a change in the distribution and proportion of the responsible immune 
cells. Although first trimester and term pregnancy decidua both contain 
macrophages, T cells and uterine NK cells, the proportions of these cell 
populations indeed change throughout pregnancy (10). During early pregnancy, 
uterine CD56brightCD16- NK cells account for up to 70% of the leukocytes in the 
deciduas basalis (4, 43), however, as pregnancy progresses, the number of 
uterine NK cells gradually declines (44). Conversely, during first trimester 
pregnancy, the total T cell population represents only 6% to 30% of the decidual 
leukocytes (4, 6, 45, 46); while in term pregnancy, T cells comprise the most 
abundant leukocyte population (9, 10). Furthermore, results from our previous 
studies of term pregnancy decidua indicated that there is a higher percentage of 
CD56bright CD16- NK cells and of CD3+ T cells expressing several activation 
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markers in the decidua parietalis in comparison to the decidua basalis (11, 12). 
The varying proportion of cell types throughout pregnancy and their function 
could account for the difference in proliferation in response to allogeneic cells 
when comparing early and term pregnancy. Our findings warrant future 
investigation using purified decidual cell populations to further understand the 
proliferative response against allogeneic and UCB cells. 
 
Although there is a significantly higher percentage of uterine NK cells and of T 
cells expressing activation markers in the decidua parietalis than in the decidua 
basalis, unexpectedly, in this study, a significantly higher proliferation was 
found when decidua basalis leukocytes were stimulated by allogeneic PBL in 
comparison to the response by decidua parietalis leukocytes. The significant 
differences in the proportion of decidual leukocytes in these two regions may 
explain this difference in proliferation. We also found in our previous studies 
that there is no significant difference in the percentage of CD45+ leukocytes or 
CD14+ macrophages when comparing the two regions of the maternal-fetal 
interface to account for the difference. Interestingly, no significant difference in 
response against UCB was found when comparing decidua basalis and decidua 
parietalis indicating a possible biological significance. 
 
It is suggested that cytokines play a significant role in the immunological 
mechanisms involving placental growth and the maintenance of pregnancy (47). 
T helper cells are subdivided according to the cytokines that they produce. TH1 
type cytokines lead to the induction of cytotoxic T cells and include IFN-γ, IL-2, 
TNF-α and IL-12. TH2 type cytokines mediate allergic and antibody responses 
and include IL-4, IL-5 and IL-6. Generally, in reproduction, there is a 
dichotomous T helper response. Established successful pregnancy is 
characterized by low levels of TH1 cytokines and by a shift in the cytokine 
pattern from TH1 to TH2 ; TH1/TH2 paradigm of reproduction suggests that 
pregnancy rejection is mediated by TH1 cytokines, while maintenance and 
acceptance is mediated by TH2 cytokines (48,49). While the TH1/TH2 paradigm 
may be an oversimplification of role of cytokines in reproduction (50), there is a 
complex network of cytokines at the maternal-fetal interface involved in 
regulation of immune responsiveness. In the current study, it is shown that TH1 
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cytokines, such as IFN-γ predominate in in vitro cultures of decidual basalis or 
decidua parietalis with UCB or allogeneic PB cells as stimulators. In the in vivo 
setting, decidual leukocytes do not come into direct physical contact with UCB 
or allogeneic PBL. However, decidual leukocytes can proliferate in response to 
HLA antigens on UCB, minor peptides via the indirect pathway, and allogeneic 
PB and are capable of maintaining a cytokine microenvironment that may lead 
to a cytotoxic immune response and be deleterious to these cells. 
 
The function of leukocytes in the decidua basalis and parietalis, including their 
ability to proliferate in response to fetal or allogeneic cells and their ability to 
produce cytokines, is important for our understanding of the dynamic balance 
occurring at the maternal-fetal interface. Future studies are necessary to 
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ABSTRACT 
OBJECTIVE 
The aim of this study was to determine the role potential of decidual leukocytes 
in intrauterine growth restriction (IUGR) and preeclampsia by quantifying the 
percentage of leukocytes in decidua basalis and parietalis associated with IUGR 
with and without preeclampsia in relation to the situation in normal pregnancy. 
 
STUDY DESIGN 
Paired decidua basalis and parietalis samples were obtained from pregnancy 
with IUGR alone (n=10), with preeclampsia and IUGR (n=11), and normal term 
pregnancy (n=30). Following mechanical isolation and staining, percentages of 
leukocytes were determined by flow cytometry. 
 
RESULTS 
The percentage of TCRγδ+CD3+ and CD4+CD25+ cells was lower in decidua 
basalis and parietalis associated with IUGR with and without preeclampsia 
compared to normal pregnancy. Furthermore, a higher percentage of uterine 
CD56+CD16- NK cells was found in decidua basalis of IUGR alone compared to 
normal control pregnancies. 
 
CONCLUSION 
Significant differences in decidual leukocytes exist between IUGR with and 
without preeclampsia, compared to normal control pregnancies, suggestive for 
an aberrant immunoregulation in both diseases. 
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INTRODUCTION 
Since the paradox of pregnancy was first proposed by Medawar in 1953 (1), the 
complex interaction between maternal and fetal cells in the placenta of normal 
pregnancy has been the focus of much research. Invasion of uterine spiral 
arteries and decidua by fetal trophoblasts accommodates for the increased blood 
flow of the fetoplacental unit. Multiple mechanisms contribute to the balance of 
invasion at the maternal-fetal interface, including the expression of classical 
HLA-C and non-classical class I HLA-G and HLA-E on fetal trophoblasts, the 
production of cytokines affecting angiogenesis and vascular stability, and the 
presence of maternal leukocytes within the decidua (2). Immune cells form a 
major component of the decidua, and throughout pregnancy, the percentage of 
CD56brightCD16- uterine cells and T cells varies in decidua basalis, the site of 
implantation, and in decidua parietalis, the tissue lining the remainder of the 
uterine cavity (3, 4). 
 
The field of reproductive immunology in part progresses in hope of providing 
clinical treatment for and improving the outcome of complicated pregnancies. 
The role of the placental bed in the pathogenesis of a variety of pregnancy 
disorders, such as preeclampsia (PE) and intrauterine growth restriction 
(IUGR), is clinically relevant, as both are associated with increased perinatal 
morbidity and mortality. PE is a significant complication of pregnancy defined 
by hypertension, proteinuria, and edema, presenting as early as the second 
trimester and affecting approximately 5-8% of pregnancies (5). IUGR is 
characterized as a syndrome marked by failure to reach growth potential, 
affecting 3-7% of pregnancies and can present alone as idiopathic IUGR or in 
association with PE (6). 
 
It is hypothesized that abnormal maternal-fetal cellular interactions within the 
placenta contribute to the pathogenesis of both IUGR and PE, but differ in 
IUGR with and without PE. To our knowledge, no previous study has 
investigated and specifically compared decidual leukocytes in IUGR with and 
without PE. Our previous studies indicate that there are significant differences 
in the distribution and proportion of leukocytes when comparing decidua basalis 
and decidua parietalis of normal term pregnancy (7, 8). The aim of this study 
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was to determine the role of decidual leukocytes in IUGR and PE by quantifying 
the distribution and percentage of leukocytes in decidua basalis and parietalis 
from placentas associated with IUGR alone or with IUGR and PE in comparison 
with that of normal term deciduas using flow cytometric analysis. 
 
MATERIALS AND METHODS 
Subjects 
Paired decidua basalis and parietalis samples were obtained from three groups: 
pregnancy associated with IUGR alone (n=10), pregnancy associated with PE 
and IUGR (PE/ IUGR) (n=11), and normal term pregnancy (n=30). All women 
were delivered by elective cesarean section. Clinical characteristics of the study 
and control groups are summarized in Table I. PE was defined according to the 
criteria of the American College of Obstetricians and Gynecologists (5). Women 
with a systolic blood pressure of 140 mmHg or higher or a diastolic blood 
pressure of 90 mmHg or higher occurring after 20 weeks of gestation in a 
woman whose blood pressure has previously been normal and proteinuria with 
excretion of 0.3 g or more of protein in a 24-hour urine specimen were selected. 
IUGR was defined by Doppler abnormalities in the umbilical artery and as fetal 
weight below the 10th percentile for appropriate population-based cross-
sectional growth charts (9). Because vaginal delivery is associated with changes 
in decidual leukocytes (10), only samples from pregnant women delivering by 
elective cesarean section prior to the onset of labor were selected. 
 
For normal term pregnancy samples, paired tissue from decidua basalis and 
parietalis was obtained from placentas following elective cesarean section before 
the onset of labor indicated for breech presentation. These samples were used in 
previous publications (7, 8). All deliveries followed uncomplicated term 
pregnancies and resulted in the birth of a non-growth restricted healthy 
neonate. Informed consent was obtained from all women in the three groups, 
and the study received the appropriate ethical approval by the Leiden 
University Medical Ethics Committee in Leiden, the Netherlands. 
 
Isolation of decidua basalis and parietalis cells 
Term decidua basalis tissue was macroscopically dissected from several 
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different locations of the basal plate and placental bed of the maternal-facing 
surface, and term decidua parietalis tissue was collected by removing the 
amnion and delicately scraping the tissue from the chorion as previously 
described (8). Areas of ischemia or necrosis were avoided. The obtained tissue 
was thoroughly washed and finely minced between two scalpel blades in 
phosphate buffered saline (PBS). Minced decidual fragments were gently 
worked through an open filter chamber (NPBI International BV, Emmer-
Compascuum, the Netherlands, and Beldico, Marche-en-Famenne, Belgium) 
with PBS. The resultant suspension was filtered through a 70µm sieve (Becton 
Dickinson, Labware; Franklin Lakes, New Jersey), washed in PBS, and layered 
on an equal volume of ficoll hypaque (Leiden University Medical Center 
Pharmacy; Leiden, the Netherlands) at room temperature for density gradient 
centrifugation (for 20 minutes at 800g). Mononuclear cells were collected from 
the interface, washed twice, and resuspended in PBS for cell staining. 
 
Cell Staining 
Directly conjugated fluorescent antibodies directed against the following 
antigens were used for two- and three-color immunofluorescence staining: CD45 
[HLe-1; Fluorescein isothyocyanate (FITC)], CD3 [Leu-4; Allophycocyanin (APC) 
or Peridinin Chlrophyll-a Protein-Cytochrome 5.5 (PerCP-Cy5)], CD8 (Leu-2a; 
FITC), CD4 [Leu-3a; Phycoerythrin (PE)], CD19 (Leu-12; FITC), CD56 (Leu-19; 
FITC, Leu-19; PE), CD16 (Leu-11a; FITC, Leu-11c; PE), CD25 (Anti-IL-2R; 
FITC), HLA-DR (Anti-HLA-DR; PE) and CD45RO (UCHL1; PE) all from Becton-
Dickinson Immunocytometry Systems (San Jose, CA, USA) and TCRγδ (5A6.E9; 
FITC, Serotec, Oxford, England and Biocarta, Hamburg, Germany).  
 
Cells were stained with monoclonal antibodies at a density of 106 cells/ ml in 
PBS (100µl/ sample) and incubated for 30 minutes at 40C in the dark. Following 
two PBS washes, cells were resuspended and fixed with PBS containing 1% 
paraformaldehyde. Cells were then analyzed on a Becton-Dickinson FACScan 
flow cytometer. Approximately 5,000 events were acquired in the CD45+ 
leukocyte gating window. The acquired data were then analyzed using Becton-
Dickinson CellQuestTM software (San Jose, CA, USA). The percentages of 
CD16+, CD56+, CD19+, CD3+, CD4+ and CD8+ cells in decidua basalis and 
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decidua parietalis were determined and calculated as a percentage of the CD45+ 
cell fraction. To further characterize the expression of CD16 and CD56, the 
percentages of CD56dimCD16+ NK cells and CD56brightCD16- uterine NK cells 
were established by delineating regions around these various populations. To 
determine T cell marker expression, cells that were within the leukocyte gate 
and also CD3+ were gated based on these two parameters and analyzed for the 
expression of the activation marker of interest. 
 
Statistical Analysis 
To compare differences in leukocyte subsets in the decidua basalis or in the 
decidua parietalis between two study groups, the Mann-Whitney test was 
performed. The Wilcoxon signed rank test was used to compare differences 
between decidua basalis and parietalis within each group. The non-parametric 
Kruskal-Wallis analysis of variance (ANOVA) test was performed to compare 
the mean percentages of the three groups. The conventional value of p<0.05 was 
defined as significant. 
 
RESULTS 
Comparison of leukocytes from decidua basalis and decidua parietalis from 
placentas associated with IUGR alone and with PE/IUGR and normal control 
pregnancies are shown in Figures 1-5. Using ANOVA analysis to compare 
IUGR, PE/IUGR and term groups, no significant difference was seen in the 
mean percentage of leukocytes in decidua basalis and in decidua parietalis 
expressing CD45, CD19, CD3, CD4, and CD8. As Figure 1 depicts, the 
percentage of TCRγδ+ cells within the CD3+ cell population however was 
significantly lower in the decidua basalis associated with IUGR alone (3.93%) 
and also PE/IUGR (5.42%) when compared with the control group (8.32%; 
ANOVA: p=0.0184; Mann-Whitney: p=0.0124 and p=0.0480, respectively). A 
similar difference also was found when comparing the percentage of TCRγδ+ 
cells within the decidua parietalis with IUGR (6.44%) and PE/IUGR (10.61%) to 
that of control group (15.85%; ANOVA: p=0.0204; Mann-Whitney: p=0.0204 and 
p=0.0363). No significant difference was found in the mean percentage of 
TCRγδ+ cells when comparing IUGR and PE/IUGR groups in decidua basalis or 
parietalis (Mann-Whitney: p=0.9623 and p=0.9623, respectively). When 
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comparing TCRγδ+ expression between decidua basalis and decidua parietalis, a 
significant difference was only found in normal term pregnancy with a higher 
percentage in decidua parietalis (Wilcoxon: p=0.0007), not in IUGR with or 
without PE. 
 
Expression of NK cell markers 
Figures 2 and 3 depict the expression of CD56 and CD16, specifically the uterine 
CD56brightCD16- NK cell population and the cytotoxic CD56dimCD16+ NK cell 
population. In the decidua basalis, the mean percentage of uterine NK cells was 
42.98% in the IUGR group, 22.36% in the PE/IUGR group, and 17.24% in the 
control group, indicating a significant difference when comparing the three 
groups (ANOVA: p=0.0366). Specifically, there was a significantly higher 






























Figure 1. Mean percentage of TCDγδ+CD3+ leukocytes within the CD45+ cell 
fraction in decidua basalis and decidua parietalis associated with normal term 
pregnancy, pregnancy associated with intrauterine growth restriction (IUGR) alone, 
and associated with preeclampsia and IUGR (PE/IUGR). ANOVA: decidua basalis: 
p=0.0184; decidua parietalis: p=0.0204. Column error bars represent the standard 
error of the mean (SEM). * p<0.05. 
Decidua basalis          Decidua parietalis 
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percentage of uterine NK cells in the decidua basalis in IUGR alone when 
compared to normal term pregnancy (Mann-Whitney: p=0.0100). This difference 
was not found in PE/IUGR (Mann-Whitney: p=0.6509). Interestingly, there was 
no significant difference in the percentage of uterine NK cells in the decidua 
parietalis when comparing the three groups (ANOVA: p=0.1912). With regard to 
CD56dimCD16+ NK cells, there was a significant difference in the decidua basalis 
when comparing all three groups (figure 3; ANOVA: p=0.0023).  Specifically, 
there was a significantly higher percentage of cytotoxic NK cells in the decidua 
basalis in IUGR alone and in PE/IUGR when compared to normal term 
pregnancy (Mann-Whitney: p=0.0027; p=0.0152, respectively). No significant 
difference in the percentage of CD56dimCD16+ cells in the decidua parietalis was 
found when comparing the three groups (ANOVA: p=0.5649). When comparing 
NK cell subsets between decidua basalis and decidua parietalis within each 


































Figure 2. Mean percentage of CD56brightCD16- leukocytes within the CD45+ cell 
fraction  in decidua basalis and decidua parietalis associated with normal term 
pregnancy, pregnancy associated with IUGR alone, and associated with PE/IUGR. 
ANOVA: decidua basalis: p=0.0366; decidua parietalis: p=0.1912. Column error bars 
represent the SEM. * p<0.05. 
Decidua basalis          Decidua parietalis 
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group, a significant difference was found only in normal term pregnancy, with a 
higher percentage of CD56brightCD16- NK cells in the decidua parietalis 
(Wilcoxon: normal p<0.0001; IUGR p=0.4688; PE/IUGR p=0.2402), while a 
higher percentage of CD56dimCD16+ NK cells in the decidua basalis of all three 
groups (Wilcoxon: normal p=0.0024; IUGR p=0.0078; PE/IUGR p=0.0273). 
 
Expression of activation markers by CD3+ T cells 
When comparing the three groups within the CD3+ population, there was a 
significant difference in the percentage of CD4+CD25+ cells in the decidua 
basalis (ANOVA: p=0.0413) and in the decidua parietalis (ANOVA: p=0.0038) 
(Figure 4). Specifically, analysis showed a lower percentage of CD4+CD25+ cells 
in IUGR decidua basalis (4.37%; Mann-Whitney: p=0.0250) and in IUGR 






























Figure 3. Mean percentage of CD56dim CD16+ leukocytes in decidua basalis and 
decidua parietalis associated with normal term pregnancy, pregnancy associated 
with IUGR alone, and associated with PE/IUGR. ANOVA: decidua basalis: p=0.0023; 
decidua parietalis: p=0.5649. Column error bars represent the SEM. * p<0.05 
Decidua basalis Decidua parietalis 
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decidua parietalis (7.95%; Mann-Whitney: p=0.0068) when compared to normal 
pregnancy decidua basalis (8.53%) and parietalis (16.53%). Also, a lower 
percentage of CD4+CD25+ cells was found in PE/IUGR decidua parietalis 
(9.81%) when compared to normal term pregnancy (Mann-Whitney: p=0.0035), 
but not in IUGR/PE decidua basalis (5.59%; Mann-Whitney: p=0.0529). 
Comparing decidua basalis and parietalis within each group showed a 
significantly lower percentage of CD4+CD25+ T cells in the decidua basalis in 
IUGR and normal pregnancy (Wilcoxon: p=0.0039 and p=0.0156, respectively). 
In the decidua basalis, no significant difference was found when comparing 
presence of CD8+CD25+, CD4+HLA-DR+, CD8+HLA-DR+, and CD45RO+ within 
the CD3+ population between all three groups (ANOVA: p>0.05) (data not 




























Figure 4. Mean percentage of CD4+CD25+ leukocytes within the CD3+ population in 
decidua basalis and decidua parietalis associated with normal term pregnancy, 
pregnancy associated with IUGR alone, and associated with PE/IUGR. ANOVA: 
decidua basalis: p=0.0413; decidua parietalis: p=0.0038. Column error bars represent 
the SEM. * <0.05. 
Decidua basalis   Decidua parietalis 
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shown). Conversely, in the decidua parietalis, while no difference was found in 
the percentage of CD8+HLA-DR+, CD8+CD25+ or CD45RO+ cells, there was a 
significantly lower percentage of CD4+HLA-DR+ cells within the T cell 
population (ANOVA: p=0.0251). Specifically, the percentage of CD4+HLA-DR+ 
cells was lower in decidua parietalis associated with PE/IUGR (p=0.0068) when 
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Figure 5. Mean percentage of CD4+HLA-DR+ leukocytes within the CD3+ population 
in decidua basalis and decidua parietalis associated with normal term pregnancy, 
pregnancy associated with IUGR alone, and associated with PE/IUGR. ANOVA: 
decidua basalis: p=0.2957; decidua parietalis: p=0.0251. Column error bars represent 
the SEM. * p<0.05. 
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Leukocyte subclasses within overlapping gestational ages 
To exclude that differences between normal and IUGR pregnancies (with and 
without preeclampsia) are explained by differences in gestational age we 
compared in these two groups the leukocyte subclasses in overlapping 
gestational ages (Table I). To increase the number of cases with a comparable 
gestational age, we combined IUGR pregnancies with and without PE, as no 
differences in leukocyte subclasses were apparent  in the original cohort.  All 
leukocyte subclasses that were different between the total cohort of IUGR and 
controls were also different in pregnancies with overlapping gestational age.  
 
Subjects 
Clinical characteristics of the IUGR group and PE/IUGR are summarized in 
Table II. No significant difference was found between IUGR and PE/IUGR 
groups when comparing maternal age, gestational age, fetal weight or placental 
weight (Mann-Whitney: p=0.3722; p=0.872; p=0.4704; p=0.7577, respectively). 
Maternal age was significantly higher in the normal term pregnancy group and 
differed when comparing all three groups (ANOVA: p=0.0403). As expected, 
gestational age, fetal weight and placental weight also were significantly higher 
in the normal term pregnancy group when comparing all three groups (ANOVA: 
p<0.0001; p<0.0001; p<0.0001, respectively). 
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Table I. Comparison of  leukocyte subsets in control and study groups with an 
overlap in gestational age. 
 Control (n=6) IUGR with and without 
PE (n=6) 
Gestational Age 
(weeks) mean (range) 
37.0 (35.6-37.4) 35.1 (34.0-36.5) * 
Decidua basalis parietalis basalis parietalis 
TCRγδ+CD3+ 5.6 ± 1.6 6.2 ± 1.1 3.1± 0.9 3.5 ± 1.0 
uNK cells 19.4 ± 8.9 45.2 ± 19.6 47.8 ± 19.4 25.1 ± 4.1 
CD4+CD25+ 9.7 ± 4.0 13.9 ± 3.3 6.2 ± 1.4 8.5 ± 3.9 




Recent studies investigating variations in morphology of placentas associated 
with PE and IUGR suggest that idiopathic IUGR and IUGR in PE have a 
separate etiology (11). IUGR alone is associated with a reduction in villous area 
alone, while IUGR in PE is associated with changes in syncytiotrophoblast 
quantity, more specifically the amount of syncytiotrophoblast cytoplasm (12). 
However, in our study, flow cytometric quantification and comparison of 
decidual leukocyte subsets in IUGR with and without PE demonstrates that 
between these two pathologies of pregnancy, no significant differences are 
evident. Both IUGR alone and PE associated with IUGR are likely to represent 
a similar pathology, as we could not found a clear distinction in the immune 
regulation between these two disease entities. Interestingly, both IUGR and PE 
are associated with shallow extravillous trophoblast invasion, the clinical 
symptoms manifested in these diseases, however, are quite different. In 
comparison to normal pregnancy, placental weight and size are lower in both PE 
(13) and in IUGR (14). In conjunction with these findings, we find substantial 
differences in decidual leukocyte subsets between, on the one hand, these two 
pathologies of pregnancies and on the other hand normal control pregnancies. 
The significantly lower percentage of TCRγδ+CD3+ cells and CD4+CD25+ T cells 
in decidua basalis and parietalis associated with IUGR with and without PE is 
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34.2 (21.4-42.3)* 31.7 (21.2-37.0) 29.8 (17.0-38.2) 
Gestational age 
(wks) 
38.4 (35.6-41.6)* 31.2 (27.0-36.1) 30.8 (26.6-36.5) 
Fetal weight 
(gm) 
3355 (1880-4975)* 1044 (577-1710) 1170 (660-2180) 
Placental 
weight (gm) 
591 (315-960)* 219 (90-310) 230 (150-273) 
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suggestive for a regulatory role of these cells in normal pregnancy. The increase 
of uterine CD56brightCD16- NK cells in decidua basalis associated with IUGR 
without PE may indicate that their contribution to the local immune response is 
different in the setting of complicated pregnancy. 
 
Because IUGR and PE often are associated with iatrogenic preterm delivery, the 
differences seen in decidual leukocytes in IUGR with and without PE may be 
gestational age dependent or may result from the pathogeneses of idiopathic 
IUGR and IUGR developing secondary to PE. To exclude the possibility that our 
findings are caused by differences in gestational age between the groups, we 
compared the findings within overlapping gestational age cohorts. Similar 
differences were observed in the groups with overlapping gestational ages, 
supporting a differential immunological environment in the maternal decidua in 
IUGR and PE/IUGR pregnancies as compared to control pregnancies, not 
explained by differences in gestational age. 
 
In previous studies, significant changes in decidual leukocytes, including 
macrophages and NK cells, were found to be associated with PE and IUGR 
(15,16). While the etiology of PE and IUGR is not fully understood, it is 
suggested that immune dysfunction or maladaptation contributes to the 
pathogenesis of PE (17) and IUGR (18). Uterine NK cells express both activating 
and inhibitory killer cell immunoglobulin-like receptors (KIR), some of which 
interact with and recognize HLA-E, HLA-C, or HLA-G antigen (19). These 
ligand-receptor pairs suggest a role of these cells in controlling extravillous 
trophoblast invasion. In a recent study by Hiby et al., HLA-C ligands on fetal 
trophoblasts and KIR on uterine NK cells are implicated as factors associated 
with PE (20). PE is significantly more prevalent in women who are homozygous 
for inhibitory KIR and is associated with fetal expression of HLA-C ligands 
specific for inhibitory KIR. The absence of activating KIR likely favors PE, and 
an overly inhibited uterine NK cell may cause trophoblasts to prematurely cease 
remodelling of uterine vessels, increasing the likelihood of PE (20). It is 
suggested that cooperation between maternal NK cells and fetal trophoblasts 
remodels the blood supply. In the current study where only PE in association 
with IUGR was studied, not PE alone, we did not see a significantly lower 
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percentage of uterine NK cells in pregnancy associated with PE/IUGR. However, 
in the setting of idiopathic IUGR we find a significantly increased percentage of 
uterine NK cells in the decidua basalis, while such a trend is also apparent for 
the decidua parietalis. 
 
In the current study, the percentage of TCRγδ+CD3+ cells was significantly lower 
in decidua basalis and parietalis associated with IUGR with and without PE/
IUGR when compared with that of normal pregnancy. Considerable research 
and controversy on the expression of the γδ T-cell receptor on decidual cells has 
developed in recent years. Although the function of these cells is not clearly 
identified, they may have a regulatory role in the decidua.  It is suggested that 
the extrathymic T-cell maturation occurs in the decidua of early pregnancy and 
that CD56dimCD16- decidual NK cells are immature progenitors for T cells (21). 
Furthermore, unlike TCRαβ+ cells, TCRγδ+ cells are not MHC-restricted. A 
significantly lower percentage of TCRγδ+CD3+ in IUGR and PE/IUGR may occur 
as a result of placental maldevelopment or may cause aberrant maldevelopment 
as a result of the lack of the necessary immune recognition of fetal antigen or 
cytokine production for proper placental development. The findings of the 
current study further suggest the potential and unique immunologic role of 
these cells in normal placental development. 
 
In the current study, also a lower percentage of CD4+CD25+ cells was found in 
IUGR decidua basalis and parietalis and in PE/IUGR decidua parietalis. Our 
previous data has shown that the majority of CD3+CD25+ cells in decidua 
basalis and parietalis express CD4 (7) and that there is a higher percentage of 
CD4+CD25bright T cells in the CD4+CD25+ T cell population in the decidua 
parietalis in comparison to the decidua basalis (22).  It has been suggested that 
CD4+CD25high regulatory T cells play an important role in the maintenance of 
pregnancy controlling the specific immune responsiveness to the fetus and that 
their recruitment or function may be impaired in pathological conditions (23). It 
is plausible that CD4+CD25+ cells are necessary for adequate fetoplacental 
development and that overly inhibited CD4+CD25+ T cells result in an immune 
response preventing such development, ultimately leading to IUGR. 
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The function of leukocytes in the decidua basalis and parietalis is important for 
our understanding of the dynamic balance occurring at the maternal-fetal 
interface. The current study does not indicate a potential distinction in immune 
regulation in the pathogenesis of IUGR with and without PE, although 
considerable differences are found compared to normal pregnancies. It is 
important to note that leukocytes at term pregnancy are remote from the events 
at early pregnancy when the pathology of IUGR and PE are believed to develop. 
Future studies are necessary to elucidate the functional roles of decidual 
leukocytes in the maintenance of pregnancy. Importantly, future research may 
establish effective preventive, diagnostic, and therapeutic strategies for IUGR 
and PE in hopes of improving future pregnancy outcomes. 
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ABSTRACT 
OBJECTIVE: To compare leukocyte populations in term decidua basalis and 
parietalis from normal pregnancy with the pregnancy of a surrogate gestational 
carrier (SGC) who was mismatched for both human leukocyte antigen (HLA)-DR 
alleles and by chance, shared one set of HLA class I alleles with the fetus. 
 
DESIGN: Case-control study. 
 
SETTING: Academic research laboratory. 
 
PATIENT(S): A SGC who received embryos conceived by in virto fertilization 
and delivered a term singleton by elective cesarean section and 20 women who 
delivered term singletons by elective cesarean section. 
 
INTERVENTION(S): Decidual samples were collected immediately following 
elective cesarean section. Decidual leukocytes were isolated by mechanical 
dispersion. Percentages of leukocyte populations were determined using flow 
cytometry.  
 
RESULT(S): In SGC decidua basalis and parietalis, there were higher 
percentages of CD45+ leukocytes, CD56+CD16- uterine NK cells, and CD3+HLA-
DR+ and CD3+CD25+ T cells in comparison to that of normal term decidua 
basalis and parietalis. A higher percentage of CD4+ T cells also was found in 
SGC decidual tissues, possibly directly related to the presence of two HLA Class 
II DR mismatches in the fetus. 
 
CONCLUSION(S): These findings suggest that during this SGC pregnancy, a 
more active immune response is present, possibly related the more profound 
presence of HLA class II mismatches and thus a greater requirement for 
immunomodulation. Further studies in SGC pregnancies are required to 
substantiate and extend these findings also to fully HLA class I and class II 
mismatched cases. 
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INTRODUCTION 
The fetus with a genetic makeup derived from both the mother and father is 
often described as a semiallograft to the maternal immune system. The 
mechanism by which the semiallogeneic fetus avoids rejection despite a 
functionally intact maternal immune system is the central question in 
reproductive immunology.  
 
The decidua, the maternal tissue in direct contact with fetal tissue, has been the 
focus of much investigation in an attempt to elucidate contributing factors 
involved in the delicate immunologic balance of pregnancy. There are two 
distinct regions of contact between the tissue of fetal origin and the maternal 
decidua – one between the invading interstitial trophoblasts and the decidua 
basalis, the site of implantation, and the other between the amniochorion and 
the decidual parietalis, the tissue lining the remainder of uterine cavity. 
Focusing primarily on the decidua basalis, immunohistological and flow 
cytometric studies of first trimester and term pregnancy decidua have identified 
numerous leukocytes, including macrophages, T lymphocytes, and large 
granular lymphocytes of the NK cell lineage with a unique CD56brightCD16-CD3- 
phenotype (1-8). Our previous studies on decidual leukocytes revealed 
significant differences in the distribution and proportion of these cells when 
comparing decidua basalis and decidua parietalis derived from placentas of 
uncomplicated term pregnancies following elective cesarean section with a 
higher percentage of CD56brightCD16- NK cells and of CD3+ T cells expressing 
activation markers CD25, Human Leukocyte Antigen (HLA)-DR, CD45RO, and 
CD69 in the decidua parietalis (9, 10). 
 
The field of reproductive immunology in part has progressed in hope of gaining a 
better understanding of not only infertility and pregnancy complications, but 
also tolerance induction and the improvement of graft survival in the setting of 
allogeneic organ transplantation. Gestational surrogacy provides a unique 
model to investigate these fields and seems to more accurately represent the 
setting of organ transplantation. In this model, the surrogate typically has no 
genetic link to the fetus and is presented with not one, but two sets of allogeneic 
histocompatibility antigens. Serving as an invaluable therapy for a woman with 
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no uterus, a nonfunctioning uterus, or a contraindication to pregnancy, 
gestational surrogacy achieves fetal conception by using the gametes of the 
couple in which pregnancy is impossible or contraindicated. The resulting 
embryo is then transferred to the hormonally primed uterus of a surrogate 
gestational carrier (SGC). The fetus, thus, could be referred to as an “allograft” 
rather than a “semiallograft.” To our knowledge, no study has yet determined 
the decidual cell populations in the setting of gestational surrogacy. 
 
Our aim in this study was to compare the proportion of different cell populations 
in the term decidua basalis and parietalis of a SGC with those in normal term 
decidua basalis and parietalis using flow cytometry and to relate these finding 
to the specific HLA mismatches between the SGC and the fetus. 
 
MATERIALS AND METHODS 
Subjects 
The pregnancy of a SGC was conceived by in vitro fertilization (IVF) using donor 
ova and sperm from the biologic mother (age 25) and biologic father (age 28). 
The biologic mother had severe chronic kidney disease contraindicating 
pregnancy and necessitating the use of a SGC. The relationship of the SGC to 
the biologic mother and father is shown in Figure 1. Two embryos at the four to 
six cell stage were transferred into the hormonally primed uterus of the SGC 
(age 38) on day 17 of her cycle. The artificial cycle was initiated using Estradiol 
Valerate (Progynova, Schering, Weesp, the Netherlands) and Progesterone, and 
ovulation was suppressed using Triptorelin aceate (Decapeptyl, Ferring, 
Hoofddorp, the Netherlands). Pregnancy was confirmed 12 days following 
embryo transfer. Fetal heart activity was seen, and the crown-rump-length was 
11mm in accordance with the gestational age of 55 days. Throughout the 
pregnancy, the growth of the fetus was monitored and progressed normally. The 
pregnancy was uncomplicated. At 41 weeks, an elective cesarean section was 
performed by maternal request without complications and resulted in the birth 
of an apparently healthy 3850 gram baby girl. A few days after birth, it was 
determined that the infant had a severe congenital heart malformation, which 
was successfully reconstructed in two subsequent operations. 
 











Control samples from twenty uncomplicated normal term singleton pregnancies 
spontaneously conceived were obtained from placentas collected after elective 
cesarean section. Some samples were also used in previous studies (9, 10). All 
cesarean sections were performed for breech presentation and resulted in the 
birth of a non-growth restricted healthy neonate. Informed consent was obtained 
from all women, and ethical approval was received from the Leiden University 
Medical Ethics Committee. The decidual cells from these samples were isolated 
as abovementioned and used to compare results with those of the SGC. 
 
HLA Typing 
To determine the specific HLA mismatches between the SGC and the fetus, 
HLA Class I and II typings of the SGC, biologic mother, biologic father, and 
baby were performed. Blood samples were obtained, and molecular typing was 
performed on DNA by polymerase chain reaction/sequence-specific 
oligonucleotide using a reverse dot-blot method (11). 
 
Isolation of decidua basalis and parietalis cells 
Decidual samples were collected from the placentas immediately following 
elective cesarean section. Decidua basalis tissue samples were macroscopically 
dissected from the maternal-facing surface, and decidua parietalis samples were 
collected by removing the amnion and delicately scraping the tissue from the 
Figure 1.  Schematic diagram showing the relationship of the SGC to the biologic 










Second wife of 
Maternal Grandfather 
SGC 
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chorion. Areas of ischemia or necrosis were avoided. The obtained tissue was 
finely minced between two scalpel blades in a small volume of phosphate 
buffered saline (PBS). Minced decidual fragments were gently worked through 
an open filter chamber (NPBI International BV; Emmer Compascuum, the 
Netherlands) with PBS. The resultant suspension was filtered through a 70µm 
sieve (Becton Dickinson Labware; Franklin Lakes, New Jersey), washed in PBS, 
and layered on an equal volume of ficoll (Leiden University Medical Center 
Pharmacy; Leiden, the Netherlands) at room temperature for density gradient 
centrifugation (for 20 min at 800g). Mononuclear cells were collected from the 
interface, washed twice, and resuspended in PBS for cell staining. 
 
Cell Staining 
Directly conjugated fluorescent antibodies directed against the following 
antigens were used for two-or three-color immunofluorescence staining: CD45 
[HLe-1; Fluorescein isothyocyanate (FITC)], CD14 [Leu-M3; Phycoerythrin 
(PE)], CD3 [Leu-4; Allophycocyanin (APC)], CD8 (Leu-2a; FITC), CD4 (Leu-3a; 
PE), CD56 (Leu-19; FITC), CD16 (Leu-11a; PE), CD25 (Anti-IL-2R; FITC), and 
HLA-DR (Anti-HLA-DR; PE) all from Becton-Dickinson Immunocytometry 
Systems (San Jose, CA, USA). 
 
All cells were stained at densities of 106 cells per ml in PBS and incubated for 30 
minutes at 40C in the dark. Following two washes with PBS, cells were 
resuspended in PBS and fixed with PBS containing 1% paraformaldehyde. Cells 
were then analyzed on a Becton-Dickinson FACScan flow cytometer. The 
double-labeled CD45 and CD14 sample was used to establish the optimal 
leukocyte gate based on light scatter profile and immunofluorescence (12). 
Approximately 3,000 events were acquired in the gating window. The acquired 
data were then analyzed using Cellquest software. The percentages of CD14+, 
CD19+, CD3+, CD56+CD16-, and CD16+ were enumerated within and 
represented as a percentage of the CD45+ cell fraction. 
 
Statistical Analysis 
For the normal term decidua basalis and parietalis samples (n=20), the 95% 
confidence interval (CI) was calculated to quantify the precision of the mean. 
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HLA mismatches between SGC and fetus 
Although the SGC was the second wife of the father of the biological mother 
(Fig. 1.), by chance, she shared the HLA class I alleles which the fetus had 
inherited from the biological father (i.e. HLA A*0301, HLA B*0702 and HLA 
C*0702). The degree of HLA class I sharing between SGC and the fetus, 
therefore, was similar to a normal pregnancy (Table I). The fetus, however, was 
mismached for both HLA class II DR alleles with the SGC, a fully allogeneic 
situation, never occurring in normal pregnancy.  
Table I. Human Leukocyte Antigen (HLA) alleles of surrogate mother, 
biological parents and infant. 
 HLA-A HLA-B HLA-Cw 
SGC *0301 *2401 *0702 *0301 *2401 *0702 
Biologic Father *0201 *0301 *0702 *4101 *17 *0702 
Biologic Mother *3201 *6801 *3501 *4002 *0202 *0401 
Infant *3201 *0301 *0702 *4002 *0202 *0702 
 HLA-DR HLA-DP HLA-DQ 
SGC *0402 *1301 *0402 *0402 *0302 *0603 
Biologic Father *0401 *0701 *0401 *1401 *0302 *0303 
Biologic Mother *11 *11 *0301 *0402 *0301 *0301 
Infant *11 *0401 *0401 *0402 *0301 *0302 
Note: Mismatches between the infant and SGC are in bold and italicized 
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Comparison of leukocyte subpopulations in the deciduas basalis of the 
SGC and of normal term pregnancy 
The percentage of isolated leukocytes from the decidua basalis of the SGC and of 
normal term pregnancy were determined by flow cytometry for cell surface 
marker expression, compared and summarized in Table II. In the decidua 
basalis of the SGC, the percentage of CD45+ cells was higher in comparison with 
that of the decidua basalis of normal term pregnancy, 50.8% and 35.3% (95% 
Confidence Interval (CI)=29.3-41.4), respectively. This difference did not 
influence the subsequent analysis, as these were expressed as a percentage of 
CD45+ cells. The percentage of CD14+ cells was similar in the decidua basalis of 
the SGC and of normal term pregnancy, 12.7% and 17.7% (95% CI=11.4-24.0), 
respectively. Alternatively, there were apparent differences in the expression of 
CD16 and CD56 in the two groups. Importantly, the CD56+CD16- uterine NK 
cell population was greater in the decidua basalis of the SGC, 31.8%, compared 
with normal term decidua basalis, 11.0% (95% CI=8.5-13.4), while the 
percentage of CD16+ cells was 32.2% in the SGC decidua basalis and 15.9% (95% 
CI=12.9-18.9) in normal term decidua basalis. 
 
The percentage of T cells, as determined by the number of CD3+ cells, was 
higher in normal term decidua basalis than in the SGC decidua basalis, 55.4% (95% 
CI=51.1-59.6) and 40.6%, respectively. Of those CD3+ cells, the percentage of CD3+CD4+ 
cells was 68.7% in the SGC decidua basalis and 52.6% (95% CI=46.4-58.9) in 
normal term decidua basalis, while the percentage of CD3+CD8+ cells was 30.1% 
in the SGC decidua basalis and 43.2% (95% CI=38.0-48.4) in normal term 
decidua basalis. Additionally, the population of CD3+ cells expressing markers of 
activation was greater than that of normal term pregnancy. The percentage of 
cells expressing CD25, the IL-2 receptor, was greatly increased on the CD3+ cells 
in the SGC decidua basalis, 36.6%, in comparison with the normal term decidua 
basalis, 15.9% (95% CI=12.6-19.3). In the SGC decidua, the percentage of 
CD3+HLA-DR+ cells was markedly increased, 92.2%, in comparison to that of 
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Comparison of leukocytes subpopulations in the decidua parietalis of 
the surrogate gestational carrier and of a normal term pregnancy 
The leukocyte subpopulations in the decidua parietalis of the SGC were also 
compared to those of normal term decidua parietalis (Table III). Like decidua 
basalis, the expression of CD45 was greatly increased in the SGC decidua 
parietalis in comparison to normal term decidua parietalis, 76.7% and 28.8% 
(95% CI=20.7-36.9), respectively. Again, as the subsequent analysis were 
performed as a percentage of CD45+ cells, the following results are not 
influenced by this difference. The percentage of CD14+ cells was 10.0% in the 
SGC decidua parietalis and 21.0% (95% CI=16.0-26.1) in normal term decidua 
parietalis. In the decidua parietalis of the SGC, the percentage of CD16+ cells 
was 10.8% and 10.9% (95% CI=6.4-15.3) in normal term decidua parietalis. As in 
decidua basalis, the uterine NK cell population in the parietalis was greater in 
the SGC, 42.9% compared with normal term decidua parietalis, 28.2% (95% 
CI=19.6-36.8). 
Table II. Percentage of leukocytes in term decidua basalis of SGC and normal 
term decidua basalis. 
SGC term  
decidua basalis 
(n=1) 
Normal term  
decidua basalis  
(n=20) 
95% CI 
CD45+ 76.7 28.8 20.7-36.9 
CD14+ 10.0 21.0 16.0-26.1 
CD3+ 62.2 60.6 49.0-72.3 
CD16+ 10.8 10.9 6.4-15.3 
Uterine NK cells 
(CD56+CD16-) 
42.9 28.2 19.6-36.8 
CD3+CD4+ 60.3 42.2 36.2-48.2 
CD3+CD8+ 36.2 53.8 48.8-58.7 
CD3+CD25+ 38.7 28.7 23.2-34.3 
CD3+HLA-DR+ 90.0 69.7 62.1-77.2 
Note: Percentages of leukocytes in the SGC pregnancy that are outside the 
ranges of the control normal term pregnancies are in bold. 
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In both the decidua parietalis of the SGC and normal term pregnancy, a similar 
percentage of CD3+ cells was found, 62.2% and 60.6% (95% CI=49.0-72.3). Of 
those CD3+ cells, the percentage of CD3+CD4+ cells was higher in the decidua 
parietalis of the SGC, 60.3%, than in the decidua parietalis of normal term 
pregnancies, 42.2% (95% CI=36.2-48.2). The percentage of CD3+CD8+ cells, on 
the other hand, was higher in the decidua parietalis of normal term pregnancy, 
53.8% (95% CI=48.8-58.7) than in the decidua parietalis of the SGC, 36.2%. 
Similar to the SGC decidua basalis, the percentage CD3+ expressing CD25 was 
increased in the SGC decidua parietalis, 38.7%, in comparison with that of 
normal term decidua parietalis, 28.7% (95% CI=23.2-34.3). Similarly, the 
percentage of CD3+HLA-DR+ cells was higher in the SGC decidua parietalis, 
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Table III. Percentage of leukocytes in term decidua basalis of SGC and normal 
term decidua basalis. 
SGC term  
decidua basalis 
(n=1) 
Normal term  
decidua basalis  
(n=20) 
95% CI 
CD45+ 50.8 35.3 29.3-41.4 
CD14+ 12.7 17.7 11.4-24.0 
CD3+ 40.6 55.4 51.1-59.6 
CD16+ 32.2 15.9 12.9-18.9 
Uterine NK cells 
(CD56+CD16-) 
31.8 11.0 8.5-13.4 
CD3+CD4+ 68.7 52.6 46.4-58.9 
CD3+CD8+ 30.1 43.2 38.0-48.4 
CD3+CD25+ 36.6 15.9 12.6-19.3 
CD3+HLA-DR+ 92.2 29.5 23.7-35.3 
Note: Percentages of leukocytes in the SGC pregnancy that are outside the 
ranges of the control normal term pregnancies are in bold. 
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DISCUSSION 
Results of this study show that in the setting of gestational surrogacy, there are 
greater percentages of CD56+CD16- uterine NK cells and activated CD3+ T cell 
expressing HLA-DR or CD25 in the SGC decidua basalis and parietalis in 
comparison with that of normal term pregnancy. Differences in leukocyte 
populations in gestational surrogacy and normal pregnancy suggest that the 
regulation and function of leukocytes may differ in these two settings. 
Contributing factors leading to these differences are unknown; however, there 
are several potential mechanisms. 
 
The difference in the percentage of T cells expressing HLA-DR or CD25 is most 
remarkable in the SGC decidua basalis, the site of implantation. This difference 
may be due to a strong immune response against fetal antigens or may serve as 
a mechanism to protect the allograft fetus. In normal pregnancy, there is recent 
evidence in the murine model that there is systemic tolerance of the fetus as 
maternal T cells acquire a transient state of tolerance to paternal antigens 
during pregnancy. Fetal antigen-specific T cells downregulate CD8 co receptors 
during pregnancy, resulting in reversible functional unresponsiveness to 
paternal antigens (23). T cells specific for fetal antigens decrease in an antigen-
specific manner during pregnancy and remain low postpartum (24). 
Furthermore, maternal regulatory T cells are expanded systemically during 
pregnancy in alloantigen-independent manner, and it is suggested that this 
population of cells is essential for the suppression of maternal immune 
aggression directed against the fetus (25). Locally, decidual leukocytes may be 
involved in maternal tolerance of the fetus. The CD3+CD25+ population was not 
further defined in this study, but it might well be that these cells represent both 
activated T cells and regulatory T cells. This will be the topic of investigation in 
further cases of SGC. 
 
The higher percentage of uterine NK and T cells expressing markers of 
activation in both the decidua basalis and parietalis in the SGC pregnancy could 
be due to the HLA differences between the SGC and fetus. In the current study, 
the SGC shares the paternal  HLA-A and -B antigens (A3 B7) with the fetus, but 
has a different HLA-DR allele, resulting in a fetus differing for both HLA-DR 
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alleles with the SGC. This additional difference or the lack of sharing of HLA-
DR allele with the mother could lead to a stronger maternal immune response, 
resulting in an increased percentage of activated CD4+ T cells. Despite this 
stronger immune response, pregnancy evolved uncomplicated.  
 
Interestingly, several studies indicate that sharing of human leukocyte antigens 
may affect the success of IVF. There is a highly significant excess of HLA 
sharing in couples where IVF treatment fails (17-19). Furthermore, HLA 
matching between couples is associated with spontaneous abortion (20, 21). 
Apparently, immune recognition of pregnancy is important for the maintenance 
of pregnancy. In fact, lack of immune recognition is thought to be deleterious to 
pregnancy (22). The differences in HLA sharing and the more intense immune 
activation observed may have been beneficial for the outcome of the SGC 
pregnancy. However, it is unclear whether a certain degree of HLA sharing 
between mother and fetus is necessity for a successful pregnancy. More studies 
stemming from this case report are required to elucidate the effects of IVF and 
HLA mismatches on the decidual cell population. 
 
Following allogeneic or autologous bone marrow transplantation, NK cells are 
among the first lymphocytes to repopulate the peripheral blood.  In some 
patients, up to 40% of peripheral blood lymphocytes are CD56brightCD16dim/- (26, 
27). It is suggested that these cells serve a unique functional role in the innate 
immune response as the primary source of NK cell-derived immunoregulatory 
cytokines (28). In pregnancy, CD56brightCD16−CD3− cells represent the major 
subset of NK cells in the uterus (2, 3). Trafficking, homing, or in situ 
proliferation have been implicated as possible mechanisms in the variation of 
uterine NK cells in the endometrium and decidua (29). Although the specific role 
of uterine NK cells is still unknown, it is suggested that they regulate placental 
development by mediating maternal mucosal and arterial function and fetal 
extraembryonic trophoblast invasion (30). It is plausible that there are 
important differences regulating uterine NK cell proliferation or function in the 
setting of gestational surrogacy compared to normal pregnancy. 
 
Generally, the IVF procedure is associated with a significantly worse perinatal 
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outcome than that of spontaneously conceived pregnancies. In pregnancy 
conceived by IVF as compared to naturally conceived pregnancy, there is 
increased incidence of vaginal bleeding, hypertension requiring hospitalization, 
intrauterine growth retardation, placenta previa, and preterm delivery (13, 14). 
Patients undergoing IVF, however, are on average older, more frequently 
primiparous than the normal obstetric population and are infertile or subfertile, 
conferring an additional risk of maternal and perinatal complications (15, 16). 
The outcome of IVF pregnancies in surrogate gestational carriers, who are 
generally healthy young fertile women, is not included in the abovementioned 
studies. In light of the current study, the IVF procedure, however, could have 
contributed to the higher percentage of activated cells and uterine NK cells. 
 
The study of the immunology of the uterus, an immune privileged site, has 
thrived in hopes of gaining a better understanding of tolerance induction in the 
setting of allogeneic organ transplantation. Over the last two decades, a wide 
array of studies has been performed on the immune components of normal early 
and term pregnancy with this goal in mind. While it has been noted that the 
comparison of pregnancy with tissue transplantation may be inaccurate and a 
misleading framework (31, 32), the setting of gestational surrogacy, 
nevertheless, is an interesting model in which to study the immunology of the 
maternal-fetal interface. The procedure, however, is relatively uncommon, 
making it difficult to obtain many samples of term decidual tissue. Although 
additional studies are necessary in order to confirm these findings, this study 
provides unique insight into the immunology and maintenance of pregnancy. 
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During pregnancy, the maternal immune system is functionally intact, capable 
of fighting infection and protecting from foreign pathogens. The fetus with a 
genetic makeup derived from both the mother and father, escapes immune 
rejection from the maternal immune system and is tolerated for the duration of 
pregnancy. The mechanism by which this phenomenon, known as the paradox of 
pregnancy, occurs is the central question in reproductive immunology and has 
been the focus of extensive research for the last fifty years. The solution to the 
paradox of pregnancy has many implications in the management and treatment 
of complicated pregnancy, infertility, assisted reproduction and allogeneic graft 
survival. To gain a better understanding of the paradox of pregnancy and local 
immunoregulatory mechanisms, we focused our studies on leukocytes at the 
maternal-fetal interface. Locally, the decidua basalis and parietalis may provide 
a special environment to mediate the delicate balance between fetal antigen 
presentation and maternal recognition and response. 
 
 
DIFFERENTIAL DISTRIBUTION OF LEUKOCYTES 
IN NORMAL TERM DECIDUA BASALIS AND PARIETALIS 
Our studies revealed that there are significant differences in the distribution 
and proportion of leukocytes when comparing decidua basalis and decidua 
parietalis derived from placentas of uncomplicated term pregnancies. In 
Chapters 2 and 3, flow cytometric quantification showed significantly higher 
percentages of CD56brightCD16- NK cells, CD3+ T cells expressing CD25, HLA-
DR, CD45RO, CD69 or TCRγδ in the decidua parietalis in comparison to the 
decidua basalis. Importantly, these differences suggest that the regulation of 
leukocytes in these two regions of the maternal-fetal interface and their in vivo 
function may differ. 
 
Mechanisms involved in differential distribution of decidual leukocytes 
The factors leading to the unequal distribution of NK cells, T cells expressing 
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activation markers and γδ T cells in the decidua basalis and parietalis are 
unknown. There are, however, several potential mechanisms. 
 
Differences between the two sites of the maternal-fetal interface exist. When 
comparing the placenta and fetal membranes, there are inherent differences in 
development, anatomy and histology (1). The placenta is the site of implantation 
and trophoblast invasion. The decidua basalis comes into direct contact with 
trophoblasts on the first day of implantation. The fetal membranes develop from 
the gestational sac and are not associated with invasion of trophoblasts. The 
decidua parietalis only comes into contact with trophoblasts after the fourth 
month of pregnancy. Macroscopically, these tissues appear very different. The 
placenta is vascular with a thick chorionic parenchyma containing several 
lineages of trophoblasts, while the fetal membranes are avascular with a thin 
chorionic membrane containing only extravillous trophoblasts. Furthermore, 
when comparing the two sites of the maternal-fetal interface, there is 
differential chorionic HLA expression (2). There are also differences in the 
cytokine microenvironment (3) and in the production of mediators, such as 
hormones and prostaglandins (4-11). Such differences could lead to or result 
from the differential distribution of cell types when comparing the two sites. 
Interaction of trophoblasts with decidual leukocytes could lead to altered 
function of either cell type resulting in differences between the decidua basalis 
and parietalis, including altered cytokine production or cell surface molecule 
upregulation or downregulation. These differences have important consequences 
for our understanding of the maternal-fetal interface. 
 
HLA expression 
A difference in the expression of HLA-C, HLA-E and HLA-G in tissue adjacent 
to decidua may account for the differential distribution. Through HLA 
expression, extravillous trophoblasts are capable of interacting with receptors 
expressed by uterine NK cells, T cell subsets and macrophages leading to 
activation or inhibition (12-17). It is plausible that differential HLA expression 
in the chorion of the placenta and fetal membranes leads to the inhibition or 
activation of leukocytes in the decidua. 
 
CHAPTER  8 
· 167 
Homing and maturation 
Another mechanism to account for the differential distribution of cells in the 
decidua, specifically the higher number of CD56brightCD16- uterine NK cells in 
the decidua parietalis may involve homing or maturation. It is plausible that 
there is homing of CD56bright cells from the maternal circulation to the decidua. 
A study on trafficking of NK cells shows that cells from secondary lymphoid 
tissues of pregnant mice can reconstitute uterine NK cells in NK-cell-deficient 
mice and that human peripheral blood CD56bright cells can adhere selectively to 
mouse uteri (18). Homing and recruitment of uterine NK cells to the maternal-
fetal interface may be mediated by adhesion molecules (18, 19, 20), by molecules 
expressed by trophoblasts, such as monocyte inflammatory protein (21), or by 
molecules expressed by NK cells, such as very late antigen-1 or CD49a (22). 
 
There is perhaps maturation from a uterine NK cell precursor in term decidua 
parietalis.  Significantly more γδ T cells are found in the decidua parietalis than 
in the decidua basalis. There has been considerable controversy concerning the 
expression of the γδ T-cell receptor on decidual T cells. The study by Mincheva-
Nilsson et al. suggests that extrathymic T-cell maturation occurs in the decidua 
of early pregnancy and that CD56+CD16- decidual NK cells are immature 
progenitors for T cells (23). The significant increase in γδ T cells and 
CD56+CD16- NK cells further suggests the potential and unique immunologic 
role of these cells in the decidua parietalis. 
 
Cytokine microenvironment and secreted mediators 
Differences in the cytokine microenvironment or presence of other secreted 
messengers between the two sites are potential explanations for the differential 
distribution. It has been suggested, for example, that uterine NK cell function 
varies in different areas of the decidua basalis; those cells which are in 
perivascular position are exposed to a different microenvironment than distant 
cells (24). In first trimester decidua, increased IFN-γ levels have been reported 
in the decidua basalis compared to decidua parietalis (3). Lastly, there is also 
differential expression of hormones and mediators like human chorionic 
gonadotropin (HCG) and pregnancy-specific glycoprotein (PSG) (4). PSG, part of 
the immunoglobulin superfamily, is selectively expressed in the membranes and 
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placenta and has been suggested to regulate T cell function during pregnancy 
(25). Estrogen and progesterone are produced by the placenta. These hormones 
are modulators of the innate and acquired immune responses (26, 27). It is 
plausible that there is differential expression of these hormones at the 
maternal-fetal interface. Lastly, numerous other messengers and peptides (5-11) 
also have differential expression when comparing the fetal membranes and 
placenta and may serve a potential role in the regulation of immune cells at the 
maternal-fetal interface. 
 
The significantly higher percentage of CD3+ T cells expressing CD25, CD69, 
HLA-DR, and CD45RO in the decidua parietalis indicated that T cells in this 
site may be activated in term pregnancy. Immunohistological and flow 
cytometric studies focusing on decidua of the first trimester have shown that 
various types of decidual lymphocytes are activated and produce cytokines (28-
37). Maternal T cells may promote and contribute positively to placental growth 
and trophoblast invasion (38). We extended these findings to suggest that 
regionally activated T cells in the decidua parietalis may play an important role 
in the maintenance of term pregnancy. Additionally, we examined peripheral 
blood samples for comparison with corresponding decidual samples for many of 
our subjects and found that were fewer CD3+ cells expressing markers of 
activation in peripheral blood, suggesting a possible difference in local and 
systemic immune regulation in pregnancy. 
 
Factors leading to the unequal distribution and activation of T cells in the 
decidua are unknown. Mediators, such as prolactin or indoleamine 2,3-
dioxygenase (IDO), are plausible candidates. Prolactin, known to be produced in 
the decidualized human endometrium, transported through fetal membranes, 
and secreted into amniotic fluid (39-41), induces cell proliferation and activation 
and is involved in the maintenance of immunocompetence (42, 43). Furthermore, 
prolactin receptors have been identified in the placenta and amnion (44). There 
are regional and periodic differences in prolactin gene expression in the decidual 
cells during pregnancy (45). Increased prolactin expression in the decidua 
parietalis could lead to T-cell activation. IDO, another important mediator, is 
synthesized and secreted by synctiotrophoblasts and catabolizes and degrades 
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tryptophan (46). Present in human placental villous explants, IDO has been 
shown to inhibit lymphocyte proliferation via tryptophan depletion (47-49). 
Increased IDO enzymatic levels or activity or lower levels of tryptophan in the 
decidual basalis are possible mechanisms for differences in T cells. In a study by 
Sedlmayr, IDO was irregularly localized in term placental samples to the 
mesenchymal core and found in isolated areas of the synctiotrophoblast (50). 
 
Fas-mediated apoptosis 
Selective Fas-mediated apoptosis is another plausible mechanism to explain 
lower percentage of activated T cells in the decidua basalis. Fas, a cell surface 
receptor of the tumor necrosis factor family (CD95), mediates apoptosis by 
binding FasL (51, 52). In a study by Hammer et al., apoptotic nuclei arising from 
CD45+ leukocytes were detected scattered within the entire functional stroma of 
the decidua parietalis. In the decidua basalis, the apoptotic leukocytes were 
irregularly distributed and concentrated in the area around necrotic nuclei and 
especially in the primary fetal-maternal contact zone where trophoblasts from 
the cell columns began to invade the maternal tissue (53). A recent study of first 
trimester decidua basalis indicates the FasL expression by maternal decidual 
cells is inversely related to Fas-expressing leukocytes in the same region (54). 
Maternal decidual cells may be involved in preventing recruitment of leukocytes 
at the maternal-fetal interface via Fas-mediated apoptosis and thus promote 
trophoblast invasion (54). In light of these studies, our studies suggest that 
there are fewer activated cells in the decidua basalis because these cells have 
been activated and then selectively programmed to die to allow trophoblast 
invasion. In the decidua parietalis, where there is no invasion by trophoblasts, 
but simply contact, the activated cells are not killed to the same extent by 
trophoblastic FasL. It is also plausible that there is perhaps a lower expression 
of Fas on T cells in the decidua parietalis or higher expression of FasL in the 
decidua cells of the fetal chorionic membrane. 
 
Contamination and technique 
It is unlikely that contamination of decidual samples by maternal peripheral 
blood or umbilical cord blood accounts for the regional differences in the two 
decidual sites. Primarily, tissue samples used in our studies were carefully 
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collected and thoroughly washed prior to cell isolation. This is a commonly 
described method to remove possibly contaminating maternal or fetal blood from 
the tissue. Secondly, in one of our uterine NK cell study, flow cytometric results 
were confirmed by immunohistochemical analysis, in which only cells located in 
the tissue and not in vessels were quantified. Additionally, the minor percentage 
of B cells found in both decidua basalis and parietalis and the lack of a 
significant difference between the percentages of B cells in the decidual sites 
suggests that circulating blood, which contains a higher percentage of B cells, 
did not appreciably contaminate decidual samples. We examined peripheral 
blood samples for comparison with corresponding decidual samples for many of 
our subjects and find that were fewer CD3+ cells expressing markers of 
activation in peripheral blood, suggesting a possible difference in local and 
systemic immune regulation in pregnancy. 
 
In our studies, data on decidual leukocytes was presented as a percentage of the 
CD45+ cell fraction. No significant difference in the absolute number of CD45+ 
cells in decidua basalis and decidua parietalis was found in any of our studies of 
normal term pregnancy. Therefore, data was presented as a percentage of the 
absolute number of CD45+ cells acquired within the flow cytometric gating 
window in order to better characterize the relative proportion of the other cell 
populations. Follow-up studies on decidual leukocytes within our group now use 
four color staining techniques with CD45 as one of the markers in every sample 
and show comparable results. 
 
Implications 
The possibility of differences between decidual cells in distinct areas of the 
placenta and fetal membranes has important consequences for in vitro studies of 
decidual leukocytes.  Numerous studies using decidua do not distinguish the 
difference between decidua basalis and decidua parietalis and do not indicate 
which tissue was used. Because of possible phenotypic and functional differences 
in the decidual leukocytes at the two sites, it will be important to clearly state 
the origin of decidua in future studies in the field. 
 
 
CHAPTER  8 
· 171 
PROPORTION OF LEUKOCYTES  
IN TERM DECIDUA BASALIS AND PARIETALIS 
Our studies verify that leukocytes are present in both the decidua basalis and 
decidua parietalis in term pregnancy. Specifically, uterine NK cells account for a 
substantial proportion of leukocytes in term decidua parietalis as confirmed by 
flow cytometry and immunohistochemistry, thus indicating that these cells, 
contrary to current belief, are not only restricted to early pregnancy. It is known 
that CD3+ lymphocytes are the most abundant lymphocyte population in term 
decidua basalis (55). We extended this finding to show that CD3+ lymphocytes 
are also the most abundant lymphocyte population in term decidua parietalis, 
and that these cells express markers of activation. 
 
Potential role of leukocytes in term decidua 
While it is well accepted that decidual leukocytes play an essential role in 
implantation and early pregnancy, the role of these cells in term pregnancy is 
less clear. Uterine NK cells in term pregnancy may serve to protect the 
fetoplacental unit from infection. NK cells are an important compenent of the 
innate immune system and potentially may reduce susceptibility to infection 
from viral or other foreign pathogens during pregnancy. While placentation has 
already been established by term pregnancy, it is plausible that the control of 
trophoblast invasion remains essential even in the third trimester. Decidual 
leukocytes may continue to control such invasion through cell-cell interaction, 
by creating the appropriate cytokine environment at the maternal-fetal 
interface and by maintaining immune recognition in pregnancy. 
 
 
FUNCTIONAL STUDY OF LEUKOCYTES  
IN TERM DECIDUA BASALIS AND PARIETALIS 
The function of decidual leukocytes is an important focus in order to understand 
the role of these cells in the maintenance of pregnancy. Using a one-way mixed 
lymphocyte culture in Chapter 5, we showed that these cells proliferate and 
produce cytokines in response to fetal and allogeneic cells, indicating that 
decidual leukocytes are capable of initiating and stimulating a classical 
alloimmune response. 
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It has been well established that decidual leukocytes from both first trimester 
and term pregnancy decidua do not proliferate in response to extravillous 
trophoblasts from the chorion or chorionic laeve (55, 56). To our knowledge, 
there are no previous studies that examine the proliferation of decidual 
leukocytes from early or term pregnancy in response to fetal UCB cells. In our 
study, a significantly higher proliferative response was seen when leukocytes 
from term decidua basalis and parietalis were cultured with UCB cells, cells of 
fetal origin, as compared to controls. It has been shown that UCB cells are 
capable of eliciting a proliferative response as stimulators in a MLC comparable 
to that of irradiated adult PBL (57). Although UCB cells essentially do not come 
into direct physical contact with decidual leukocytes as a result of anatomical 
separation, fetal cells of hematopoietic origin such as nucleated red blood cells, 
lymphocytes, and stem cells enter the maternal circulation during all 
pregnancies (58, 59, 60). Furthermore, it is of scientific interest to confirm that 
term decidual leukocytes are capable of eliciting an immune response against 
cells of fetal origin, a finding not previously reported. 
 
In our study, we also showed that in the decidua, alloreactive cells respond to 
HLA mismatched allogeneic PBL and towards UCB of the fetus. It is plausible 
that the mechanism by which decidual leukocytes recognize and mount an 
immune response may occur via the indirect pathway of allorecognition. 
Although it is suggested that the fetus escapes rejection from the maternal 
immune system by mechanisms involving HLA, KIR, and cytokines, these data 
suggest that there is a local role for regulatory mechanisms controlling the 
specific immune responsiveness to the fetus in which (CD4+CD25hi/bright) 
regulatory T cells may be involved. In preliminary studies performed by our 
group, analysis confirms the presence of this population in the decidua basalis 
and parietalis (61). Although it has been shown by others that early human 
pregnancy decidua contains functional CD4+CD25bright T cells (62), functional 
studies of term decidual regulatory T cells are currently ongoing. Term 
regulatory T cells could potentially serve as mediators in maternal tolerance of 
the fetal compartment by potently suppressing the activation and proliferation 
of CD4+CD25- T cells, CD4+CD25+ T cells, and also CD8+ T cells. 
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Interestingly, it has been shown that decidual leukocytes derived from first 
trimester decidua are not capable of proliferating in response to allogeneic PBL 
(32, 56, 63). In the study by King et al., no proliferative response was observed 
in decidual leukocytes from first trimester tissue cultured with irradiated 
allogeneic PBL as stimulators in a one-way MLC (64). In our functional study, 
we shown that decidual leukocytes from uncomplicated term pregnancy, in 
contrast to that described from early pregnancy, significantly proliferate in 
response to allogeneic PBL. The difference in the proliferative response of first 
trimester and term pregnancy decidua derived leukocytes against allogeneic 
PBL is likely due to a change in the distribution and proportion of the 
responsible immune cells. The varying proportion of cell types throughout 
pregnancy and their function could account for the difference in proliferation in 
response to allogeneic cells when comparing early and term pregnancy. 
 
 
ELECTIVE CESAREAN SECTION AND SPONTANEOUS VAGINAL 
DELIVERY 
To pursue our studies further, we compared leukocytes from decidua basalis and 
parietalis collected after spontaneous vaginal delivery (SVD) and cesarean 
section (CS) as described in Chapter 4. Our findings showed that labor also is 
associated with significant differences in the distribution and proportion of 
decidual leukocyte subpopulations within the CD45+ cell fraction, including a 
higher percentage of macrophages, CD56dimCD16+ NK cells and B cells and a 
lower percentage of CD3+CD4+CD25+ cells, CD3+CD4+HLA-DR+ and 
CD3+CD8+HLA-DR+ cells. 
 
Spontaneous labor at term can be described as a cascade of events that is 
associated with specific changes in leukocyte subpopulations, cell adhesion 
molecule expression and various immunologic mediators (65-68). A possible 
mechanism to account for the changes in decidual leukocytes following labor 
may involve migration of these cells to or from other tissue sites, such as to the 
cervix or myometrium or from peripheral blood (66, 69, 70). The decreased 
percentage of macrophages found in the decidua basalis and parietalis following 
labor may account for the presence of these cells in the cervix or myometrium. It 
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has been suggested that cell adhesion molecules are involved in the control of 
leukocyte infiltration in the cervix and myometrium during late pregnancy, 
cervical dilation and labor (67, 70, 71). 
 
The increased percentage of CD56dimCD16+ NK cells found in the decidua 
basalis and parietalis following labor may be mediated by specific signaling 
mediators, such as cytokines or chemokines. CD56dimCD16+ NK cells express 
chemokine receptors CXCR1, CXCR2, CXCR3, CXCR4 and CX3CR1 (72). It is 
also plausible that these cells are recruited from the peripheral blood where 
they represent the major NK cell subclass to the decidua during labor by 
chemokines. In the current study, there was a significantly higher percentage of 
CD19+ B cells in decidua basalis from SVD compared to that from CS. It is 
possible that labor preferentially attracts and activate B cells in decidua basalis. 
 
Importantly, a reduction in CD4+CD25+ T cells was observed when SVD samples 
were compared to CS samples. While these cells may represent a small 
population of regulatory T cells, we did not specifically distinguish these cells as 
regulatory T cells based on high CD25 expression. Theoretically, in the setting 
of labor, a decrease or disappearance of regulatory T cells from the decidua may 
enable the activated alloreactive CD4+CD25- and CD8+ T cells to reach their 





Normal placentation is critical for a successful pregnancy. Studies into the role 
of immune cells at the maternal-fetal interface may be beneficial for the 
management of pathologic pregnancies in which placentation is abnormal. Fetal 
trophoblasts must safely and accurately invade the maternal endometrium in 
order to establish the crucial uteroplacental circulation. This invasion is a 
highly delicate balance. Excessive invasion at the surface of the myometrium or 
muscle layer of the uterus is a condition known as placenta accreta. Excessive 
invasion into the myometrium is known as placenta increta, while through the 
myometrium is known as placenta percreta. Such disorders are associated with 
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maternal risks such as hemorrhage and even death. Inadequate invasion is 
associated with preeclampsia. Preeclampsia is a significant complication of 
pregnancy defined by hypertension, proteinuria, and edema, presenting during 
the second trimester, affecting approximately 5-8% of pregnancies (73). IUGR is 
also a clinically relevant complication of pregnancy associated with increased 
perinatal morbidity and mortality. It is characterized as a syndrome marked by 
failure to reach growth potential, affecting 3-7% of pregnancies and can present 
alone as idiopathic IUGR or in association with PE (74, 75). 
 
Because complications such as preeclampsia, placenta accreta, increta and 
percreta and IUGR may reflect complications in placentation much earlier in 
pregnancy, it is important to study the potential immunoregulatory mechanisms 
involved at the maternal-fetal interface in both early and term decidual tissue. 
One of our studies focused on the role of decidual leukocytes in IUGR and PE by 
quantifying the distribution and percentage of leukocytes in decidua basalis and 
parietalis from placentas associated with IUGR with and without PE and by 
comparing with normal term decidua in Chapter 6. Results showed significant 
differences in decidual leukocytes exist between IUGR with and without PE 
indicating a potential distinction in the role of these cells in the 
immunoregulation of each disease.  
 
While the etiology of PE and IUGR is not fully understood, it is suggested that 
immune dysfunction or maladaptation contributes to the pathogenesis of PE 
(76) and IUGR (77). Primipaternity (78), decreased sperm exposure (79), donor 
insemination (80), oocyte donation (81), family history (82) and genetic 
predisposition (83) confer an increased risk. Uterine NK cells also are implicated 
in the immune regulation of pathologic pregnancies. In a recent study by Hiby et 
al., HLA-C ligands on fetal trophoblasts and KIR on uterine NK cells are 
implicated as factors associated with PE (83). PE is significantly more prevalent 
in women who are homozygous for inhibitory KIR genes than in those who are 
heterozygous or homozygous for activating KIR. The increased prevalence in 
women homozygous for inhibitory KIR was due to pregnancies where the fetus 
expressed HLA-C ligands that were specific for inhibitory KIR. The study 
suggests that the absence of activating KIR favors PE and that an overly 
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inhibited uterine NK cell causes trophoblasts to prematurely cease remodeling 
of uterine blood vessels, increasing the likelihood of PE. 
 
Other pathologic complications associated with pregnancy and potentially or 
partially mediated by immune dysregulation include molar pregnancy and 
recurrent miscarriage. A molar pregnancy or hydatidiform mole is a gestational 
trophoblastic disease in which trophoblast cells proliferate abnormally. A 
complete hydatidiform mole is derived entirely from the paternal genome, is 
diploid with a 46,XX karyotype and characterized by generalized trophoblastic 
hyperplasia and no fetus. Because its chromosomes are entirely paternal in 
origin, a complete mole represents a fetal allograft rather than semiallograft 
and thus represents a unique setting in which to study the immunology of the 
maternal immune response. Studies have shown an increase in activated CD4+ 
T cells in decidua associated with complete hydatidiform moles compared with 
normal early pregnancy suggesting an altered maternal immune response 
against molar trophoblast (84). Recurrent miscarriage, usually defined as the 
loss of three or more consecutive pregnancies prior to 20 or even 28 weeks of 
pregnancy (85), also represents a complication in pregnancy and is another 
interesting model in which to study immune cells at the maternal-fetal 
interface. Studies on recurrent miscarriage or spontaneous abortion suggest 
that it is associated with an increase in CD56+ cells (86, 87) in peripheral blood 
and a concurrent decrease in CD56+ cells (88) and T cells (89) in the decidua. 
 
Assisted reproduction 
An important goal of understanding the immunology of the maternal-fetal 
interface is to improve the diagnosis and management of infertility with assisted 
reproduction. The setting of gestational surrogacy is an interesting model in 
which to study the topic and is described in Chapter 7. In this model, the 
surrogate typically has no genetic link to the fetus and is presented with not 
one, but two sets of mismatched histocompatibility antigens. Serving as an 
invaluable therapy for a woman with no uterus, a nonfunctioning uterus, or a 
contraindication to pregnancy, gestational surrogacy achieves fetal conception 
by using the gametes of the “infertile” couple, and the resulting embryo is then 
transferred to the hormonally primed uterus of the surrogate gestational carrier 
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(SGC). The fetus, thus, could be referred to as an “allograft” rather than a 
“semiallograft.” We reported the case of a surrogate gestational carrier and 
found that there are higher percentages of CD56+ CD16- uterine NK cells, and 
activated CD3+ HLA-DR+ and CD3+ CD25+ T cells in comparison to that of 
normal term decidua basalis and parietalis. Although further studies using this 
model are required to elucidate the function of these cells, this case report 
provides new insight into the immunology of the maternal-fetal interface. 
 
Ultimately, developing techniques to control mechanisms involved in maternal 
immune tolerance to the fetus would be highly beneficial in the clinical setting 
of obstetrics and transplantation. Such techniques may help overcome such 
complications as preterm labor, infertility, and preeclampsia. It appears that a 
specific balance of immune responsiveness is necessary to promote the normal 




In summary, our study establishes that there are significant differences in the 
distribution and function of leukocytes in term decidua basalis and decidua 
parietalis in the setting of normal term pregnancy, complicated pregnancy, and 
gestational surrogacy. To improve our understanding, it is important that future 
studies concentrate on mechanisms involved in the regional distribution, 
including a testable model to specifically study the interaction between 
leukocytes in decidua parietalis and amniochorion. An important focus may 
involve mediators in recruitment, proliferation and cell death at the maternal-
fetal interface. Functional studies using purified decidual cell populations are 
warranted to better understand the proliferative response against allogeneic 
and UCB cells. There is also interest in  further characterization of several cell 
populations, including NKT cells, dendritic cells, macrophages and γδ T cells, 
but most importantly the CD3+CD4+CD25+ regulatory T cell population, both 
phenotypically and functionally. could be an important focus of future research. 
Expectantly, the next fifty years of research in the field of reproductive 
immunology will prove to be as fruitful as the last fifty years, ultimately 
resulting in powerful advances in immunology, obstetrics and transplantation. 
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Tijdens de zwangerschap is het maternale immuun systeem intact. Het blijft in 
staat het lichaam tegen infecties te verdedigen. Merkwaardig genoeg ontsnapt 
de foetus tijdens de zwangerschap aan deze immuunafweer, hoewel de foetus 
voor de helft uit vaderlijke genen bestaat.  Het mechanisme achter deze paradox 
van de zwangerschap is de vraag waar het in de reproductieve immunologie om 
draait, en vormt de kern van uitgebreid onderzoek op dit gebied gedurende de 
laatste vijftig jaar.  Het vinden van de oplossing van deze paradoxale puzzel kan 
belangrijke implicaties met zich mee brengen voor de begeleiding en 
behandeling van gecompliceerde zwangerschappen, als ook voor 
vruchtbaarheidsbehandelingen en zelfs voor orgaanoverleving na 
transplantatie. Onze studies richtten zich op de leukocyten op het grensgebied 
tussen moeder en kind in de placenta om zo een beter begrip te verkrijgen van 
de immuunregulatie die daar plaatsvindt. De decidua basalis en parietalis 
zouden een belangrijke omgeving kunnen vormen die de delicate balans tussen 
het aanbod van foetale antigenen aan de ene kant en maternale antigeen 
herkenning en reactie aan de andere kant medieert.  
 
 
PROPORTIONELE VERDELING VAN LEUKOCYTEN 
IN DE NORMALE ÀTERME DECIDUA BASALIS EN PARIETALIS 
Onze experimenten laten significante verschillen in de proportionele verdeling 
van leukocyten zien in de decidua basalis in vergelijking met de decidua 
parietalis verkregen uit placenta's na normale, ongecompliceerde àterme 
zwangerschappen. In hoofdstuk 2 en 3 worden door middel van flow 
cytometrie leukocyten gekwantificeerd. Significant hogere percentages 
CD56brightCD16- NK cellen, CD3+ T cellen die tevens CD25 tot expressie brengen, 
HLA-DR, CD45RO, CD69, of TCRγδ worden aangetroffen in de decidua 
parietalis dan in de decidua basalis. Dit is een belangrijke bevinding die 
suggereert dat de immuunregulatie en de in vivo functie in deze foeto-maternale 
grensgebieden verschilt. 
SAMENVATTING 
188 ·  
De factoren die tot een onevenredige verdeling van NK cellen, geactiveerde T 
cellen en γδ T cellen in de decidua basalis en parietalis leiden zijn onbekend. Er 
zijn echter verscheidene mechanismen mogelijk: Er bestaan belangrijke 
verschillen tussen de twee foeto-maternale grensgebieden. Zowel anatomische, 
histologische als ook verschillen in de ontwikkeling moeten in acht genomen 
worden wanneer de placenta en de foetale membranen worden vergeleken (1).  
De placenta ontstaat waar de foetus zich innestelt in de uterus door middel van 
ingroei van trophoblasten. De decidua basalis komt in direct contact met de 
trophoblasten op de eerste dag van implantatie. De foetale membranen 
ontwikkelen zich uit de dooierzak en nemen niet deel aan de ingroei zoals 
trophoblasten. De decidua parietalis komt pas in direct contact met 
trophoblasten na de vierde maand van de zwangerschap. Macroscopisch zien 
deze weefsels er dan ook heel verschillend uit. De placenta is zeer 
gevasculariseerd en heeft een dikke laag chorion parenchym dat vele lagen met 
verscheidene soorten trophoblasten bevat. De foetale membranen zijn juist 
avasculair, en bestaan uit een dunne laag chorion die alleen 
extravilleuzetrophoblasten bevat. In verdere vergelijking tussen de twee 
plaatsen  waar foeto-maternaal  contact plaatsvindt, komt naar voren dat 
verschillend chorion HLA tot expressie komt in deze gebieden (2), als ook 
verschillen in productie van  cytokines (3), en andere mediatoren zoals 
hormonen en prostaglandines (4-11).   
 
Onze bevindingen hebben belangrijke consequenties voor in vitro studies naar 
de rol van deciduale leukocyten. De talloze studies die de decidua onderzochten 
maakten geen onderscheid tussen decidua basalis en de decidua parietalis.  
Vanwege phenotypische en functionele verschillen is het voortaan in publicaties 
in dit vakgebied uiterst belangrijk om duidelijk de oorsprong van de decidua aan 
te geven. 
 
Voorts bevestigt ons onderzoek dat uterine NK cellen een belangrijk deel van de 
leukocyten vormen in de àterme decidua parietalis en, in tegenstelling tot wat 
tot heden aangenomen werd, zeker niet alleen gelimiteerd zijn tot de vroege 
zwangerschap. Uterine NK cellen in àterme zwangerschap zouden een 
belangrijke rol kunnen spelen in de bescherming van de foeto-placentale 
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eenheid. NK cellen vormen een belangrijk deel van het aangeboren 
immuunsysteem en zouden mogelijk kwetsbaarheid voor infectie door virale en 
andere pathogenen kunnen verminderen tijdens de zwangerschap. Hoewel de 
placenta volgroeid is aan het eind van de zwangerschap, is het aannemelijk dat 
controle van de ingroei van trophoblasten essentieel blijft, zelfs in het derde 
trimester. Deciduale leukocyten zouden zeer wel de controle kunnen blijven 
uitvoeren op de ingroei door middel van directe cel-cel interactie of door het 
juiste cytokinemilieu te creëren in het foeto-maternale  grensgebied, of mogelijk 
ook door de antigenherkenning tijdens de zwangerschap te onderhouden. 
 
 
ONDERZOEK NAAR DE FUNCTIE VAN LEUKOCYTEN 
IN DE NORMALE ÀTERME DECIDUA BASALIS EN PARIETALIS 
De functie van leukocyten in de decidua basalis en parietalis verdient 
belangrijke aandacht om de rol van deze cellen beter te leren begrijpen in het 
onderhouden van de zwangerschap. Door middel van het toepassen van de 
zogenaamde “one-way mixed lymphocyte culture” techniek in hoodstuk 5 
hebben we aangetoond dat de deciduale leukocyten prolifereren en aangezet 
worden tot het produceren van cytokines wanneer zij in aanraking komen met 
foetale en allogene cellen.  
 
Het is wel bekend dat deciduale leukocyten verkregen uit eerste trimester 
zwangerschappen als ook uit àterme decidua geen proliferatie respons vertonen 
wanneer zij in aanraking komen met extravilleuze trophoblasten uit het chorion 
of het chorion membraan (12, 13). Er zijn ons geen studies bekend die 
onderzochten of er proliferatie van deciduale leukocyten verkregen uit vroege of 
àterme zwangerschap plaatsvindt, in respons op foetale navelstreng bloedcellen 
(UCB). In ons onderzoek was er een significant sterkere proliferatierespons van 
leukocyten van zowel decidua basalis als ook parietalis wanneer zij in 
weefselcultuur werden gebracht met UCB cellen, van foetale oorsprong, in 
vergelijking met controles. Voorts is het van wetenschappelijk belang dat hier 
tevens bevestigd wordt dat àterme deciduale leukocyten in staat zijn een 
immuunreactie te vertonen tegen cellen van foetale oorsprong, een vinding die 
niet eerder gerapporteerd was. 
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ELECTIEVE KEIZERSNEDE EN SPONTANE BEVALLING 
In vervolg op onze eerdere studies vergeleken we leukocyten uit de decidua 
basalis en parietalis verkregen na spontane bevalling en keizersnede zoals 
beschreven in hoofdstuk 4.  Onze resultaten suggereren dat het bevallen als 
zodanig geassocieerd is met significante verschillen in de distributie en 
proportie van subpopulaties van deciduale leukocyten binnen de CD45+ 
celfractie, alsmede hogere percentages macrofagen, CD56dimCD16+ NK cellen en 
B cellen en een lager percentage CD3+CD4+CD25+, CD3+CD4+HLA-DR+ en 
CD3+CD8+HLA-DR+ cellen. 
 
De spontane àterm bevalling kan beschreven worden als een opeenvolging van 
gebeurtenissen die geassocieerd is met specifieke veranderingen in de 
subpopulaties van leukocyten, celadhesiemolecuul expressie, en verscheidene 
immunologische mediatoren (14-17). Een mogelijk mechanisme dat de 
veranderingen in de deciduale leukocyten na een bevalling kan verklaren zou 
kunnen zijn dat deciduale leukocyten migreren naar andere weefsels zoals de 
cervix, het myometrium of naar de perifere bloedsomloop (15, 18, 19). 
 
KLINISCHE IMPLICATIES 
De pathologische zwangerschap 
Het vormen van een normale placenta is essentieel voor een succesvolle 
zwangerschap. Studies die de rol van immuuncellen op het foeto-maternale 
grensgebied onderzoeken kunnen belangrijk bijdragen aan het begrip en 
behandeling van pathologische zwangerschappen waarbij er verstoringen 
plaatsvinden in de vorming van een normale placenta, zoals het geval is bij 
preeclampsie (PE), en intrauterine groei vertraging (IUGR). Preeclampsie is een 
belangrijke complicatie van de zwangerschap die gedefinieerd wordt door hoge 
bloeddruk, proteïnurie en oedeem en presenteert zich meestal in het tweede 
trimester in ongeveer 5 tot 8% van de zwangerschappen (20).  IUGR is ook een 
klinisch relevante complicatie van zwangerschap en is geassocieerd met 
verhoogde perinatale morbiditeit en mortaliteit. IUGR wordt gekarakteriseerd 
als een syndroom dat leidt tot de sterk verminderde groei van de foetus, en komt 
voor in 3 tot 7% van de zwangerschappen. Het kan geïsoleerd voorkomen of in 
associatie met PE (21, 22). 
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Een van onze studies richtte zich op de rol van deciduale leukocyten in IUGR en 
PE, door de distributie en percentages van de leukocyten in de decidua basalis 
en parietalis te kwantificeren in placenta's verkregen van zwangerschappen met 
IUGR met en zonder PE in hoofdstuk 6. De resultaten laten zien dat er 
belangrijke verschillen bestaan in de distributie en percentages van deciduale 
leukocyten in IUGR met of zonder PE in vergelijking met normale 
zwangerschappen. Dit suggereert een mogelijk belangrijke rol van deze cellen in 
de immuunregulatie van deze aandoeningen. 
 
Vruchtbaarheidsbehandelingen 
Een beter begrip van de immunologie van het foeto-maternale grensgebied is 
een belangrijk doel dat kan leiden tot het verbeteren van de diagnostiek en 
behandeling van infertiliteit en mogelijk vruchtbaarheidsbehandelingen. Een 
interessant model is draagmoederschap zoals beschreven in hoofdstuk 7. In dit 
model heeft de draagmoeder geen genetische overeenkomst met de foetus en 
wordt in de baarmoeder geconfronteerd met niet één maar twee 
histocompatibiliteits antigenen (of meer) . Zowel de vaderlijke genen alsook de 
genen van de moeder, de donor van de eicel, zijn vreemd voor de vrouw die de 
vrucht in haar baarmoeder huisvest. De foetus kan in deze situatie dus als een 
“allograft” beschouwd worden in plaats van een “semi-allograft.” Wij 
rapporteren hier een casus van een draagmoeder en vinden hogere percentages 
CD56+CD16- uterine NK cellen en geactiveerde CD3+HLA-DR+ en CD3+CD25+ 
Tcellen in vergelijking met normale àterme decidua basilis en parietalis. Hoewel 
er meer onderzoek nodig is in dit model om de rol van deze cellen te begrijpen, 
geeft deze casus nieuw inzicht in de immunologie van het foeto-maternale  
grensgebied.  
 
Uiteindelijk kunnen hopelijk technieken ontwikkeld worden waarmee controle 
uitgeoefend kan worden op de mechanismen die van belang zijn voor de 
tolerantie van de moeder voor de foetus. Deze technieken zouden kunnen leiden 
tot belangrijke verbeteringen in het de klinische obstetrie en mogelijk in de 
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TOEKOMSTIG ONDERZOEK 
Samenvattend laat ons onderzoek zien dat er belangrijke verschillen bestaan in 
de functie en verdeling van  leukocyten in de àterme decidua basalis en decidua 
parietalis. Dit is het geval zowel in normale zwangerschappen, gecompliceerde 
zwangerschappen en bij draagmoederschap. Om  een beter begrip te verkrijgen 
zullen toekomstige studies zich moeten richten op de mechanismen die deze 
verschillen kunnen verklaren.  Vervolgonderzoek zal de aandacht moeten 
vestigen op mediatoren, mechanismen die tot het rekruteren, of prolifereren of 
zelfs celdood van de leukocyten op het foeto-maternaal grensgebied leiden. Het 
lijkt belangrijk met betrekking tot het doen van functionele studies om met 
gezuiverde, geïsoleerde celpopulaties uit te zoeken hoe de proliferatie reactie op 
allogenen en UCB cellen tot stand komt. Naast deze functionele studies zal ook 
het bestuderen van de cellulaire interactie op weefselniveau, met behulp van 
recent ontwikkelde, meerkleuren immunohistochemische technieken van belang 
zijn. Confocale microscopische technieken, waarmee verschillende cellulaire 
subpopulaties, in onderlinge interactie met elkaar, in beeld kunnen worden 
gebracht zijn wat dit betreft belovend.  Wij hebben ook interesse in het 
karakteriseren van de CD3+CD4+CD25+ regulatoire Tcel populatie, zowel 
fenotypisch als functioneel. Verder onderzoek naar andere subpopulaties zoals 
NKT cellen, dendritische cellen, macrofagen en γδ T cellen in de decidua basalis 
en parietalis tijdens zowel normale als gecompliceerde zwangerschap is nodig. 
Hopelijk zijn de volgende vijftig jaar onderzoek op het gebied van de foetale en 
maternale immunologie  net zo vruchtbaar als de afgelopen vijftig jaar. 
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